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Abstract 
Analysis of pharmaceuticals and biomolecules using HPLC coupled to ICP-
MS and ESI-MS 
Andrew James Cartwright 
The work described within this thesis explores the use of HPLC coupled with ICP-
MS and ESI-MS in order to develop novel methods which overcome specific 
analytical challenges in the pharmaceutical industry. 
A membrane desolvation interface has been evaluated for coupling high 
performance liquid chromatography (HPLC) with inductively coupled plasma mass 
spectrometry (ICP-MS). Desolvation of the sample prior to reaching the plasma 
was shown to facilitate a versatile coupling of the two instrumental techniques, 
enabling chromatographic eluents containing up to 100 % organic to be used. This 
interface also allowed gradient elution to be used with ICP-MS. 
Tris(2,4,6-trimethoxyphenyl)phosphonium propylamine bromide (TMPP) was used 
for the derivatisation of maleic, fumaric, sorbic and salicylic acids to facilitate 
determination by HPLC-electrospray ionisation tandem mass spectrometry (ESI-
MS/MS) in positive ion mode. Improvements in detection limits post-derivatisation 
were achieved, and this method was successfully used for the determination of 
sorbic acid in a sample of Panadol™. 
HPLC coupled with sector field inductively coupled plasma mass spectrometry 
(SF-ICP-MS) has been used for the determination of maleic, sorbic and fumaric 
acids after derivatisation with TMPP. This allowed 31 P+ selective detection to be 
performed for these compounds, which are normally undetectable by ICP-MS. 
Optimal reagent conditions for the derivatisation of 0.1 mM maleic acid were: 1 
mM TMPP; 10 mM 2-chloro-1-methylpyridinium iodide (CMPI); 11 mM 
triethylamine. The efficiency of the derivatisation reaction was estimated to be 
between 10-20%. Detection limits, estimated as 3 times baseline noise, were 
0.046 nmol for TMPP and 0.25 nmol for derivatised maleic acid, for a 5 f.JL 
injection. 
Following on from this, a novel derivatising reagent, tris(3,5-dibromo-2,4,6-
trimethoxyphenyl) phosphonium propylamine bromide (BrTMPP), was synthesised 
and subsequently characterised by proton NMR spectroscopy and ESI-MS. This 
was utilised to derivatise maleic acid, with a 9-fold increase in sensitivity gained 
when analysed by bromine selective detection as apposed to phosphorus 
selective ICP-MS. This derivatising reagent (BrTMPP) was also utilised to 
determine the degree of phosphorylation on phosphorylated peptides. A 
phosphorus containing carboxylic acid was successfully derivatised and the 
correct Br:P ratio was determined for this compound by ICP-MS. However, 
phosphorylated peptides were not successfully derivatised by BrTMPP. A 
combination of UV and phosphorus selective ICP-MS was also used to distinguish 
between phosphorylated and un-phosphorylated peptides after HPLC separation. 
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Chapter One 
Introduction 
1.1 Analytical Challenges in the Pharmaceutical Industry 
1.1.1 Research and Development of New Drugs 
The development of our understanding of disease processes and the resulting 
discovery of new drugs for their treatment has improved the quality of life 
throughout the world. lt is estimated the world-wide expenditures for ethical 
pharmaceuticals reached over $300,000,000,000 in 20001. In the US during 2000, 
sales of prescription drugs amounted to $112,000,000,000. According to the 
Pharmaceutical Research and Manufacturer's Association 1, $25,600,000,000 was 
invested during 2000 on the research and development for the next generation of 
pharmaceuticals. Unfortunately, even with this level of effort dedicated to the 
eradication of disease, it is estimated that only 1/3 of all diseases known can be 
causally treated and cured. 
The process of bringing a new medicine to market has evolved over the past 25 
years. Increased focus on more complex diseases and the production of more 
sophisticated drug delivery systems have increased the time needed for drug 
research and development. Over the same period of time, increased legislation 
has led to longer clinical trial periods resulting in extended times for a drug to 
reach the market. lt is estimated that the time taken to develop a new drug from 
the laboratory to FDA approval is between ten to fifteen years. For every new drug 
that is approved as a new medicine, it is estimated that approximately 5,000 fail. 
1 
This, together with the cost implications of the whole process, makes the 
development of a new drug a risky business. For these reasons, it is invaluable to 
a company that the process of research and development achieves as many new 
medicines in the shortest amount of time possible. This enables the manufacturing 
company to achieve the required sales to return the cost outlay whilst the drug is 
still under patent. Hence, much research is now being performed within 
pharmaceutical laboratories to improve and reduce the time taken to analyse 
samples to yield more confidence in the result in less time. This analysis can be 
anything from the initial drug candidates produced through combinatorial 
chemistry, to the biological fluids extracted throughout the phase 1-111 trials. 
1.1.2 Protection of Intellectual Property Rights 
Strong patent protection for pharmaceuticals drives medical progress by providing 
economic incentives for innovation. Without international respect for 
pharmaceutical patents, medical innovation would suffer. In fact, a 1988 study of 
12 industries estimated that 65 percent of pharmaceutical products would not have 
been introduced without adequate patent protection2. Without intellectual property 
protection in the pharmaceutical industry, nearly two-thirds of the important 
medicines available today (chemotherapy drugs, clot-busters that save the lives of 
heart attack patients, AIDS medicines, drugs that save the lives of premature 
babies and many others) would not have been developed. 
The underlying reason why pharmaceutical progress is dependent on intellectual 
property protection is the staggering cost of drug development. lt costs an average 
of $500 million to develop a new medicine 1. Perhaps in no other industry can an 
invention that costs so much to discover and develop be copied or reverse-
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engineered so inexpensively, at a small fraction of the innovator's research and 
development costs. Without strong patent protection, pharmaceutical companies 
could not attract the investment needed to conduct this expensive, high-risk 
research. 
Pharmaceutical manufacturers are facing increased risks related to counterfeit 
drug activities, including serious health risks, brand reputation risk, and adverse 
economic impact. Globalisation has sparked increased intellectual property rights 
(IPR) infringement activity. Consequently, IPR protection has become an urgent 
supply chain focus for multinational pharmaceutical companies producing and 
distributing medicines for global markets. 
IPR infringement takes the form of counterfeit goods (unauthorised use of a 
registered trademark or tradename), pirated goods (unauthorised use of copyright) 
and black market goods (genuine goods manufactured in a foreign country bearing 
a trademark and imported without the consent of the trademark owner). Such illicit 
activity costs the pharmaceutical companies billions of dollars in lost revenue and 
creates the potential for unquantifiable harm to the company brand and reputation. 
The availability of counterfeit medicines also increases risks to public health. 
Pharmaceutical products fall prey to IPR infringement because consumers are 
attracted to discounted prices, which provide criminals with financial incentives. 
Growing price differentials between the developed countries is causing the 
incidence of IPR infringement to increase. 
To protect their brand name and company profile, pharmaceutical companies are 
taking IPR infringement very seriously. A major problem in controlling IPR 
infringement is identifying it in the first place. The easiest way to detect an 
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infringement can occur on the packaging of the counterfeit goods. This can include 
spelling mistakes on the packaging, or even on the material itself. 
Many of the other methods of identifying infringement are to analyse the suspect 
material itself. These could be as simple as confirming that the active ingredient is 
that stated on the packaging to identifying fingerprints of excipients and impurities, 
to prove the material is not genuine. This process can be very specialised, and is 
highly secretive. For this reason, many pharmaceutical companies now have 
dedicated groups whose main responsibility is to confirm whether IPR has been 
infringed or not. 
1.1.3 Quality assurance and regulatory requirements 
Anyone working within the pharmaceutical industry will be aware that a great 
amount of their everyday work requires conformance of quality with standards 
dictated by various regulatory authorities3. These quality control procedures are 
essential to ensure the integrity of the product which will eventually be used by the 
patient. At all stages through drug production, from raw material testing through to 
testing of the final product, quality procedures must be adhered to. 
The pharmaceutical industry has some of the most stringent quality assurance 
procedures to conform to. This is because the general public do not have the 
required equipment to test their product; so much trust is put onto the 
manufacturers of the product they are using. When the medicine is given to 
patients it must have been appropriately manufactured, tested and packaged to 
assure thae: 
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• lt is the correct product. 
• lt is the correct strength/dosage. 
• lt has not degraded. 
• lt is free from harmful impurities and micro-organisms. 
• lt has not been contaminated. 
• lt is correctly labelled. 
• lt is properly sealed in a suitable container. 
To assure the quality of the product, quality must be built into each stage of the 
manufacturing process. Any factor that may have an effect on the quality of the 
final medicinal product must be controlled. The philosophy of quality assurance is 
that batch to batch consistency should be maintained by reducing variability of all 
supporting processes3. Hence, if these procedures control all of these factors and 
trained personnel follow these procedures, then a product consistently meeting its 
predetermined specification should be produced. 
According to the current International Conference on Harmonisation (ICH) 
guidelines, impurities and degradation products of pharmaceutical drug 
substances that exceed the threshold of 0.1% mass fraction relative to the active 
pharmaceutical ingredient (m/m) must be identified and qualified by appropriate 
toxicological studies4• This requirement has presented more challenges for 
pharmaceutical companies because methods have been developed for known 
target impurities, but many impurities may have been overlooked by the limitations 
of the analytical methods previously adopted. However, the introduction of Liquid 
Chromatography-Mass Spectrometry has resulted in increased confidence that no 
significant impurity has escaped attention. 
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1.2 Mass Spectrometry 
Mass spectrometry is now widely accepted as a crucial analytical tool for the 
analysis of organic molecules. Although it is regarded as a spectroscopic 
technique, it does not rely on the interaction with electromagnetic radiation for the 
analysis. Rather, it is a micro-chemical technique relying on the production of 
characteristic ions, followed by separation and detection of those ions3• Due to its 
operation, mass spectrometry is a destructive technique, unlike other techniques 
such as nuclear magnetic resonance (NMR), infrared (IR) and Raman/UV 
spectroscopies. However, mass spectrometry is so sensitive that molecular weight 
and structural information can be provided on very small samples (attomolar (10"15 
molar) amounts). 
Mass spectrometry is used in a variety of ways. lt can be interfaced with a wide 
variety of separation techniques (such as gas chromatography (GC), high 
performance liquid chromatography (HPLC) or capillary electrophoresis (CE) to 
name the most common ones) to give on-line analysis of mixtures. Its sensitivity 
allows detection, molecular weight determination and structural elucidation of 
minor components eluting from a column. As a quantitative technique it can be 
used as an assay tool, including the on-line monitoring for the optimisation of 
yields and minimisation of impurities3. 
The first mass spectrometer dates back to the work of J. J. Thompson in 1912, but 
the instrument that serves as a model for more recent mass spectrometers was 
built in 19325. The ionisation source of the mass spectrometer produces charged 
particles of the analyte molecule. The source can be chosen to yield varying 
degrees of fragmentation, i.e. ranging from complete atomisation and ionisation to 
the formation of molecular ions. The mass spectrometer then sorts these ions out 
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according to their mass to charge ratio (m/z). The mass spectrum is a record of 
the relative number of ions of different m/z which is characteristic of the analyte 
compound and its isomers6. 
Functionally, all mass spectrometers perform three basic tasks: 
• Create gaseous ion fragments from the sample; 
• Separate these ions according to their mass to charge ratio; 
• Measure the relative abundance of ions at each mass. 
To date, there is no universal design and configuration of mass spectrometer able 
to meet all analytical requirements7• For this reason, many different mass 
analysers and ionisation sources have been developed, with those most frequently 
used discussed in this introduction. 
1.2.1 Mass analysers 
The function of the mass analyser is to separate the ions produced in the ion 
source according to their mass/charge ratios. These ions are transported from the 
ion source to the analyser by a series of electrostatic lenses which accelerate and 
focus the ion beam. 
1.2.1.1 Magnetic sector mass analysers 
The magnetic sector analyser incorporates a magnetic field that causes the ions to 
be deflected along curved paths. As ions enter the magnetic sector analyser, they 
are subjected to a magnetic field applied parallel to the slits but perpendicular to 
the ion beam. This causes the ions to deviate from their initial path and curve in a 
circular fashion. A stable, controllable magnetic field (H) separates the 
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components of the ion beam according to momentum. This causes the ion beam 
to separate spatially and each ion has a unique radius of curvature or trajectory 
(R) according to its m/z. Only ions with a single m/z value will posses the correct 
trajectory that focuses the ion on the exit slit of the detector. By changing the 
magnetic field strength, ions with differing m/z values are focussed at the detector 
slit. To obtain a complete mass spectrum from a magnetic sector analyser, either 
the accelerating voltage (V) or the magnetic field strength (H) is varied. Each m/z 
ion from light to heavy is then focussed sequentially onto the detector, producing 
the mass spectrum. 
1.2.1.2 Double focusing sector mass analysers 
In a single-focusing magnetic sector instrument there is a lack of uniformity of ion 
energies, since the accelerating potential experienced by an ion depends on 
where in the source it is formed7. The result is peak broadening and low to 
moderate mass resolution. 
Double focusing magnetic/electrostatic sector instruments use magnetic and 
electrical fields to disperse ions according to their momentum and translational 
energy6• An electrostatic deflection field is incorporated between the ion source 
and the mass analyser. Ions are accelerated out of the source and are forced into 
a narrow beam by a set of slits. In these devices, the electric sector acts as an 
energy analyser, while the magnetic sector acts as a mass analyser'. With such 
instruments, resolving powers of the order of 1 05 can be achieved. 
8 
1.2.1.3 Time of flight mass analysers 
Time of flight (TOF) mass analysers operate in a pulsed mode rather than a 
continuous mode, so the ions are formed in the source as a discrete ion packet. 
These ion packets are then accelerated and introduced into a region that contains 
no external fields. This is known as the drift tube and is 30-100 cm long. The main 
principle behind TOF analysis is that if all ions with different masses are all 
accelerated to the same kinetic energy, with each ion acquiring a characteristic 
velocity depending upon its m/z ratio7. As a result, ions of different mass travel 
down the flight tube at different speeds, thereby separating spatially along the 
flight tube, with the lighter, faster ions reaching the detector up to 30 IJS before the 
heavier ions. 
1.2.1.4 Quadrupole mass analysers 
The quadrupole mass analyser is formed by four parallel electrically conducting 
rods arranged in a square geometrl. Opposite pairs of rods are connected 
electrically. A voltage made up of two components is applied to the rods; the first 
component is a standard DC potential, whereas the second is an alternating 
radiofrequency (RF) components. The result is the formation of an oscillating 
hyperbolic field in the area between the rods6. As ions pass through the z-axis of 
the quadrupole analyser, they experience traverse motion in the x- and y-planes 
and thus oscillate. If the ratio between the DC voltage and the RF field is kept 
constant, but both parameters are varied together, the ions of different m/z values 
can be analysed and a mass scan can be mades. 
The quadrupole mass analyser has certain advantages over magnetic sector 
instrumentss. These are: 
9 
• lt is relatively cheap to build 
• lt is smaller and lighter 
• lt is more robust 
• More accuracy is achieved in computer control of rod voltages rather than 
magnetic fields 
• Scanning is very fast 
1.2.1.5 Ion traps 
An ion trap is generally used in multi-stage mass spectrometry to help in 
characterisation studies. The ion trap can store ions for an extended period of time 
using electric and/or magnetic fields8. The most common traps consist of a central 
doughnut-shaped ring electrode and a pair of end-cap electrodes. A variable RF 
voltage is applied to the ring electrode, with the two end-cap electrodes connected 
to earth. Ions entering the trap through a hole in the end cap begin to oscillates. 
The RF voltage is then increased causing ions of increasing m/z to destabilise and 
leave the trap, where they are detected. 
1.2.2 Ionisation sources 
The ion source is that part of the mass spectrometer that ionises the material 
under analysis. The ions are then transported by magnetic or electrical fields to the 
mass analyser. Techniques for ionisation have been key to determining what types 
of samples can be analysed by mass spectrometry. The function of the ionisation 
source is to produce an ion, or ions representative of the analyte molecule. The 
most common process of ionisation is the removal of an electron which produces a 
positively charged molecular radical ions. 
10 
M---+ M++ e· 
Some ionisation sources also break down the analyte molecule into fragment ions, 
or in some cases totally dissociate the analyte molecule into its constituent atoms 
and ions. The way the ions are produced and the physical from in which the 
sample is presented to the ionisation source are the main differences between 
most ionisation sources. As there are many different ways to ionise samples, only 
the most frequently used techniques are discussed. 
1.2.2.1 Electron ionisation 
Electron ionisation (El, formerly known as electron impact) is an ionisation 
technique widely used in mass spectrometry. In an El source, electrons are 
produced through thermionic emissions by heating a wire filament that has an 
electric current running through ie. The electrons are accelerated through the 
ionisation space towards an anode. In the ionisation space, they interact with 
analyte molecules in the gas phase, causing them to ionise to a radical ion, and 
frequently cause numerous cleavage reactions that give rise to fragment ions, 
which can convey structural information about the analyte. 
The efficiency of ionisation and production of fragment ions depends strongly on 
the chemistry of the analyte and the energy of the electrons. At low energies 
(around 20 eV), the interactions between the electrons and the analyte molecules 
do not transfer enough energy to cause ionisation9. At around 70 eV, the de 
Broglie wavelength of the electrons matches the length of typical bonds in organic 
molecules (about 0.14 nm), and energy transfer to organic analyte molecules is 
maximised, leading to the strongest possible ionisation and fragmentation. Under 
these conditions, about 1 in 1000 analyte molecules in the source are ionised. At 
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higher energies, the de Broglie wavelength of the electrons becomes shorter than 
the bond lengths in typical analytes; the molecules then become "transparent" to 
the electrons, and ionisation efficiency decreases. 
1.2.2.2 Chemical ionisation 
As electron ionisation often leads to fragmentation of the molecular ion, chemical 
ionisation (Cl) is a detection technique that produces ions with little excess energy, 
generating a spectrum in which the molecular species is easily recognised. 
Chemical ionisation consists of producing ions through a collision of the analyte 
molecule with a large excess of a reagent gas present in the source9. Reactions 
between ions and molecules normally take one of the following forms6: 
• Proton transfer 
• Charge exchange 
• Electrophilic addition 
• Anionic abstraction 
M + XH+ --+ MH+ + X 
M + X+ --+ M+ + X 
M+ x+--+ MX+ 
MH + x+ --+ M+ + HX 
Proton transfer is by far the most common Cl process. The occurrence of such a 
reaction is related to the proton affinities of the analytes and reagent ion. If the 
proton affinity of the analyte is greater than that of the reagent ion, the proton 
transfer will occur. Typical reagent gases used for proton transfer Cl are hydrogen, 
methane, isobutene and ammonia with the proton affinity increasing 
H<CH4<C4H10<NH310. 
1.2.2.3 Fast atom bombardment 
Fast atom bombardment (FAB) is an ionisation technique in which an analyte and 
liquid matrix mixture is bombarded by an -8KeV particle beam of usually an inert 
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gas such as argon. This gas is ionised by a hot filament-type ion source, then 
accelerated in an electrostatic field, and focussed into a beam that bombards the 
sample. This Ar+ provides high kinetic energy as well as undergoing charge 
exchange with the solvent. Common matrices used in FAB include glycerol and 3-
nitrobenzyl alcohol (3-NBA). FABS is a relatively soft ionization technique and 
produces primarily quasimolecular ions such as [M+HJ'" and [M-Hr ions. 
1.2.2.4 Electrospray ionisation mass spectrometry (ESI-MS) 
The phenomena of electrospray has been known for hundreds of years, but it was 
not until the early parts of the 20th century that its significance to science was fully 
understood11 • Some 30 years later, the pioneering experiments by Malcolm Dole 
et a/. 12· 13 demonstrated the use of electrospray to ionise intact chemical species 
and the technique of electrospray ionisation (ESI) was invented. A further 20 years 
elapsed until work in the laboratory of John Fenn demonstrated the use of ESI for 
the ionisation of high mass biologically important compounds and their subsequent 
analysis by mass spectrometry14-16. This work won John Fenn' a share of the 2002 
Nobel Prize for Chemistry - the 4th time a Nobel Prize has been awarded to mass 
spectrometry pioneers. In the original papers from the late 1980's, Fenn and his 
eo-workers successfully demonstrated the basic experimental principles and 
methodologies of the ESI technique, including soft ionisation of involatile and 
thermally labile compounds, multiple charging of proteins and intact ionisation of 
complexes. Since that time, LC/ESI-MS has developed rapidly in applications, 
interface designs, in MS instrumentation and in computer software for analysis. 
'The prize was awarded jointly to John B. Fenn and Koichi Tanaka "for their development of soft 
desorption ionisation methods for mass spectrometric analyses of biological macromolecules" 
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The LC/ESI-MS literature is now extensive, with many reviews, special journal 
issues and books having been published17"22. 
The ESI source has undergone continued development since the earliest 
examples, but the general arrangement has remained basically the same (Figure 
1.1 ). The analyte is introduced into the source in solution either from a syringe 
pump or as the eluent flow from liquid chromatography. The analyte solution flow 
passes through the electrospray needle which has a high potential difference (with 
respect to the counter electrode) applied to it (typically in the range from 3 to 5 
kV)9· 23 . This forces the spraying of charged droplets from the needle with a 
surface charge of the same polarity as the charge on the needle. The droplets are 
repelled from the needle towards the source sampling cone or heated capillary on 
the counter electrode. As the droplets traverse the space between the needle tip 
and the cone, solvent evaporation occurs, assisted by a flow of warm nitrogen gas, 
(known as the drying gas) which passes across the front of the source. As solvent 
evaporation occurs the droplets shrink until they reach the point that the surface 
tension can no longer sustain the charge (the Rayleigh limit) at which point a 
"Coulombic explosion" occurs and the droplets are ripped apart. This produces 
smaller droplets that can repeat, and eventually solvent free, charged sample ions 
are released from the droplets24 . These charged analyte molecules (they are not 
strictly ions) can be singly or multiply charged. This is a very soft method of 
ionisation because very little residual energy is retained by the analyte upon 
ionisation, and this is why ESI-MS is such an important technique in biological 
studies, where the analyst often requires that non-covalent molecule-protein or 
protein-protein interactions are representatively transferred into the gas-phase. 
The major disadvantage of the technique is that very little (usually no) 
fragmentation is produced (although often this is desirable). For structural 
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elucidation studies, this leads to the requirement for tandem mass spectrometry 
where the analyte molecules can be fragmented. 
Heated stainless steel capillary 
Stainless steel electrospray capillary 
t 
+ 3-5 kV Sample solution 
High 
Atmospheric pressure 
vacuum 
Figure 1.1 Simplified diagram t of the Finnigan Matt LCQ ™ electrospray 
ionisation source with droplet and gas phase ion production. 
The advantages and disadvantages of ESI interfaces for production of gas-phase 
ions are subjective and often somewhat dependent on whether an existing, non-
MS based chromatographic method is being converted to a method based on LC 
with ESI-MS detection, or whether a new method is being developed for analytes 
that were not previously detectable by other methods. The following is a guide to 
some of the main advantages and disadvantages of ESI25: 
t Reproduced with permission from Dr. Paul McCormack 125) 
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Advantages: 
• Suitable for non-volatile, polar and thermally unstable compounds. 
• ESI-MS is sensitive (fmol or lower, dependent on analyte ). 
• Positive and negative ions can be produced. 
• Soft ionization produces mainly protonated molecules (or cation adduct 
ions) in positive ion mode and deprotonated molecules in negative ion 
mode allowing accurate molecular weights to be determined. 
• Optimum chromatographic resolution is not required if analytes that eo-elute 
have different m/z and do not cause ion suppression of one or other 
analyte. 
• Structural information can be determined from protonated molecules by 
collision induced dissociation (CID), collision activated dissociation (CAD) 
or resonance induced dissociation and multistage mass spectrometry 
(MS"). 
• Multiply charged ions can be produced, allowing ionised high molecular 
weight molecules to be within the mass to charge (m/z) range of most mass 
analysers. 
• Method is compatible with flow rates from nl min·1 to 1-2 ml min-1. 
• Method is concentration and mass sensitive. Flow splitting of LC eluents 
prior to ESt interface therefore does not reduce sensitivity (excluding peak 
broadening effects), thereby allowing conventional chromatography 
columns (4.6 mm diameter) with 1 - 2 ml min-1 flow rates to be used. The 
diverted eluent can be directed to other detectors for complementary data. 
• ESt is, or can be made, compatible with many LC techniques such as: 
reversed phase (RPLC), normal phase (NPLC), supercritical fluid (SFC), 
size exclusion (SEC), ion-exchange (IEC), affinity (AC), ion-pair (IPC), 
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hydrophobic interaction (HIC}, capillary electrophoresis (CE} and other 
electro-chromatography techniques. 
Disadvantages: 
• ESI is not compatible with high ionic strength solutions or high 
concentrations of involatile buffers/mobile phase modifiers used in many 
traditional chromatographic methods. ESI normally requires modification of 
such methods to allow the use of volatile reagents. 
• Many traditional chromatographic phases and methods require the analyte 
to be non-ionised, whereas ESI requires the analyte to be ionised in 
solution. Post column addition of acid/base to eluent may be required to 
adjust solution pH. 
• High purity solvents, reagents and chromatographic phases are required in 
order to reduce background chemical noise. 
• Soft ionization produces mainly protonated (or deprotonated) molecules. 
CID methods (in source or tandem instruments (MS/MS or MSn)) are then 
required to obtain structural information. 
1.2.2.5 Atmospheric pressure chemical ionisation 
Atmospheric pressure chemical ionisation (APCI) is a form of chemical ionisation 
which takes place at atmospheric pressure. The primary ions are produced by 
corona discharges on a solvent spray. The APCI technique is mainly applied to 
polar and ionic compounds with moderate molecular weights up to about 1500 Da 
and generally giving mono-charged ions9 . This ionisation technique allows for the 
high flow rates typical of standard bore HPLC to be used directly, often without 
diverting the larger fraction of volume to waste. This flow is directed into a 
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pneumatic nebuliser where it is converted into a fine aerosol by a high-speed 
nitrogen beam. After desolvation, these compounds are carried along a corona 
discharge where ionisation occurs. 
As the ionisation of the substrata occurs at atmospheric pressure with a high 
collision frequency, this method of ionisation is very efficient. In addition, the high 
frequency of collisions serves to thermalise the reactant species. The result is 
ionisation yielding predominantly ions of molecular species with few 
fragmentations. 
1.2.2.6 Matrix-assisted laser desorption Ionisation 
The ionisation is triggered by a laser beam, normally a nitrogen-laser. A matrix is 
used to protect the biomolecule from being destroyed by direct laser beam. The 
matrix consists of crystallised molecules, of which the three most commonly used 
are 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid), a-cyano-4-
hydroxycinnamic acid (alpha-cyano or alpha-matrix) and 2,5-dihydroxybenzoic 
acid (DHB). A solution of one of these molecules is made, in a mixture of highly 
purified water and an organic compound (normally acetonitrile or ethanol). 
The matrix-solution is then mixed with the analyte molecule of interest (e.g. 
protein-sample). The organic compound ACN allows for the hydrophobic proteins 
in the sample to dissolve into the solution, while the water allows for hydrophilic 
proteins to do the same. This solution is spotted onto a MALDI plate (usually a 
metal plate designed for this purpose). The solvents vaporise, leaving only the re-
crystallised matrix, but now with proteins spread throughout the crystals. The 
matrix and the analyte are said to be eo-crystallised in a MALDI spot. 
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The laser is fired at the crystals in the MALDI spot. The spot absorbs the laser 
energy and it is thought that primarily the matrix is ionised by this event. The 
matrix components are then thought to transfer part of their charge to the analyte 
(e.g. a protein), thus ionising the protein while still protecting it from the disruptive 
energy of the laser. Ions observed after this process are quasi-molecular ions that 
are ionised by the addition of a proton to [M+Ht, or another cation such as sodium 
[M+Nat, or the removal of a proton [M-Hr. MALDI generally produces singly-
charged ions, but doubly-charged ions such as [M+2H]2+ have been observed as 
well. 
1.2.2. 7 Inductively coupled plasma mass spectrometry 
Atmospheric-pressure inductively coupled plasmas (ICPs) are flame-like electrical 
discharges that have transformed the practice of elemental and isotopic ratio 
analysis26. The argon ICP has now become the most widely used atomic 
spectroscopy source in routine analytical chemistrf6. Much work on the 
development of the ICP source and the practical implications were originally 
addressed in the 1960's, with ICP-AES first explored in 196427• lt was a further ten 
years before ICP-MS was developed by Gral8. Further developments in the use 
of ICPs as an ion source for mass spectrometry were made by Date and Gral9· 30 
and Houk and Fassel31 in the 1980's. 
The ICP is generated by coupling energy from a radio frequency generator into a 
suitable gas via a magnetic field surrounding a water-cooled, three turn copper 
coil. The gas flows through a quartz torch which consists of three concentric tubes, 
and is mounted axially in the copper load coil (Figure 1.2). The generator operates 
at a frequency of 27 or 40 MHz to yield typical output powers of 1 to 2 kW. To 
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initiate the plasma, the gas streams are supplied with free electrons via a tesla 
coil. This produces a potential large enough to overcome the dielectric resistance 
of the gas, thus the electrons accelerate in the electric and magnetic fields 
associated with the load coil and ionise the gas in the field32• A stable, self 
sustaining plasma is maintained as long as the gas flows in a symmetrical pattern 
and the magnetic field strength is sufficiently high26. Importantly, the largest 
current flow occurs in the periphery of the plasma which gives the ICP a distinctive 
annular configuration. This ring type structure ensures the efficient introduction of 
sample aerosol into the central channel of the plasma resulting in the efficient 
desolvation, vaporisation, atomisation, excitation and ionisation of the sample. The 
ionisation conditions within the plasma lead to highly efficient ionisation of most 
periodic table elements, with almost all being singly charged. 
Liquid sample introduction is the most common way of introducing a sample into 
the plasma. Typical introduction systems consist of a nebuliser (e.g. concentric) 
and spray chamber (e.g. cyclonic). The process of nebulisation produces a fine 
aerosol of the liquid sample, with the spray chamber (which can be cooled) acting 
as a desolvation mechanism to remove the larger droplets. The nebuliser gas flow 
carries the finer droplets into the plasma where these undergo desolvation, 
vaporisation, atomisation, excitation and ionisation. 
The ICP is an extremely efficient ion source, thus the interfacing of this with mass 
spectrometry yields a highly sensitive and specific elemental detector. The 
problems related to the coupling of the two techniques stem from the fact that an 
ICP operates at atmospheric pressure, whereas a mass spectrometer requires a 
high vacuum. These problems were overcome by using a small cooled orifice to 
transfer the sampled plasma into the high vacuum system31 . The size of this orifice 
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is designed to ensure a continuous flow of analyte through the vacuum to the 
mass spectrometer. Ions pass from the central channel of the plasma through the 
sampling cone (a cone with a small orifice, 1.0 mm) and enter into a low vacuum 
region called the transfer/expansion chamber. A small percentage of these ions 
then pass through a second cone (skimmer, 0.7 mm) into a second, high vacuum 
region, where the ion beam is focused by a series of ion lenses. This focused ion 
beam passes to the mass spectrometer where the ions are separated by their 
mass to charge ratio and then detected by an electron multiplier or other similar 
detector. 
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Figure 1.2 Schematic of a quadrupole ICP-MS instrument 
1.2.3 Qualitative Mass Spectrometry 
Initially organic mass spectrometry was primarily a tool for analysing unknown 
compounds to provide clues to their structures33. Now, the mass spectrometer can 
be used qualitatively to provide the analyst with much more information about the 
sample than just the molecular weight information. Structural elucidation is 
required in all areas of drug development. Within chemical development it is 
needed to identify impurities which may arise throughout the synthesis. 
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1.2.3.1 Determination of molecular weight 
Although this procedure sounds simple, this process is full of potential pitfalls to 
catch the analyst out. Due to the soft ionisation procedure used, the molecules 
remain generally intact, but may also pick up other cluster ions/adduct ions to form 
clusters. The most commonly observed are those with sodium (M + Na+), 
potassium (M + K+) and ammonium (M + NH4 +). When these clusters are formed, 
the mass of the analyte is not the mass observed, but the mass of the analyte plus 
the cluster ion. Analysts must be careful to identify these clusters. 
1.2.3.2 Collisionally induced decomposition and MSn 
The generation of an ion related to the intact molecule is useful, but on its own 
tells us little about the structure. In order to study the structure of this ion, we need 
to look at the various components making up the ion. This involves the 
fragmentation of the molecule using a collision gas in a collision cell, or an input of 
RF voltage to generate fragmentation. These fragmentations can be controlled by 
the amount of collision gas or voltage to enable different fragments to be formed. 
These fragments can then be fragmented again to yield multi-stage fragmentation 
(MSn). Together this information can be interpreted to provide information about 
the functional groups present, thus aiding the analyst with structural information. 
1.2.3.3 Accurate mass measurement 
High resolution instruments, including double focusing and Fourier transform ion 
cyclotron resonance (FTICR) mass spectrometers are capable in principle of 
measuring the mass of an ion with sufficient accuracy to allow the determination of 
its elemental composition9. This is possible because each element has a slightly 
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different characteristic mass defect, so the accurate mass measurement that 
shows the total mass defect provides an identification of its elemental composition. 
However, the accuracy requirements in measuring mass and thus the resolution 
requirements increase very rapidly as the mass increases9. For example, C24H,9N 
and C2,H23S with masses of 321.1517 and 321.1551 m/z respectively, require an 
accuracy of 11 ppm for their distinction. 
1.2.4 Quantitative mass spectrometry 
Mass spectrometers are specific detectors and the substantial reduction in noise 
allows sensitive detection and quantitation of analytes even in complex matrices 
such as biofluids or formulated tablets3• The degree of specificity of quantitative 
analysis depends on how the spectrometer is used and even more so on the 
signal that is used during the correlation9. For example, the ion current can be 
used as a signal to determine the concentration of a compound that is studied as 
long as there are no interferences with other substances. 
In mass spectrometry, the limit of detection depends considerably on the 
abundance of the ionic species that is measured. These can therefore be 
dependent on the modification of ionisation conditions, the mode of operation 
(positive or negative ion mode) and the ionisation technique. For some 
compounds, sensitivities (detection limits) in the range of low pg ml·1 are 
achievable. 
The errors in measurement arising due to the mass spectrometer are numerous, 
such as the variation in source conditions and instability of the mass scale. For 
statistical reasons, every measurement of a signal intensity carries a minimal 
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intrinsic error. This error is inversely proportional to the square root of the number 
of ions detected for that signal. Thus, in order to optimise the reproducibility or the 
precision of the measurements, a maximum number of ions must be detected for 
every ionic species. These errors can be reduced by using an internal standard, or 
using an isotope dilution method. 
To perform quantitative measurements using mass spectrometry, generally a 
standard of the compound of interest is needed. This can be introduced into the 
mass spectrometer at varying concentrations to produce a calibration curve for 
that specific compound. The use of an internal standard can improve the 
calibration, e.g. it can compensate for the effects of variation in small injection 
volumes and ionisation phenomena. The major drawback of this method is the fact 
that a specific standard of the analyte of interest must be used. The one exception 
to this is when JCP-MS detection is employed. As this is an element selective 
detection, then standards containing that specific element can be used. For 
example, if dichlorobenzene was to be quantified, a calibration curve could be 
produced using any standard with chlorine within the molecule. 
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1.3 High Performance Liquid Chromatography - Electrospray 
Ionisation Mass Spectrometry 
1.3.1 High Performance Liquid Chromatography (HPLC) 
The general principle of chromatography has been known for many years and 
involves two immiscible phases, one stationary and the other mobile which are 
brought into contact. A sample is introduced into the mobile phase and solutes in 
the sample undergo a repeated series of partitions between the mobile and 
stationary phases. When these phases are properly chosen, the solutes present in 
the sample separate into distinct bands in the mobile phase and emerge in order 
of increasing interaction with the stationary phase. Chromatography has many 
applications from purification to separation of mixtures and can be used with on or 
off-line detection techniques for qualitative and quantitative analysis. 
Prior to the 1970's, few reliable chromatographic methods were commercially 
available to the laboratory scientist. During the 1970's, most chemical separations 
were performed using a variety of techniques, including open-column 
chromatography, paper chromatography, and thin-layer chromatography. 
However, these chromatographic techniques were not ideally suited for 
quantification of compounds and resolution between similar compounds. During 
this time, pressure liquid chromatography began to be used to decrease flow-
through time, thus reducing purification times of compounds being isolated by 
column chromatography. 
High pressure liquid chromatography (as it was known then) was developed in the 
mid-1970's and quickly improved with the development of column packing 
materials and the additional convenience of on-line detectors. In the late 1970's, 
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new methods including reversed phase liquid chromatography allowed for 
improved separation between very similar compounds and it is this technique 
which has been used throughout the experimental chapters of this thesis so a brief 
description of this follows. 
1.3.1.1 Reversed phase HPLC 
Reversed phase chromatography is used to describe the state in which the 
stationary phase is less polar than the mobile phase34. Chemically bonded 
octadecylsilane (ODS), an n-alkane with 18 carbon atoms, is the most frequently 
used stationary phase. Shorter alkyl groups including ethyl (C-2), Octyl (C-8) and 
also cyclohexyl and phenyl groups provide other alternatives to aid 
chromatographic separation of compounds. The mobile phase (eluent) generally 
consists of mixtures of water or aqueous buffer solutions with various water 
miscible solvents, e.g. methanol and acetonitrile. The type of mobile phase used 
may have a big effect on the retention. lt can promote or suppress ionisation of the 
analyte molecules, and it can also shield an accessible residual silanol or any 
other active adsorption centres on the adsorbent surface. 
In reversed phase chromatography partition occurs between the bonded organic 
phase and mobile liquid phase. Let us consider a separation of a two component 
mixture dissolved in the eluent. Assume that component A has the same 
interaction with the adsorbent surface as the eluent, and component 8 has strong 
interaction with the stationary phase. On injection onto the column, these 
components will be forced through by the flow of the mobile phase. Molecules of 
the component A will interact with the adsorbent surface and retain on it in the 
26 
same way as eluent molecules. Thus, as an average result, component A will 
move through the column with the same speed as the eluent. 
Molecules of component B, being adsorbed on the stationary phase due to their 
strong excessive interactions will interact with it much longer. Thus, they will move 
through the column slower than the eluent flow. This will result in two distinct 
separated peaks. The first peak to elute will be from component A, which has the 
same interaction with the stationary phase as the eluent. The second peak to elute 
will be compound B. This elutes later because it had been interacting with the 
stationary phase, and has thus been slower to move through the column. 
Usually a relatively narrow band is injected (5- 20 !JL injection volume). During the 
run, the original chromatographic band will be spread due to the non-even flows 
around and inside the porous particles, slow adsorption kinetics, longitudinal 
diffusion, and other factors. These processes together produce so called band 
broadening of the chromatographic zone. In general, the longer the component is 
retained on the column, the broader its zone (peak on the chromatogram). 
Separation performance depends on both component retention and band 
broadening. Band broadening is, in general, a kinetic parameter, dependent on the 
adsorbent particle size, porosity, pore size, column size, shape, and packing 
performance. On the other hand, retention does not depend on the above 
mentioned parameters, but rather reflects molecular surface interactions and 
depends on the total adsorbent surface. With the continuous improvement of 
column packing materials, these band broadening effects are becoming less 
apparent with newer columns. 
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The retention of the analyte depends on it's affinity to the mobile phase and 
stationary phase, so extensive method development, requiring changing the 
stationary and mobile phases is often necessary to enable adequate resolution 
between analytes. As a general rule for reversed phase chromatography, polar 
substances interact better with the mobile phase and elute first, as the 
hydrophobic character of the analyte increases, retention increases34. 
1.3.2 HPLC coupled to mass spectrometry 
The need for more definitive identification of HPLC eluates than that provided by 
detectors such as UVNis and refractive index lead to the evolution of mass 
spectrometry as a HPLC detector. Initially, the combination of the two techniques 
involved the isolation of fractions as they eluted from the HPLC column, followed 
by the removal of the mobile phase, generally by evaporation, followed by mass 
spectrometry detection35. This obviously has inherent disadvantages due to loss of 
analyte during fraction collection, mixed spectra from unresolved peaks, thermal 
decomposition of analytes with evaporation, and the ionisation technique needs to 
be chosen very carefully5. Direct coupling of HPLC to mass spectrometry 
alleviates many of these problems, but can suffer from incompatibility between the 
two techniques. The major problems are the need to remove much of the HPLC 
mobile phase before entry into the mass spectrometer, and the requirement for the 
formation of volatilised ions from involatile and highly polar analytes. This has lead 
to a number of interfaces being developed, including direct introduction, moving-
belt, thermospray, atmospheric pressure chemical ionisation (APCI) and 
electrospray ionisation (ESI). Some of the earlier interfaces did not lend 
themselves to routine analysis, but the introduction of APCI/ESI systems in the 
1990's has pushed the boundaries of LC-MS and the technique has become 
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widespread with hundreds of applications for both quantitative and qualitative 
analyses. 
1.4 Liquid chromatography with Mass spectrometry in the 
pharmaceutical industry 
There are many applications of LC-MS within the pharmaceutical industry such as 
impurity identification, characterisation, analysis of waste effluents and clinical trial 
metabolites. These can be brought together into two categories namely qualitative 
and quantitative analysis. LC-MS has high sensitivity, thereby reducing the need 
for time-consuming preparative chromatography, and thus enabling impurities to 
be detected at the 0.1% area ratio level (relative to the main compound) online. 
Small molecules (less than 150 Da) are not easily amenable to trace analysis by 
LC-MS, due to the high background signal resulting from mobile phase impurities, 
ion adducts4 and the large signal of the main peak. Wolff et a/.36 reported the use 
of a signal actuated switching valve for diverting the main matrix compound to 
waste, hence preventing it from entering the mass spectrometer and ensuring that 
the large chemical background resulting from the tailing of the main component did 
not affect later eluting impurities. This improved the detection limit for the trace 
impurities eluting after the drug substance by a factor of 4-5. The increase in 
sensitivity was dependent on the type of ion source which was used to interface 
the mass spectrometer. The limit of detection was improved by a factor of 10 with 
a line of sight type source but only by a factor of 5 with the orthogonal source. 
The introduction of new instrumentation including tandem mass spectrometry 
(MS") and high resolution instruments has resulted in large advances in qualitative 
analysis. Tandem mass spectrometry involves at least two stages of mass 
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analysis, usually with a dissociation process or chemical reaction that causes a 
change in the mass or charge of an ion9. In the most common MS/MS experiments 
the first mass analysis isolates a precursor ion which then undergoes 
fragmentation to yield product ions. These product ions are subjected to a second 
mass analysis and then detected. This can be repeated 'n' times to yield MS" 
experiments. At each stage, the analyte molecule and product ions are further 
fragmented leading to data where functional groups have been removed. By 
piecing together this data, and using knowledge of the possible components of the 
injected sample, a tentative structure can be deduced, which will need to be 
confirmed by other spectroscopic techniques such as IR, Raman and NMR. 
Accurate mass measurement of small molecules is used to determine the 
elemental formulae of an unknown compound. The higher the accuracy, the less 
the ambiguity in the resule7. Accurate mass measurements can be performed 
using a variety of mass spectrometers. Fourier transform ion cyclotron resonance 
mass spectrometry (FT-ICR-MS) offers the highest mass resolution and mass 
accuracy of any mass spectrometer with a mass resolving power in excess of 1 x 
106 and mass accuracy of 1 ppm. A number of reports have demonstrated that 
high accuracy mass measurements can be recorded using quadrupole-TOF mass 
spectrometers. Wolff et a/.38 achieved mass measurement accuracy to within 2 
mDa of the theoretical values for the identification of impurities in drug substances. 
The high level of mass accuracy obtained using these instruments enables a 
molecular formula to be obtained, which can then be used in conjunction with 
libraries and knowledge of the possible contents of the sample, to determine the 
structure of the compound. 
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1.5 Liquid Chromatography Inductively Coupled Plasma Mass 
Spectrometry (LC-ICP-MS) 
1.5.1 Chromatography coupled to ICP-MS 
Inductively coupled plasma mass spectrometry (ICP-MS) is now recognised as 
one of the most useful and powerful techniques for element selective detection of 
trace elements in chromatographic eluents39• The sensitivity and selectivity of this 
method of detection enables the analysis of both metals and non-metals in a wide 
variety of samples. The use of ICP-MS as a chromatographic detector was initially 
described in the late 1980's and, since that time, the versatility of the detector has 
been realised for many chromatographic applications. Many papers which 
describe ICP-MS as a chromatographic detector are specifically aimed at 
speciation analysis, which is used to determine the chemical form of an element in 
a sample. 
Various separation techniques have been utilised for both multi-element and 
elemental speciation analyses including liquid chromatography, gas 
chromatography, supercritical fluid chromatography and capillary electrophoresis. 
Many papers have been published within the last 15 years utilising these 
separation techniques with ICP-MS detection, and a comprehensive review has 
been published by Sutton et al. 39 
Traditional detectors for LC, such as UVNis absorbance and refractive index 
detectors, lack the sensitivity that is required for the determination of elements in 
environmental and biological samples40. To some degree, ICP-MS overcomes this, 
and can offer improvements in sensitivity up to three orders of magnitude 
31 
depending on the element under study. ICP-MS is an element selective detector 
so the mass spectrometer is usually set to monitor the isotopic signal of an 
element or several elements either sequentially or simultaneously, thus the 
resulting chromatograms only show peaks for the element/isotope of interest. This 
is a distinct advantage over detectors such as UVNis absorbance, which yield 
chromatograms of all species absorbing at the specified wavelength. 
Mobile phase flow rates used in most chromatographic separations are of the 
order of 0.1 to 1 ml min"1 39. These are comparable to the direct aspiration rates of 
standard ICP-MS nebulisers. Thus, conventional pneumatic nebulisation with 
concentric and cross-flow nebulisers may be used along with single or double-
pass spray chambers. To connect the LC outlet to the ICP-MS sample introduction 
system, a simple piece of inert tubing of PEEK or PTFE may be used. The internal 
diameter and length of this tubing should be kept to a minimum to ensure that 
minimal peak broadening is experienced. 
Conventional nebulisers and sample introduction systems are relatively inefficient 
because only 1-3% of the actual sample enters the plasma39. Hence, an increase 
in this efficiency would improve the sensitivity of the technique and lower the limits 
of detection. Nebulisers with higher transport efficiencies have been described for 
LC-ICP-MS such as the Micro Mist41 and the Direct injection high efficiency 
nebuliser42 . 
Reversed-phase chromatography coupled with ICP-MS has now become widely 
established for the analysis of environmental samples and general analytical 
samples. Atomic spectroscopy methods generally determine the total 
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concentration or amount of the element(s) of interest. If more information about the 
speciation of the element(s) is required then a coupled technique is necessary. By 
coupling reversed phase liquid chromatography (RPLC) with ICP-MS these 
speciation analyses are possible with excellent sensitivity and selectivity. 
One issue to consider when coupling reversed phase HPLC with ICP-MS is that 
the introduction of organic solvents changes the sensitivity of the ICP-MS and 
deposition of unburnt carbon on the sampler and skimmer cones can cause 
blocking43• These problems can be overcome to a certain degree by the addition of 
a small amount of oxygen to the nebuliser gas flow and operating the plasma at 
higher powers. The underlying problem is that organic solvents have a higher 
vapour pressure which leads to an increased solvent loading on the plasma 44 • An 
increased solvent load reduces the stability of the plasma and adversely affects 
the electron number density, ionisation and excitation temperatures of the plasma 
45
• Thus, the chromatography required for the separation could involve the use of 
eluents which will extinguish the plasma and limit the versatility of ICP-MS as an 
HPLC detector. This problem is discussed in more detail in Chapter Two. 
1.5.2 Applications of HPLC-ICP-MS in the pharmaceutical industry 
Axelsson et a/.46 reported the use of LC-ICP-MS as a generic detector for 
structurally non-correlated compounds with common elements like phosphorus 
and iodine. The use of this element selective detection resulted in improved 
quantification of tested 'unknowns' compared to UV and organic mass 
spectrometry. They reported that the dynamic range was found to exceed 2.5 
orders of magnitude. This application of LC-ICP-MS to pharmaceutical drugs and 
33 
formulations has shown that impurities can be quantified below the 0.1 mol-% 
level. 
For identification and quantification of impurities in pharmaceutical products, new 
methods with high sensitivity and ease for calibration are required. Usually 
HPLC/ESI-MS is applied for this purpose, but quantification is hampered because 
the ionisation efficiency depends on the chemical structure and is therefore 
restricted to those compounds where standards are available. Busker et a/. 10 
described how HPLC/ICP-MS could be used as an element specific method for 
quantitative phosphorus determination even without standards for those 
compounds. This is possible because phosphorus sensitivity is independent of the 
specific chemical structure, so other phosphorus compounds with similar retention 
times can be used for quantification. This is one of the major advantages of ICP-
MS as a quantitative detector for HPLC. 
Traditionally, ICP-MS has been used to determine low levels of trace elements in 
environmental samples. Due to its high sensitivity, selectivity and sample 
throughput, ICP-MS is able to determine most elements in the periodic table 
simultaneously in the range of pg L-1 to IJg L-1 for a wide range of samples40• In the 
pharmaceutical industry, metal contamination of bulk drug substances and their 
intermediates may be introduced in many ways, including raw materials, reagents, 
solvents, catalysts and plumbing47. For regulatory approval, these metals must be 
monitored and their concentrations established for both process intermediates and 
final drug substances. Traditionally the pharmacopoeia! methods involve the 
precipitation of metal sulphides, followed by visual comparison of the colour. This 
method suffers from some obvious limitations. The technique of choice to 
determine the metal content of pharmaceuticals has become ICP optical emission 
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spectroscopy. Similarly, the introduction of commercial ICP-MS instrumentation 
with published methods will lead to the use of ICP-MS analysis in many 
pharmaceutical quality control laboratories. The ability of the technique to 
determine many elements in a single analysis enables many samples to be 
analysed, and makes a less laborious analysis. Lewen et al.48 have developed and 
utilised an ICP-MS method to specifically detect and quantify 14 different metals in 
a single run for nearly 60 different pharmaceutically important sample matrices. 
The described method also demonstrates superior recoveries when compared to 
the corresponding pharmacopoeia! methods. An alternative method has been 
published by Wang et al. 47 who have used ICP-MS to determine and quantify up to 
69 elements simultaneously for pharmaceutical samples. 
Other pharmaceutical applications have recently been developed utilising ICP-MS, 
but these have not been as wide spread as those for high-throughput trace 
element analysis. Kannamkumarath et al. 49 utilised the element selectivity of ICP-
MS with iodine selective detection to compare its limits of detection against UV to 
determine levothyroxine and its degradation products after HPLC separation. ICP-
MS detection improved the detection of these compounds by 175-375 times when 
compared with UV. Lam et al. 50 utilised laser ablation (LA) technology to analyse 
pharmaceutical tablets by ICP-MS. This removes the need for complicated and 
laborious sample dissolution, giving results in minutes. The limits of detection 
achieved were 40 !Jg g·1 for AI and 6 !Jg g-1 for Mg. 
1.6 Liquid Chromatography with ICP-MS and ESI-MS detection 
The detection and identification of impurities/metabolites structurally related to a 
drug substance are of utmost importance. Conventional methods of analysis to 
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detect, track, quantify and/or identify drug substance/or related impurities often 
use mass spectrometry with atmospheric pressure ionisation (API-MS)51 · 52. 
However, this approach is not foolproof because some impurities are poorly 
ionised, or eo-elute with the main peak, making them hard to observe. A 
significant number of drug substances contain heteroatoms, (e.g. sulphur, 
bromine} for which a sensitive element selective detector such as ICP-MS is 
ideally suited. 
Neither inductively coupled plasma-mass spectrometry nor electrospray alone will 
be adequate for the identification of unknown elemental species at trace levels 53. 
However, the two techniques can be used in parallel in a synergistic way to 
provide both selective elemental analysis and molecular identification to detect 
and characterise previously unidentified compounds54. 
Corcoran et al. 55 applied HPLC linked to ICP-MS and orthogonal time-of-flight 
mass spectrometry (oa-TOFMS} for the identification of phase I and 11 urinary 
metabolites of diclofenac. The metabolites were separated by reversed-phase 
HPLC monitored with a UV diode array detector (UV-DAD) after which, 90% of the 
eluent was passed to an ICP-MS source, and the remainder going to the oa-TOF 
mass spectrometer. Compounds containing 35CI, 37CI and 32S were detected 
specifically using ICP-MS, and then identified by oa-TOF. A previously unreported 
in vivo metabolite, an N-acetylcysteinyl conjugate of diclofenac, was detected in 
this way and was further characterised by oa-TOF. This was the first application of 
the combination of HPLC/UV-DAD/ICP-MS/oa-TOFMS for the identification of the 
metabolic fate of chlorinated xenobiotics by direct biofluid analysis. 
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Evans et al. 56 described the use of liquid chromatography coupled to sector field 
inductively plasma mass spectrometry (SF-ICP-MS) for the specific detection of 
sulphur-containing compounds in cimetidine drug substance. Here, structurally 
related impurities below the 0.1% mass fraction level (relative to the main drug 
substance) could easily be detected. Further analysis using electrospray mass 
spectrometry (ESI-MS) confirmed the structure of most of the impurities, thus 
highlighting the benefit of these complementary techniques in drug analysis. The 
limit of detection by SF-ICP-MS for cimetidine in solution was -4-20 ng g-1 at a 
resolution of 6000, but this was blank limited. At this resolution the main isotope of 
sulphur e2s, abundance 95.018%), was resolved from the serious interference of 
the polyatomic ion 160 160+, which would not be possible without the high-
resolution capabilities of the instrument used. 
Whereas ICP-MS detection is very sensitive, it does not provide structural 
information of molecules so the characterisation of unknowns is very difficult. In 
comparison, electrospray mass spectrometry does provide structural information, 
but does suffer in the fact that ionisation is compound dependent. The combination 
of both these detection techniques running in parallel enables the analyst to both 
identify the components within the mixture, which contain the element of interest, 
and also determine the molecular mass of the compound, and thus aid in the 
structural identification of the compound. 
1.7 Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic Resonance (NMR) spectroscopy is used, in this study, to 
characterise synthesised derivatising reagents. NMR is an isotope specific 
technique based on the principle that many nuclei have a magnetic moment, or a 
non-zero spin quantum number. Of these, isotopes having a ground state nuclear 
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spin, I, of% are the easiest to study. In a magnetic field, such nuclei have a lower 
energy when aligned with the field than when opposed to the field. The energy 
difference between the aligned and opposed states corresponds to radio 
frequencies in the electromagnetic spectrum, hence the nuclei are able to absorb 
and re-emit radio waves. The precise resonance frequency of the individual 
nucleus is dependent on the effective magnetic field at that nucleus, and is 
affected by electron shielding, which is in turn dependent on the chemical 
environment. This frequency dependence, measured as the chemical shift (o, 
ppm), makes NMR spectroscopy a powerful analytical tool. Since the value of the 
chemical shift is proportional to the magnetic field strength the resonance 
frequency is ratioed to the spectrometer frequency to normalise it. As such, 
chemical shifts measured using different spectrometers can be compared directly. 
NMR spectroscopy is primarily employed for the structural elucidation of organic 
molecules. The sample (typically 1 mg) is placed in a constant, homogenous 
magnetic field which induces individual nuclei within the molecule to align with or 
against the direction of the field. A pulse of radio frequency (RF) energies is 
applied, thereby effecting a change in the orientation of the NMR sensitive 
isotopes within the magnetic field. Following this 'resonance' state the energised 
isotopes 'relax' back to their original orientation. lt is these energy changes that 
are measured to give an NMR spectrum, which can then be enhanced by repeated 
cycles of RF pulsing/relaxation to improve sensitivity. Data is acquired as a 
resonance frequency versus time spectrum, which is subsequently processed to a 
resonance frequency versus amplitude spectrum by means of a Fourier transform 
algorithm. 
The most common isotope studied by NMR spectroscopy is the proton CH), as it is 
the most receptive and abundant, followed by 13C. However there are over 20 
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isotopes in the periodic table having I = Y:z which are thus relatively straightforward 
to study. An important feature of NMR spectroscopy is that solvents employed 
should ideally not contain any of the isotope under study. Thus, deuterated 
solvents are employed for use in 1H NMR. The use of deuterated solvents also 
allows the magnetic field around the sample to be built homogeneously, and, as 
deuterated solvents typically contain up to 0.1% 1H, provide a reference point from 
the residual protonated solvent. 
A further feature of NMR spectroscopy is that other NMR active isotopes in the 
molecule(s) under study will also induce changes in the spectrum due to magnetic 
interactions, or coupling, between these isotopes and the isotope under study. 
Every hydrogen atom in a molecule spins, and moving charged particles generate 
their own magnetic field. The protons on neighbouring carbons (carbons adjacent 
to the carbon whose protons are generating the NMR signal) will generate 
magnetic fields whose magnetic moments will interact with the magnetic moment 
of the external magnetic field. This results in the splitting of the NMR signal. We 
can determine how many times the signal will split by adding up all the 
neighbouring protons that are non-equivalent to the protons whose NMR signal is 
being generated. lt turns out that the number of ways the signal is split can be 
determined by the so called "n+1" rule where n = number of non-equivalent 
neighbouring protons. For example, if we consider the compound propane, 
CH3CH2CH3 then there will be two different electronic environments. The two 
methyl groups on each end will generate one signal and the CH2 will generate a 
second NMR signal at a different chemical shift. For the methyl signal, there are 
only a total of 2 neighbouring protons (those on the CH2) so according to the n+1 
rule the signal will be split three ways called a triplet. For the CH2 signal there are 
a total of 6 neighbouring protons (three from each neighbouring methyl) so that 
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signal should be split 6+1 or 7 ways called a septet. Neighbouring protons that are 
equivalent to the protons whose signal is being generated will not split the signal. 
So for example, 1,2-dichloroethane will only have one signal since the CH2 
protons are equivalent (homotopic) and the signal will be a singlet not having been 
split. 
1.8 Aims of this study 
The work described within this thesis is directed towards developing LC-ICP-MS 
and LC-ESI-MS methods, to investigate the capability of these techniques and 
how they can be used simultaneously to provide complimentary information. The 
initial development work is to focus on developing a suitable interface to couple 
HPLC with ICP-MS detection, overcoming some of the incompatibility problems 
between these two techniques. 
Utilising this HPLC-ICP-MS interface, both ICP-MS and ESI-MS methods are to be 
developed to analyse some organic acids after HPLC separation. By derivatising 
these acids with a phosphorus containing derivatising reagent, any advantages in 
ESI-MS detection are to be investigated. This derivatisation may also enable 
phosphorus selective ICP-MS detection to be utilised to detect these derivatised 
acids. 
By utilising this derivatisation technology, a novel brominated derivatising reagent 
is to be synthesised. Any improvement in detection by ICP-MS utilising bromine 
selective detection is to be investigated, with also phosphorus and bromine ratios 
obtained with ICP-MS detection to be calculated. This has the possibility to 
determine the degree of phosphorylation of peptides, which is also to be 
examined. 
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Chapter Two 
Interfacing High Performance Liquid Chromatography with 
Inductively Coupled Plasma Mass Spectrometry 
2.1 Introduction 
Inductively Coupled Plasma Mass Spectrometry is a convenient and sensitive 
detector for interfacing with HPLC. The ICP ion source is at atmospheric pressure, 
so an elaborate interface to reduce the pressure prior to introducing the sample is 
not required. The use of a mass spectrometer as a detector, in combination with 
the efficient ionisation of the ICP offers lower detection limits than optical emission 
or atomic absorption detectors. However, a major limitation of HPLC-ICP-MS is 
the low tolerance of the plasma for organic solvents used in HPLC mobile phases, 
thus, the adaptability of ICP-MS as an element selective detector for speciation 
analysis is determined by the composition and flow rate of the eluent, which in turn 
is dependent on the chromatography utilised. To alter the chromatographic 
separations, it is often necessary to modify the organic solvents or dissolved salts 
in the mobile phase. The ICP is intolerant to large amounts of either of these, so 
mobile phase selection must be carefully considered. The most critical 
consideration when coupling ICP-MS to HPLC is to maximise analyte transport but 
minimise solvent transport to the plasma. 
The underlying problem is that organic solvents have a higher vapour pressure 
than water which leads to an increased solvent loading on the plasma44 . This 
reduces the stability of the plasma because it adversely affects the electron 
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number density as well as the ionisation and excitation temperatures45 and also 
causes a change in the capacitance of the plasma resulting in a higher reflected 
powe~2 . If the reflected power increases too much, then the RF tuning circuit will 
be unable to cope and the power supply will be shut down. Tuning the capacitance 
circuits in the torch box can help compensate for small amounts of solvents, but 
not entirely. Further problems are encountered with organic solvents and gradient 
elution57. As the eluent composition changes (to an increased organic content in 
reversed phase chromatography) the nature of the plasma changes, meaning that 
the ion lens settings and nebuliser gas flows that gave an optimal signal at the 
start of a gradient may not be optimal at the end of an elution gradient. This results 
in varying sensitivity over a chromatographic run leading to sloping baselines, 
calibration and quantification problems. 
Another problem is that the solvent vapour is atomised but not oxidised32, and the 
carbon produced can build up on the sampler and skimmer cones, causing a drop 
in sensitivity when the cone orifices become blocked. Any carbon travelling 
through the cones will also build up on the ion lenses causing a further drop in 
sensitivitl3. These problems can be overcome to a certain degree by the addition 
of a small amount of oxygen to the nebuliser gas flow, which oxidises the carbon 
Ideally, only aqueous mobile phases would be utilised with HPLC separations 
employing ICP-MS detection41 . However, for the majority of reversed phase 
separations, the use of 100% aqueous solvents will not result in the required 
separation resolution. One possible solution is to reduce the solvent load on the 
plasma by reducing the mobile phase flow rates, combined with smaller bore 
columns. For example, if a standard-bore column (4.6 mm id) was changed to a 
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micro-bore column (1-2 mm id), typical flow rates would decrease from around 1 
mL min-1 to 100 IJL min-1 while maintaining the same linear velocity of the eluent 
through the column. The disadvantage is that high efficiency nebulisers are 
required to maintain the limits of detection due to the smaller sample volumes 
which are used. Conventional nebulisers and sample introduction systems are 
relatively inefficient because only 1-3% of the actual sample enters the plasma39. 
An increase in this efficiency leads to improved sensitivity of the technique and 
lower limits of detection. Nebulisers with higher transport efficiencies such as the 
direct injection nebuliser (DIN) and the direct injection high efficiency nebuliser 
(DIHEN) have been described for LC-ICP-MS41 • 42 . An alternative approach is to 
produce a desolvated aerosol, i.e. removal of the solvent to produce a dry analyte 
particle, which can be introduced into the plasma44• This has been achieved in a 
number of ways. 
2.1.1 Methods of aerosol desolvation 
In order to remove the organic solvent from the carrier stream all of the solvent 
present must be in the vapour phase, leaving the remaining analyte molecules as 
dry particles. This has been attempted using a number of methods in combination 
with pneumatic, ultrasonic and thermospray nebulisation32. 
The most common method has been the utilisation of a heated spray chamber and 
condenser arrangement in series. Heated spray chamber desolvators have been 
used sporadically in atomic spectroscopy for more than 30 years in order to 
increase the proportion of sample that is conveyed to the plasma or flame to 
improve sensitivitl9. Initial studies exhibited problems of drift, instability, long 
wash-out times and sample carry-over, as these earlier models used ohmic 
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electrical heaters placed outside the heated chamber where nebulisation was 
taking place. Since then the technology has been modified, with Luo et a/.60 
describing a high efficiency nebuliser coupled with a heated tube and two-stage 
condenser which removed 97% of aqueous solvents and 94% of methanolic 
solvents. The analyte mass transport efficiency was 24%, leading to detection 
limits an order of magnitude lower for most of the elements under investigation. 
Eastgate et al. 59 compared the effects of heating the spray chamber, both 
radiatively or conductively. Measurements of sensitivity, stability and sample 
carryover indicated that radiant heating was superior, giving better short-term 
stability and sharply reduced wash-out times and carryover effects. 
Ultrasonic nebulisers (USNs) have been used since the initial introduction of ICP's 
by Wendt and Fassel61 , who used one to generate an aerosol into their ICP 
configurations. The ultrasonic nebuliser utilises a piezoelectric transducer to 
produce ultrasonic waves that pass through the solution and produce an aerosol at 
the surface of the solution62. This aerosol is then volatilised in a heated tube, 
followed by a condenser cooled to approximately 0 oc. to produce desolvated 
analyte particles. 
The thermospray nebuliser was initially developed as an interface between LC and 
MS63. Here the liquid begins to boil near the outlet of the capillary and is converted 
to an aerosol by the expanding solution vapour. These nebulisers provide aerosols 
with finer droplets than pneumatic nebulisers, and produce higher solvent vapour 
loads on the plasma. Therefore desolvation is necessary and is achieved by 
heating the aerosol sufficiently to evaporate the solvent from the aerosol63. 
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Probably the most promising approach to remove the solvent vapour is to use a 
membrane desolvation device. A membrane desolvator used at the interface 
between the spray chamber and torch may be used to remove close to 100% of 
organic solvent44. Within a membrane desolvator, the sample vapour enters a 
heated membrane and a counter-current flow of sweep gas (usually argon) is used 
to remove solvent vapours that diffuse across the membrane. The theory is that 
the solvent molecules are so small that they diffuse through the membrane, 
whereas the larger analyte molecules are too large and are not removed by the 
membrane. The removal of the solvent vapour, and thus the sensitivity of the 
instrument, is dependent on optimising the sweep gas flow. An internal schematic 
of a Membrane desolvation system is shown in Figure 2.1. 
The Cetac Arid us TM is a commercially available membrane desolvator which 
incorporates a low-flow, fluoropolymer nebuliser with a normal aspiration rate of 
approximately 60 1-JL min-1, enabling successful analysis with less than 1 ml of 
sample. Not only do these membrane desolvators effectively remove sample 
solvent vapour, they markedly reduce interferences caused by oxide and hydride 
molecules in the mass spectrum. lt is claimed that the Arid us ™ system can 
effectively reduce the interferences of ArH+ at m/z 39 and ArO+ at m/z 56 by 
factors of 700 and 175, respectively64. 
From 
Nebuliser 
Argon Sweep Gas Out 
Argon Sweep Gas in 
To ICP-MS 
Figure 2.1 Schematic cross-section diagram of a membrane desolvator 
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2.1.2 Aims of this Chapter 
Due to the incompatibility problems which are associated with the introduction of 
organic solvents into the ICP-MS, a procedure was required to enable effective 
coupling of HPLC operating with gradient elution. In order to identify the most 
suitable approach both low flow nebulisation and membrane desolvation were 
examined. The effects of different nebulisers, including low-flow nebulisers, and 
their effect on sample uptake and signal intensity with varying nebuliser gas flow 
rates and varying organic solvent content was investigated. A range of desolvation 
membranes were examined to investigate their utility with regard to desolvation of 
various mobile phases. 
2.2 Experimental 
2.2.1 Chemicals and reagents 
HPLC grade acetonitrile and methanol were obtained from Fisher Scientific UK 
Ltd. (Loughborough, Leicestershire, UK). High purity water (18.2 MO) was 
obtained using an Elga Maxima water purifying system. BDH Aristar grade lndium 
atomic spectroscopy standard was purchased from WVR International (Poole, 
Dorset, UK). 2,4-dichlorobenzoic acid and 2,4-dichlorobenzaldehde were 
purchased from Sigma-Aidrich (Poole, Dorset, UK). Lamotrigine drug substance 
was supplied by GlaxoSmithKiine (Stevenage, Hertfordshire, UK). 
2.2.2 Nebuliser experiments with ICP-MS analyses 
All experiments were performed using a sector-field inductively coupled plasma 
mass spectrometer (SF-ICP-MS, Thermo Elemental Axiom, Winsford, U.K.), using 
a mass resolution setting of 400. Operating conditions are shown in Table 2.1. 
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Table 2.1 Operating conditions for SF-ICP-MS 
ICP 
Nebuliser gas flow/Lmin"1 
Auxiliary gas flow/Lmin"1 
Coolant gas flow/Lmin"1 
Nebuliser 
Spray Chamber 
Torch 
Interface 
Sampling cone 
Skimmer cone 
Scanning 
Resolution 
Slit setting 
Masses monitored 
Dwell time/ms 
Points 
2.2.3 Nebuliser experiments 
Range of flows (see specific experiment) 
0.85 
14.0 
Micromist (50 and 200 JJL min"1) and glass 
concentric (1 ml min.1) (all Glass Expansion, 
Switzer1and) 
Jacketed quartz cinnabar, cooled to variable 
temperatures (Glass Expansion, Switzer1and) 
Quartz Fassel-type with quartz bonnet, with 
platinum shield 
Nickel 1 mm Ld. 
Nickel, 0. 7 mm Ld. 
400 
Source, 1000; collector, 1000 
lndium, (scanning between 114.401 and 115.407 
m/z) 
50 
20 
To examine the natural uptake rates of the nebulisers, a HP1050 modular 
chromatography system (Agilent Technologies, Stockport, U.K.) was used at a 
flow rate of 1.0 ml min"1 to deliver the liquids. A chromatographic T-piece (PEEK, 
Fisher Scientific, Loughborough, UK) was used before the nebuliser, to enable the 
nebuliser to uptake at its natural rate (Figure 2.2). The un-nebulised flow was 
directed to waste. A flow rate of 1 ml min"1 was chosen as this represents the 
standard flow rates used in "normal" bore chromatography with 4.6 mm i.d. 
columns. 
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Nebuliser 
HPLC Pump 
'T'-piece 
Figure 2.2 'T'·piece arrangement showing the nebuliser self aspiration set· 
up 
2.2.4 Membrane desolvator experiments 
Two different membrane desolvators were evaluated. A Universal Interface Model 
8 desolvation device (Vestec Corporation, Houston, USA) and an Arid us TM sample 
introduction system (Cetac Technologies, Omaha, NE, USA). The sweep gas was 
optimised daily at approximately 2.0 L min"1 to ensure the maximum signal for 
1151n+ was achieved. The Vestec desolvator was connected by simply inserting the 
end of the tubing from the HPLC column into the sample uptake inlet of the 
nebuliser, and the output from the spray chamber was introduced into the 
desolvator. The Aridus™ desolvator incorporates a low-flow (60 IJL min-1) 
nebuliser and spray chamber, so this was connected by using a 'T' -piece post 
column, with the nebuliser self aspirating (as shown in Figure 2.2). The dry aerosol 
exiting the desolvator was then transferred to the ICP torch via 1 m of 0.25 in. i.d. 
Tygon tubing. 
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2.2.5 Lamotrigine analysis 
All samples were dissolved in methanol to contain 1 mg ml"1 of the compound in 
solution. 20 f.JL of this sample was injected using a HP 1090 chromatography 
system (Agilent Technologies, Stockport, U.K.). The HPLC column was a Nova-
Pak C18 3.9 x 150 mm column (Waters, Elstree, Hertfordshire, UK). The elution 
conditions used are shown in Table 2.2. The HPLC waste outlet (after the UV 
detector) was connected to a 1 ml min"1 conikal nebuliser (Glass Expansion, 
Switzerland) via 2 m of 0.17 in. i.d. PTFE tubing. The nebuliser sprayed into a 
jacketed cyclonic spray chamber (Glass Expansion, Switzerland) cooled to 5°C. 
After the spray chamber, the outlet was connected to the Vestec membrane 
desolvator using 1 m of 0.25 in. i.d. Tygon tubing. After desolvation, the dry 
aerosol was transferred to the ICP-MS torch via 1 m of 0.25 in. i.d. Tygon tubing. 
All experiments were performed using a quadrupole inductively coupled plasma 
mass spectrometer (Thermo Elemental PQ3, Winsford, U.K.). The operating 
conditions were optimised daily to give the maximum signal for 35CI+. Typical 
operating conditions are shown in Table 2.3. 
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Table 2.2 Gradient elution profile used for Lamotrigine analysis 
Time /minutes % 0.05M Ammonium Acetate in % Acetonitrile 
DDW 
0 100 0 
30 5 95 
35 5 95 
50(#) 100 0 
# Th1s mvolves a step from 5:95 % to 100:0% O.OSM Ammomum 
acetate:acetonitrile, not a gradient. 
Table 2.3 Operating conditions for quadrupole-ICP-MS 
ICP 
Nebuliser gas flow/Lmin-1 
Auxiliary gas flow/Lmin'1 
Coolant gas flow/Lmin-1 
RF Forward Power/W 
Nebuliser 
Spray Chamber 
Torch 
Interface 
Sampling cone 
Skimmer cone 
Time Resolved Analysis 
Masses monitored 
Dwell time/ms 
1.10 
0.85 
14.0 
1450 
Glass Concentric (Glass Expansion, Switzerland) 
Jacketed quartz cyclonic, cooled to 5 oc 
Quartz Fassel-type without shield 
Nickel 1 mm i.d. 
Nickel, 0. 7 mm i.d. 
Single ion monitoring for 35CI+ at m/z 35 
500 
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2.3 Results and Discussion 
2.3.1 Nebuliser uptake rates 
Initial investigations were focused on measuring the aspiration rates of various 
nebulisers for different organic solvent compositions. Three different nebulisers 
were examined, a 1 mL min-1 glass concentric, a 200 J,JL min-1 Micromist and a 50 
J.JL min-1 Micromist (all from Glass Expansion, Vevey, Switzerland). In each case 
the spray chamber was cooled to 5°C, and all connections were made using 
identical tubing, and the nebulisers were allowed to self aspirate via a 'T'-piece. 
The uptake rate of each nebuliser was determined for solutions with different 
compositions in order to establish the effect of this on aspiration rate. Methanol 
and acetonitrile were chosen as the organic solvents because they are the two 
most commonly used solvents in reversed phase chromatography. The aspiration 
rates were calculated by weighing the amount collected from the 'T'-piece waste 
over a 20 minute period and subtracting that from the total flow. By taking into 
account the density of the solutions, the amount aspirated in J,JL min-1 was 
calculated. The nebuliser gas flow was kept constant at 0.90 L min-1 for all 
nebulisers. The results obtained are shown in Figure 2.3, Figure 2.4 and Figure 
2.5. For all nebulisers, the amount of nebulised solvent increased with increasing 
organic content. All the nebulisers tested self-aspirated 1 00 % aqueous solution at 
a much lower rate than that specified by the manufacturer. In practice, this 
increasing uptake rate would affect the nebulisation efficiency, solvent loading and 
sample transport of the analyte to the plasma, which in turn would result in 
changing sensitivity and increasing reflected power, with the plasma eventually 
being extinguished if the solvent loading increased sufficiently. 
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Figure 2.3 Self-aspiration rates for the 1 ml min-1 glass concentric 
nebuliser with varying organic solutions 
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Figure 2.4 Self-aspiration rates for the 200 fJL min-1 Micromist nebuliser 
with varying organic solutions 
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Figure 2.5 Self-aspiration rates for the 50 J,JL min"1 Micromist nebuliser with 
varying organic solutions 
2.3.2 Effect of nebuliser gas flow and organic content on sensitivity 
These experiments were designed to establish how the 1151n+ signal was affected 
by nebuliser gas flow rate and the proportion of acetonitrile in the solvent. All three 
nebulisers detailed in the previous section were studied spraying into a Cinnabar 
spray chamber cooled to 5°C. Due to the high aspiration rate of the 1 ml min·1 
concentric nebuliser the reflected power increased above the threshold of 50 W 
and the plasma extinguished when 20% volume fraction acetonitrile was 
introduced. Acetonitrile volume fractions greater than this are often used in 
chromatographic separations, so this nebuliser would not be suitable for these 
applications, and was not studied further. Both the 200 and 50 ~L min-1 nebulisers 
were examined by self-aspirating from a 1 ml min-1 stream of eluent pumped from 
the HPLC pump. The effect of the nebuliser flow rate and acetonitrile volume 
fraction on the 1151n+ signal for the 200 ~L min-1 nebuliser is shown in Figure 2.6. 
As can be seen, for the 100% aqueous solution, the nebuliser flow rate had a very 
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large influence on the signal intensity. Thus, if the nebuliser gas was not 
optimised, large variations in signal intensity would be observed. The other plots 
for varying acetonitrile volume fractions exhibited similar trends, with an optimal 
nebuliser flow rate which was different for each of the solutions. For the 100 % 
aqueous solution, the optimal nebuliser flow rate for maximum signal was 1.0 L 
min-1, whereas for the 90 % water/1 0% acetonitrile volume fraction solution, the 
optimum was at a nebuliser gas flow of 0.8 L min·1• A decrease in signal intensity 
with increasing acetonitrile volume fraction was also observed, with the signal 
decreasing from 600,000 cps for 100% aqueous, to 100,000 cps for the 10% 
acetonitrile solution. Thus, if a gradient elution was used during a chromatographic 
run the nebuliser gas flow would require re-optimisation corresponding to the 
acetonitrile volume fraction at the exact time at which the peak of interest eluted. 
When solutions containing an organic solvent were aspirated two signal maxima at 
different nebuliser flow rates were observed. lt is also worth noting that, at the 
higher acetonitrile volume fractions (30 and 40 %), the stability of the plasma 
deteriorated and there was a considerable amount of carbon build up on the 
sampler and skimmer cones. This may have contributed to the decrease in signal 
with increasing organic content. Also, if solutions containing more than 30% 
acetonitrile are aspirated for more than an hour, there is the possibility that too 
much carbon build up could lead to the cone orifices blocking. These results 
suggest that this nebuliser was not ideally suited for chromatographic analysis due 
to the large variation in signal intensity observed for different organic solvent 
compositions. 
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Figure 2.6 The effect of nebuliser gas flow rate and acetonitrile content on 
1151n+ signal for a Micromist nebuliser (200 IJL min"1) with self 
aspiration 
Similar plots for the 50 ~L min·1 nebuliser are shown in Figure 2.7. In this case 
optimal signal intensity for the 20, 30 and 40 % acetonitrile volume fraction 
solutions was observed at a nebuliser argon gas flow of 0.40 L min·1. However, for 
the 10 % acetonitrile solution, the optimum was at 0.85 L min·1 and for the 100 % 
aqueous solution, the optimum was at 0.95 L min·1• This demonstrates that, if the 
nebuliser gas flow was optimised for 1 00 % aqueous, then a large decrease in 
signal would be observed during a gradient chromatographic run wherein the 
volume fraction of acetonitrile was increased. If the acetonitrile volume fraction at 
which the peak of interest eluted was known, then the optimum nebuliser gas flow 
rate could be chosen and utilised. With this nebuliser, the largest signal intensity 
was achieved with the higher acetonitrile volume fractions, probably due to 
increased nebuliser efficiency at higher acetonitrile volume fractions. There was 
also a distinct trend in the optimum signal from 1 00% aqueous to 60% aqueous 
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with the changeover occurring at 90% aqueous. At 80% aqueous and lower, a 
stable optimum signal is achieved at a nebuliser gas flow of 0.40 L min-1. lt is also 
worth noting that, at 40 % acetonitrile, there was visible carbon build up on the 
sampler cone, but this was not as extensive as with the 200 IJL min-1 nebuliser. 
However, if this volume fraction of acetonitrile was used for long periods, or if 
solutions containing more than 40 % acetonitrile were nebulised, then the carbon 
build up caused blocking of the cone orifices, the reflected power eventually 
increased over the threshold and the plasma extinguished. There is also a double 
maxima observed with the organic containing solutions. This can be explained by 
there being an optimum sample transport efficiency, and also a separate optimum 
solvent loading of the plasma65. As these two variables were examined 
simultaneously, two peak maxima were observed. 
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Figure 2.7 The effect of nebuliser gas flow rate and acetonitrile content on 
1151n+ signal for a Micromist nebuliser (50 IJL min-1) with self 
aspiration 
56 
Experiments with the 50 IJL min-1 nebuliser were repeated , but this time the spray 
chamber was cooled to -5 oc instead of 5 °C. The intention being that, at the lower 
spray chamber temperature, more of the nebulised solution would condense on 
the spray chamber walls, with a resultant decrease in solvent vapour reaching the 
plasma. Results are shown in Figure 2.8, with very similar trends to those with the 
spray chamber cooled to 5 oc being observed. In this case, the greatest signal 
was obtained for 10 % acetonitrile with a nebuliser argon gas flow of 0.85 L min-1. 
Also, at this spray chamber temperature, some of the nebulised liquid froze on the 
spray chamber wall , thereby limiting the function of the spray chamber. 
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Figure 2.8 The effect of nebuliser gas flow rate and acetonitrile content on 
1151n+ signal for a Micromist nebuliser (50 IJL min"1) self 
aspirating with the spray chamber cooled to -5 oc 
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To asses whether the differences in signal intensity were due to the total amount 
of solution being nebulised, the experiments were repeated at a constant uptake 
rate. The 50 ~L min-1 nebuliser was used but the self-aspirating 'T'-piece was 
removed and the nebuliser pumped at a constant flow rate of 0.1 ml min-1 with the 
spray chamber cooled to 5 oc. Results are shown in Figure 2.9. As can be seen, 
the largest signal was obtained with 100 % water. Results are shown for solutions 
containing only up to 30% acetonitrile, because at 40 % the reflected power 
increased above the threshold and the plasma extinguished. 
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Figure 2.9 The effect of gas nebuliser flow rate and acetonitrile content on 
1151n+ signal for a Micromist nebuliser (50 ~L min-1) pumped at 
0.1 ml min'1 
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As can be seen (Figure 2.9) both the nebuliser gas flow and acetonitrile had a 
considerable effect on the signal obtained. At an acetonitrile volume fraction 
greater than 30%, the carbon build up on the cones became extensive and the 
increase in reflected power caused the plasma to extinguish. If this setup was to 
be used for chromatographic separations, then the organic content of the mobile 
phase at the elution time of the peak of interest would have to be known. Using the 
information in the graphs above, the optimum nebuliser gas flow rate can be 
determined and used to achieve the maximum sensitivity. 
2.3.3 Effect of membrane desolvation 
The Cetac Arid us ™ and Vestec membrane desolvators were evaluated and 
compared to determine whether any decrease in solvent reaching the plasma 
could be achieved. When the desolvators were used, varying volume fractions of 
organic solvent (methanol and/or acetonitrile) in the mobile phase had no effect on 
the reflected power of the ICP-MS, even up to concentrations of 100%. The 
plasma was very stable, and did not extinguish throughout the experiments. Even 
after continued use for seven hours very little carbon build-up was observed on the 
cones, thus enabling many chromatographic runs to be performed without the 
need to switch off the instrument and clean the cones. For both systems, the 
signal was highly dependent on the flow of argon sweep gas. However, once 
optimised (usually with 100% aqueous) this optimised setting was constant 
throughout the chromatographic run. Typical count rates obtained for DDW blank 
samples run with the two different membrane desolvators are shown in Table 2.4. 
As these results show, the Vestec membrane desolvator generally gave lower 
background levels than the Cetac Arid us ™, except in the case of sulphur where a 
higher background level was achieved with the Vestec unit. Both membrane 
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desolvators yielded the same sensitivity for 1 ng ml"1 1151n, with a signal of 
800,000 counts per second. One distinct disadvantage of the Aridus™ membrane 
is that it utilises a low flow nebuliser which frequently blocked. For these reasons, 
it was decided that the Vestec membrane would be more suitable for our 
applications. 
Table 2.4 Blank count rates for a DDW sample with the two membrane 
desolvation units using SF-ICP-MS 
Element Scanning Counts per second Counts per second 
Resolution achieved with Vestec achieved with Arid us ™ 
;us 3000 530,000 150,000 
"'P 3000 500 3,500 
~cl 3000 3,250 11,000 
'l!Br 420 275,000 1,000,000 
'"Br 420 290,000 1,000,000 
1ul 420 14,000 125,000 
<!11Si 420 50,000 2,500,000 
ll!F 3000 0 0 
11
"1n 400 400 500 
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These membrane desolvators enabled mobile phases containing up to 100% 
organic solvent to be used and also removes many polyatomic interferences 
caused by the solvent. The most abundant polyatomic ions which have the same 
nominal mass as 31 P+ are shown in Table 2.5. These polyatomic ions contain 
oxygen and hydrogen, which are formed mainly from the sample introduction 
solvent. However, because the membrane desolvator removes almost all of the 
solvent, these interferences are reduced to a very low level. For illustrative 
purposes, the mass spectrum obtained in the region of rnlz 31, at a resolution 
setting of 3000, is shown without (Figure 2.10) and with (Figure 2.11) desolvation. 
As can be seen 14N160H+ was reduced to a level which enabled a quadrupole 
instrument to be used for phosphorus detection with a detection limit of 1 0 ng ml -1 
(see chapter six). 
Table 2.5 Accurate masses of 31P+ and of the most abundant polyatomic 
ions at m/z 31 
Ion Accurate mass 
Jlp+ 30.9738 
15N1s0 + 30.9950 
14N1s0 1H+ 31.0058 
12C1H
3
1s0 + 31.0184 
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Figure 2.10 Background signal of phosphorus and the two major 
interferences without desolvation at a resolution setting of 3000 
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Figure 2.11 Background signal of phosphorus and the two major 
interferences after desolvation at a resolution setting of 3000 
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2.3.4 Lamotrigine Analysis 
Lamotrigine is an anti-epileptic drug produced by GlaxoSmithKiine. This drug 
contains two chlorine atoms within the molecule, so is ideally suited for chlorine 
selective detection using ICP-MS. In order to detect low-level chlorine containing 
impurities in the drug substance/product a sensitive technique (e.g. ICP-MS) is 
required. Impurities detected using HPLC-ICP-MS can be further characterised 
using HPLC-ESI-MS. Two probable impurities are 2,4-dichlorobenzoic acid and 
2,4-dichlorobenzaldehyde, because both are involved in the production process of 
Lamotrigine (see Figure 2.12). ICP-MS has the capability to become a selective 
detector for all lamotrigine related impurities which contain at least one chlorine 
atom. LC-ESI-MS is not well suited since some impurities, e.g. dichlorobenzoic 
acid, only respond in negative ion mode, whereas lamotrigine itself and other 
related impurities respond in positive ion ionisation mode. Other impurities 
including dichlorobenzaldehyde do not ionise at all in ESI ionisation and would 
therefore need a different ionisation source. The aim of this experiment was to 
determine Lamotrigine, 2,4-dichlorobenzoic acid and 2,4-dichlorobenzaldehyde 
using HPLC-UV-ICP-MS with a view to determine the feasibility of this 
arrangement for 35CI+ selective detection for impurity profiling. 
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Figure 2.12 Reaction scheme showing the synthesis of Lamotrigine 
The UV (at 306 nm) and 35CI+ selective ICP-MS chromatograms for Lamotrigine 
are shown in Figure 2.13. A large single peak for Lamotrigine was observed in 
both cases as expected. The variation in retention times for the UV and ICP-MS 
response was due to the time taken to transfer from the UV detector through the 
nebuliser (void volume of the system), spray chamber and desolvator to the ICP-
MS. The response is normalised for each detection technique. 
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Figure 2.13 35CI+ selective ICP-MS and UV at 306 nm chromatograms for 
Lamotrigine 
Figure 2.14 and Figure 2.15 show the UV and ICP-MS responses for 2,4-
dichlorobenzoic acid and 2,4-dichlorobenzaldehyde respectively. The UV 
chromatograms for 2,4-dichlorobenzoic acid 2,4-dichlorobenzaldehyde were 
obtained at 278 nm and 256 nm respectively, because both these compounds 
have poor UV chromophores at 306 nm. Analytical peaks were observed in the 
UV, but no peaks were observed when ICP-MS was used for detection. The ICP-
MS response appears to just show baseline noise and drift obtained when the 
gradient elution occurs. After consultation with the literature, 56• 67 it was postulated 
that the lack of ICP-MS response was caused by the membrane desolvator. 
Membrane desolvators are designed to allow small polar solvent molecules from 
the sample stream to pass through the membrane. Both 2,4-dichlorobenzoic acid 
and 2,4-dichlorobenzaldehyde are more polar and smaller than Lamotrigine so 
were probably removed by the desolvator, thus a desolvation membrane is not 
suitable for this type of analysis. This can be a major drawback when using a 
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membrane desolvator and it is worth noting that, when unknowns are analysed, 
other analytes may be present in the sample which do not reach the ICP-MS and 
are therefore not detected. 
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Figure 2.14 35CI+ selective ICP-MS and UV at 278 nm chromatograms for 2,4-
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Figure 2.15 35CI+ selective ICP-MS and UV at 256 nm chromatograms for 2,4-
dichlorobenzaldehyde 
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2.4 Conclusions 
Two different methods were investigated for interfacing HPLC with ICP-MS 
detection to enable organic solvents to be used for the chromatographic 
separation. The use of a low-flow nebuliser, with the nebuliser aspirating at its 
optimum rate, resulted in a much reduced solvent load on the plasma. However, 
as the concentration of the organic phase changed during a gradient elution, the 
uptake of the nebuliser, and hence the analyte signal, also changed. The optimal 
nebuliser gas flow rate for 100 % aqueous was totally different to the optimum gas 
flow rate for a 10 % volume fraction acetonitrile eluent. This would make it 
extremely difficult to perform quantitative analysis without making a correction for 
signal drift. Also, even with flow rates as low as 100 !JL min-1, too much solvent 
reached the plasma when the acetonitrile volume fraction reached 30%, causing 
the plasma to extinguish. 
The use of a membrane desolvator prior to the aerosol entering the plasma did 
enable up to 1 00 % acetonitrile solutions to be nebulised with little detrimental 
effect on the plasma. Gradient elution was also possible, with the nebuliser gas 
flow rate being optimal throughout the chromatographic run. A desolvator also has 
the advantage of removing many polyatomic ion interferences thereby enabling 
phosphorus selective detection using low resolution quadrupole ICP-MS. The 
major problem encountered when using a desolvator membrane, was that some 
small polar analytes were removed along with the solvent. lt is therefore limited to 
analyses where the analytes are large and not too polar. 
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Chapter Three 
Derivatisation of Carboxylic Acids with Tris(2,4,6-
trimethoxyphenyl) phosphonium propylamine bromide and 
Analysis by Liquid Chromatography - Electrospray Ionization 
Mass Spectrometry (LC-ESI-MS) 
3.1 Introduction 
3.1.1 Derivatisation of Carboxylic acids 
Chemical derivatisation is an established process of modifying the properties of an 
analyte molecule to facilitate detection using a given analytical technique68. 
Derivatisation has been used to enhance detection in mass spectrometry69, 
ultraviolet/visible (UVNis) spectroscopl0 and fluorescence spectroscopl1 and 
also to improve chromatographic properties in techniques such as LC-MS and GC-
MS. The chemically added species, i.e. the derivatising reagent, can be chosen 
according to the properties it possesses and the application of these properties to 
the detector in use. 
Many pharmaceutical drug substances contain carboxylic acids either as a main 
constituent or as impurities at low levels. Mass spectrometry is ideally suited to 
detection due to its high sensitivity and selectivity. However, carboxylic acids tend 
to be poorly ionised by ionisation sources used in mass spectrometry (in 
atmospheric ionisation sources like ESI, carboxylic acids ionise in negative ion 
68 
mode, which generally is less sensitive than positive ion mode), and hence the 
derivatisation of carboxylic acids to enhance their detection for chromatographic 
analysis has been a subject of some investigation68• 72-76• By exploring the nature 
and chemical properties of a molecule, a method for modification and subsequent 
analysis can be devised. Published methods for derivatising carboxylic acids 
generally involve the incorporation of fluorescent tags71 or electrochemical 
detection methods77, with very little published work on analysis by liquid 
chromatography-mass spectrometry (LC-MS). 
The choice of derivatisation reagent is an important consideration when 
considering ESI-MS detection. Ideally, the reagent should be pre-charged to 
remove the dependence on the electrospray ionisation source to initiate ionisation. 
As ESI-MS is a soft ionisation source, some molecules are poorly ionised by the 
electrospray process, thus if the molecule is pre-charged this electrospray process 
becomes less important. The derivatising reagent must possess a suitable reactive 
group to react with the functional group of the analyte molecule and must be stable 
and remain intact throughout the reaction process in order to ensure that the 
maximum signal is achieved with the derivatised product. The molar mass and 
structure of the derivatisation reagent is also a consideration; smaller reagents 
have an advantage in that steric hindrance is not an important factor in the 
reaction process, but larger reagents have the advantage that their derivatised 
products have a high mass, and thus will enable a signal to be observed in the 
less noisy region of the mass spectrum. In addition, the reaction should be a rapid, 
single step reaction with a high yield, using inexpensive and commercially 
available (or easily synthesised) reagents. Also, the derivatisation product, when 
not pre-charged, is often less polar than the carboxylic acid, thus increasing the 
retention time on a conventional C18 column and improving ionisation in 
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electrospray (ESI) due to a more stable spray being generated with more organic 
solvent present. 
There are some disadvantages in using a derivatisation reaction. The reaction 
procedure adds extra time to the analysis, with extra materials and glassware 
needed for the reaction. The reaction may also produce other compounds within 
the reaction, including partially derivatised products, unwanted side products, and 
the reaction of the carboxylic acid with any impurities present in the derivatising 
reagent. The use of chromatography prior to mass spectroscopy detection can 
overcome some of these problems by separating the derivatised analyte from any 
interfering by-products of the derivatisation reaction. 
In this chapter tris(2,4,6-trimethoxyphenyl)phosphonium propylamine bromide (see 
Structure 3.1) is used as the derivatising reagent. This is a large positively-
charged phosphonium reagent thus enabling detection by ESI-MS in the +ve ion 
mode. This reagent has an amine functional group, which reacts with a carboxylic 
acid to form an amide. However, amides are difficult to prepare by direct reaction 
of amines and carboxylic acids since the basicity of the amine converts the acidic 
carbonyl groups into their carboxylate anions and removes their reactivity. This 
derivatisation incorporates a coupling reaction with 1-chloro-4-methylpyridinium 
iodide and triethylamine to activate the carbonyl group on the carboxylic acid prior 
to nucleophilic attack by the amine group on the coupling reagent. The resulting 
derivatised carboxylic acid contains a stable amide bond linking the derivatising 
reagent with the carboxylic acid. The overall reaction is superficially similar to the 
kind of nucleophilic substitution that occurs during SN2 reactions, but the 
mechanisms are different. Whereas an SN2 reaction occurs in a single back-side 
displacement step of the leaving group, nucleophilic acyl substitutions take place 
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in two steps and involves a tetrahedral intermediate as detailed in Scheme 3.1. In 
this way, carboxylic acids can react with alcohols to form esters, amines to form 
amides or even other carboxylic acids to form acid anhydrides. 
In this chapter, detection of underivatised maleic, fumaric, salicylic and sorbic 
acids by LC-ESI-MS-MS, operated in negative ion mode, has been compared with 
detection of the TMPP-derivatised carboxylic acids in positive ion mode. 
M eO OMe 
Molecular Formula =C30H41 N09P . Br 
Structure 3.1 Tris(2,4,6-trimethoxyphenyl)phosphonium propylamine 
bromide (TMPP) 
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Scheme 3.1 The mechanism of acylation through nucleophilic attack 
3.2 Experimental 
3.2.1 Chemicals and reagents 
Carboxylic acids, 2-chloro-1-methylpyridinium iodide (CMPI), triethylamine (TEA) 
and formic acid were obtained from Sigma-Aidrich (Poole, Dorset, UK). Acetonitrile 
(HPLC grade) was obtained from Fisher Scientific UK Ltd. (Loughborough, 
Leicestershire, UK). High purity water (18.2 MO) was obtained using an Elga 
Maxima water purifying system. 
3.2.2 Synthesis of tris(2,4,6-trimethoxyphenyl)phosphonium propylamine 
bromide (TMPP) (Scheme 3.2) 
TMPP was synthesised in-house using an adaptation of the procedure detailed by 
Leavens et ae8 To a solution of 3-bromopropylamine hydrobromide (4.98 g, 22.74 
mmol,) in water (20 mL) was added potassium carbonate (2.24 g) and toluene (20 
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ml) with stirring. The resultant toluene phase was isolated, clarified with saturated 
brine (20 ml), and dried over magnesium sulphate. This dry toluene phase was 
filtered directly into a pre-refluxing solution of tris(2,4,6-trimethoxyphenyl) 
phosphine (2.12 g, 3.98 mmol) in toluene (40 ml). The mixture was refluxed for a 
further 30 m in and the resulting white precipitate was isolated by filtration, washed 
with toluene (2 x 5 ml) and diethyl ether (25 ml) and dried overnight at 30 ·c to 
give the title compound. 
B~NH2 
.HBr 
J.bromopmpylamile hytlrobromlde 
,...-/NH2 
K,C03• H20 
Toluene 
M•O~:)SOM• 
Tris(2,4,6-Uimethoxyphenyt)phosphonium pmpylami.., bromide 
Scheme 3.2 Synthesis of tris(2,4,6-trimethoxyphenyl)phosphonium 
propylamine bromide (TMPP) 
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3.2.3 Coupling of TMPP propylamine with carboxylic acids 
A solution of CMPI was prepared by dissolving 37.98 mg of CMPI in approximately 
20 mL of acetonitrile in a 25 mL volumetric flask. Triethylamine (41.4 JlL) was 
added, and the solution made up to volume with acetonitrile. To 100 JlL of 100 JlM 
carboxylic acid in 90:10% volume fraction water:acetonitrile were added 100 JlL of 
CMPI/TEA coupling reagent (prepared as above). After thorough mixing for five 
minutes at room temperature, 100 JlL of a 1 mM TMPP propylamine solution in 
acetonitrile was added. The solution was left to react for 30 minutes in an 
ultrasonic bath at room temperature. A schematic of the reaction is shown in 
Scheme 3.3. 
OH 
o=< + (E~N) 
R 
Carboxylic add 
2-chloro+melh)1pyridinlum iodide 
OMe 
Whae Ac = Moo--Q 
OMe 
+ HCI 
I • 
A~NH2 
Ar-P 
I 
Ar 
lris(2,4,6~rimelhoxypllenyt)phosphonlum propylamine 
H R A~N--{ 
'· 0 Ar-P 
I 
Ar 
+ u +HI 
N 0 
I 
CH3 
TMPP prop)1 derivatM! of carboxylic acid Malh)1 Pyridlnone 
Scheme 3.3 Activation of carboxylic acids with 2-chloro-1-methyl pyridinium 
iodide (CMPI) and reaction with TMPP propylamine. 
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3.2.4 Preparation of Panadol™ sample and subsequent derivatisation with 
TMPP propylamine 
A commercially available Panadol™ tablet (GiaxoSmithKiine), an analgesic 
containing paracetamol as the active pharmaceutical ingredient and potassium 
sorbate as preservative, was crushed with a pestle and mortar until a fine powder 
was achieved. A small amount of this powder (18.1 mg) was added to a centrifuge 
tube along with 1 ml of 90:10% volume fraction water:acetonitrile and centrifuged 
at 13,000 rpm for 8 minutes. To 100 11l of this supernatant were added 100 11l of 
CMPI/TEA coupling reagent (prepared as above). After thorough mixing for five 
minutes at room temperature, 100 11l of a 1 mM TMPP propylamine solution in 
acetonitrile was added. The solution was left to react for 30 minutes in an 
ultrasonic bath at room temperature prior to analysis. 
3.2.5 Chromatography 
For the HPlC-ESI-MS-MS analyses, an Agilent 1100 chromatography system 
(Agilent Technologies, Stockport, U.K.) was used. All separations were performed 
using a Phenomenex luna C18 (2) reversed phase column (100 x 4.6 mm, 3 11m 
particle size) at 40 oc. The mobile phases contained the following: (A) water I 
acetonitrile (90:10 vlv) containing 0.05% (vlv) formic acid and (B) water I 
acetonitrile (10:90 vlv) containing 0.05% (vlv) formic acid. For negative ion mode 
ESI-MS-MS a stepped gradient elution was used: 0-5 min, 100 % A; 5-5.5 min, 
100-70% A; 5.5-15 min 70% A; 15-15.5 min, 70-100% A; 15.5-20 min 100% A. 
Similarly, for positive ion mode ESI-MS-MS an isocratic stepped gradient elution 
was used: 0-10 min, 70% A; 10-10.1 min, 70-50% A; 10.1-13 min 50% A; 13-
13.1 min. 50-70 % A; 13.1-20 min 70 % A. The flow rate was 1 ml min·1 with an 
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analyte injection volume of 5 Jll. These step gradients were chosen to enhance 
quantitation using ESI-MS. 
3.2.6 Electrospray mass spectrometry 
For analysis of the underivatised carboxylic acids, negative ion mass spectra were 
acquired, whereas for derivatised carboxylic acids, positive ion mode was used to 
detect them. Spectra were acquired on an Applied Biosystems MDS Sciex API 
4000 (Applied Biosystems Ltd, Foster City, California, USA) equipped with a 
TurboV™ Ion Spray ionisation source. The detection limits were determined using 
MRM (multiple reaction monitoring) which is the most sensitive technique available 
on a triple quadrupole instrument. The other parameters used are shown in Table 
3.1 and Table 3.2. Data processing was performed using Analyst 1.3 software. 
The dwell time for each MRM transition was 250 ms and both quadrupoles were 
operated at unit mass resolution. For all the gases, the settings are arbitrary units. 
For characterisation of the synthesised TMPP, the same system set-up was used, 
except no HPLC column was adopted. The spectrum was recorded in the positive 
ion mode within 190-2000 m/z. 
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Table 3.1 ESI-MS/MS mass spectrometer operating conditions for 
analysis of underivatised acids 
Acid 
Maleic Fumaric Salicylic Sorbic 
Quadrupole 1 (m/z) 115 115 137 111 
Quadrupole 3 (m/z) 71 71 93 67 
Curtain gas 10 10 10 10 
(arbitrary units) 
Collision gas 6 6 6 6 
(arbitrary units) 
lonspray potential -4200 -4200 -4200 -4200 
(arbitrary units) 
Temperature (0 C) 500 500 500 500 
Nebuliser gas 20 20 20 20 
(arbitrary units) 
Auxiliary gas 0 0 0 0 
(arbitrary units) 
Interface heater ON ON ON ON 
Declustering -25 -30 -30 -40 
potential (V) 
Entrance potential -10 -10 -10 -10 
(V) 
Collision energy -14 -12 -24 -14 
(eV) 
Collision cell exit -5 -5 -5 -5 
potential (V) 
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Table 3.2 ESI-MS/MS mass spectrometer operating conditions for 
analysis of TMPP derivatised carboxylic acids 
Acid 
Maleic Fumaric Salicylic Sorbic 
Quadrupole 1 (m/z) 688 688 710 684 
Quadrupole 3 (m/z) 590 642 590 181 
Curtain gas 10 10 10 10 
(arbitrary units) 
Collision gas 4.00 4.00 4.00 4.00 
{arbitrary units) 
lonspray potential 5500 5500 5500 5500 
(arbitrary units) 
Temperature (0 C) 650 650 650 650 
Nebuliser gas 20 20 20 20 
(arbitrary units) 
Auxiliary gas 0 0 0 0 
(arbitrary units) 
Interface heater ON ON ON ON 
Declustering 95 95 100 100 
potential (V) 
Entrance potential 10 10 10 10 
(V) 
Collision energy 55 75 50 70 
(eV) 
Collision cell exit 8 8 8 8 
potential (V) 
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3.2. 7 Nuclear Magnetic Resonance 
The 1H NMR spectra were acquired at 270 MHz using a Jeol EX270 Fourier 
Transform NMR spectrometer. Deuterated acetonitrile (CD3CN, Goss Scientific, 
Great Baddow, UK) was chosen as the solvent as the residual protio methyl 
(CD2HCN) group, o 1.9 ppm, which was used to reference the 1H spectra does not 
interfere with the expected chemical shifts for the synthesised TMPP. 31 P NMR 
spectra were acquired using the same instrument at 109 MHz, but in this case the 
centre of the spectral window acquired, 700 ppm, was set too 0 ppm and used to 
reference the spectra because the solvent used did not contain any phosphorus to 
reference the signal to. 
3.3 Results and Discussion 
3.3.1 Synthesis of tris(2,4,6-trimethoxyphenyl)phosphonium propylamine 
bromide (TMPP) (Scheme 3.2) 
Initial attempts to synthesise the TMPP derivatising reagent using the reference 
method78 were unsuccessful, with the propylamine side chain appearing not to 
have attached to the tertiary phosphonium. This may be because, unlike the 
hydrobromide salt, the 3-bromopropylamine free-base was unstable and tended to 
condense with itself by nucleophilic displacement of bromide by the primary 
amine. The reference paper did not indicate the length of time necessary to 
liberate the free amine from the salt with K2C03, nor the subsequent clarification 
with brine/drying over magnesium sulphate, so it is probably important to perform 
this part of the process as quickly as possible. Hence, the literature method was 
modified. The tris(2,4,6-trimethoxyphenyl) phosphine was weighed and dissolved 
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in enough toluene to ensure complete dissolution and refluxed for 20 minutes. The 
formation of 3-bromopropylamine free-base was prepared as quickly as possible, 
and the filtration of the dry toluene phase was directed straight into the pre-
refluxing tris(2,4,6-trimethoxyphenyl) phosphine. This yielded a white crystalline 
precipitate, which was isolated with a yield of 0.74 g, 27.9%. Confirmation that 
TMPP had been synthesised was achieved using 1H and 31P NMR, and flow 
injection ESI-MS. The mass spectrum of the synthesised material yielded a large 
peak with a mass of 590 rnlz in positive ion mode (Figure 3.1 ). This is the 
characteristic mass of TMPP and is the same as the mass observed by Leavens 
et al. 78 Moreover, two in-source formed fragment ions support this structure. The 
fragment ion at m/z 54 7 corresponds to the loss of CH2=CH-NH2 from the 
quaternary phosphonium ion and the ion at mlz 422 corresponds to the loss of one 
of the trimethoxyphenyl groups. The 1H NMR spectrum obtained for the 
synthesised TMPP dissolved in deuterated acetonitrile is shown in Figure 3.2 
along with the spectral data given in Table 3.3. For comparison, the 1H NMR 
spectrum obtained for the tris (2,4,6-trimethoxyphenyl) phosphine starting material 
is shown in Figure 3.3 along with the spectral data shown in Table 3.4. By 
comparing these spectra, the synthesised TMPP showed peaks for the 
propylamine side chain (at 3.04, 2.62 and 1.34 <>ppm), which are not observed in 
the spectrum of the phosphine starting material. This data, along with the mass 
spectral data, confirmed that TMPP was synthesised successfully. This is 
confirmed by comparison with Leavens et a/?8 which quoted peak shifts and 
integrals identical to those obtained in these experiments. Further evidence to 
support the synthesis was provided by 31 P NMR experiments. These were 
performed for the tris(2,4,6-trimethoxyphenyl) phosphine starting material and for 
the synthesised TMPP. For the starting material, a chemical shift of -66.67 ppm 
was observed (Figure 3.4), whereas for the synthesised TMPP a chemical shift of 
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6.65 ppm was observed (Figure 3.5). This large difference in chemical shift gives 
more confidence in the successful synthesis of a quartemarised phosphorus. 
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Figure 3.1 Positive ion ESI-MS of the synthesised TMPP: A, total ion 
current of the flow injected compound; and B, mass spectrum of 
the peak at 1.34 mins 
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Figure 3.2 1H NMR spectrum for synthesised TMPP, the data for each 
signal (lettered) is shown in Table 3.3 
Table 3.3 1H NMR spectral data and peak assignment for the synthesised 
TMPP 
Peak 1.0. Chemical Integral Coupling Assignment 
Shift {~~m} ~attern 
a 6.21 6 Doublet 3- and 5-H aromatic protons 
b 3.85 9 Singlet 4- OCH3 
c 3.58 18 Singlet 2- and 6- OCH3 
d 3.04 2 Multiplet C.!:!.2CH2CH2NH2 
e 2.62 2 Triplet CH2CH2C.!:!.2NH2 
f 2.15 From Solvent 
g 1.92 From Solvent 
h 1.34 2 Multiplet CH2C.!:!.2CH2NH2 
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Figure 3.3 1H NMR spectrum for tris (2,4,6-trimethoxyphenyl) phosphine 
starting material, the data for each signal (lettered) is shown in 
Table 3.4 
Table 3.4 1H NMR spectral data and peak assignment for the tris (2,4,6-
trimethoxyphenyl) phosphine starting material 
Peak 1.0. Chemical Integral Coupling Assignment 
Shift {p~m} ~attern 
a 6.07 6 Doublet 3- and 5-H aromatic protons 
b 3.75 9 Singlet 4- OCH3 
c 3.46 18 Singlet 2- and 6- OCH3 
d 2.04 From Solvent 
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Figure 3.4 31P NMR spectrum for tris (2,4,6-trimethoxyphenyl) phosphine 
starting material 
300 200 100 0 -100 -200 -300 
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Figure 3.5 31P NMR spectrum for synthesised TMPP 
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3.3.2 Derivatisation of carboxylic acids 
The detennination of fumaric, sorbic, maleic and salicylic acid was investigated. 
These acids were chosen because they are commonly found in many 
phannaceutical products as additives or impurities, and are difficult to determine 
using conventional ESI-MS because they do not fonn positive ions and have low 
molecular weights. Negative ion ionisation is possible, but due to their low 
molecular weight, there is a lot of chemical noise in the mass spectra, e.g. from 
common LC additives such as acetic acid, fonnic acid and especially trifluoroacetic 
acid (m/z = 113 and its cluster ion at m/z = 227). In addition, since they are poorly 
retained on conventional reversed phase columns which are typically used for 
phannaceutical analysis, they elute in a highly aqueous matrix which is not ideal 
for electrospray ionisation. lt leads to an unstable spray if the organic content of 
the eluent is too low. lt would be advantageous to be able to detennine these 
compounds using the standard approach of reversed phase LC, coupled with ESI-
MS operated in positive ion mode, to enable co-detennination of all analytes. 
In order to evaluate any possible benefits of derivatisation of the acids with TMPP 
the analysis was performed using LC-ESI-MS-MS in negative ion mode without 
derivatisation and in positive ion mode with derivatisation. This represented the 
two best case scenarios for the analysis of the acids with and without 
derivatisation. Chromatograms showing the separation and detection of the four 
acids using both modes of detection are shown in Figure 3.6. Detection was 
performed by monitoring the appropriate precursor ion in quadrupole 1 and the 
most abundant product ion in quadrupole 3 (Table 3.5 and Table 3.6). Quadrupole 
2 uses RF only and acts as a collision cell, where a collision gas is introduced at a 
pressure such that an ion entering the quadrupole undergoes one or several 
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collisions9. The ion then fragments and the producUfragment ions are analysed in 
quadrupole 3. In multiple reaction mode (MRM}, the most abundant precursor ion, 
along with the most abundant product ion, combine to improve the sensitivity of 
the instrument, as two specific masses are being analysed. Thus, in theory, if all 
ions are fragmented each ion is detected twice. Also, because only ions 
transmitted by quadrupole 1 are detected at the rnlz determined by quadrupole 3, 
a very low background signal is observed, resulting in an enhanced signal-to-noise 
ratio, hence lowering the limits of detection. 
For the underivatised acids, the most abundant fragment ion corresponded to the 
loss of C02 (a loss of 44 m/z} from the precursor ion, whereas for the derivatised 
acids this fragmentation is variable, hence the most abundant fragment was that 
used in the analyses. In order to improve the duty cycle not all product ions of the 
compounds to be analysed were monitored throughout the chromatographic run, 
but instead the mass spectrometer switched to the most appropriate mass during 
elution of each individual carboxylic acid, hence the changing baseline observed in 
Figure 3.6 A. 
A three point calibration was performed for each of the acids and detection limits 
were calculated based on 3o of the baseline noise. This was calculated by taking 
the standard deviation of ten randomly picked points on the baseline, and 
calculating the standard deviation of these points. Using three times this standard 
deviation and correlating this to the linear response equation for each acid, the 
detection limits were calculated. Detection limits for the underivatised and 
derivatised carboxylic acids are given in Table 3.5 and Table 3.6 respectively. As 
can be seen, detection limits for fumaric, sorbic and maleic acids were 
approximately one order of magnitude lower after derivatisation and +ve ion 
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detection, thereby confirming the utility of this method for the enhanced detection 
of these acids. In contrast, a fivefold decrease for the detection limit was observed 
for salicylic acid. This is probably due to strong internal hydrogen bonding making 
salicylic acid a poor nucleophile leading to an inefficient reaction with the CMPI 
activating reagent 
Table 3.5 Detection limits obtained for the underivatised carboxylic acids 
obtained using LC-ESI-MS-MS in the -ve ion mode 
Acid 01 m/z 03 m/z Detection limit 
(precursor) (product) /fmol 
Fumaric 115 71 24 
Sorbic 111 67 51 
Maleic 115 71 2 
Salicylic 137 93 117 
Table 3.6 Calculated detection limits for the derivatised carboxylic acids 
obtained using LC-ESI-MS-MS in the +ve ion mode 
Acid 01 m/z 03 m/z Detection limit 
(precursor) (product) /fmol 
Fumaric 688 642 2 
Sorbic 684 181 4 
Maleic 688 590 0.4 
Salicylic 710 590 540 
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Figure 3.6 Chromatograms for a mixture of carboxylic acids (2 iJmol L"1) 
with detection by multiple reaction monitoring electrospray 
mass spectrometry: A, underivatised carboxylic acids and 
negative ion mode ESI-MS/MS; B, derivatised carboxylic acids 
and positive ion mode ESI-MS/MS 
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3.3.3 Analysis of Panadol™ tablets 
Panadol Extra ™ is the proprietary name of an oral analgesic medicine 
manufactured by GlaxoSmithKiine, which would normally contain paracetamol, 
caffeine and potassium sorbate (used as preservative) together with excipients. 
Hence, the absence of sorbate in any so-called Panadol Extra m product would 
indicate that the product was counterfeit. Analysis was performed using LC-ESI-
MS/MS in both negative and positive ion mode after derivatisation with TMPP 
propylamine; the resulting chromatograms are shown in Figure 3.7. Derivatisation 
of the sorbic acid (Figure 3.7 B) resulted in an improvement in chromatographic 
resolution and signal-to-noise compared to the underivatised sample (Figure 3.7 
A). An added advantage of the derivatisation is that analysis can be performed 
using positive ion mode ESI-MS, so both paracetamol and caffeine can also be 
determined simultaneously if necessary. 
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Figure 3.7 Selected ion chromatograms for Panadol™ samples, showing 
the presence of sorbate, obtained in: A, negative ion mode 
without derivatisation; B, positive ion mode after derivatisation 
with TMPP 
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Chapter Four 
Detection of phosphorus tagged carboxylic acids using HPLC-SF-
ICP-MS 
4.1 Introduction 
4.1.1 ICP-MS detection of carboxylic acids 
The vast majority of organic compounds are essentially not detectable by 
inductively coupled plasma mass spectrometry (ICP-MS) because they only 
contain H, C, 0 and N. These elements have extremely high background signals 
because they are either present in the solvents used during sample introduction or 
present in atmospheric air entrained into the plasma, hence, trace analysis is 
impossible. The exceptions to this are the determination of C at minor and trace 
levels79-81 and element selective detection of organic compounds which contain a 
hetero-atom such as P, S, Si, Cl, Br, I, a metal or metalloid. For example, 
detection of phosphorus containing compounds has previously been performed for 
the determination of phosphorylated peptides82"84 and for sulphur-containing 
compounds in pharmaceuticals56. However, if a means of making all organic 
compounds detectable by ICP-MS could be achieved, many new applications 
would be realised. For example, high accuracy quantitative analysis of organic 
compounds could be achieved using external calibration; and many biological 
molecules could be determined in metabolic studies85. An alternative has recently 
been proposed by Smith et a/.86 which uses aqueous eluents only (at temperatures 
of 60 and 160 ·c) or isotopically enriched solvents to detect carbon in organic 
compounds by LC-ICP-MS. 
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Leavens et al. 78 have previously reported on the synthesis of a large molecular 
weight phosphorus reagent, tris(2,4,6-trimethoxyphenyl) phosphonium 
propylamine bromide (TMPP), which was used to derivatise organic compounds to 
make them amenable to detection by +ve ion electrospray ionization mass 
spectrometry (ESI-MS), and it has been shown how this can be used for the 
determination of low molecular weight carboxylic acids in pharmaceutical 
samples87• As the majority of carboxylic acids do not contain a heteroatom so 
cannot be detected using ICP-MS, by derivatising these acids with TMPP, they 
have effectively been tagged with phosphorus, so 31 P+ selective detection using 
ICP-MS can be performed. This has useful applications in pre-screening for quality 
control and investigations involving intellectual property rights56. In this chapter 
some pharmaceutically important carboxylic acids (maleic, fumaric, salicylic and 
sorbic) were derivatised by TMPP and detected by phosphorus selective LC-ICP-
MS. The derivatisation reaction was also examined to further enhance the 
derivatisation procedure to lead to more sensitive detection, and hence lower 
detection limits. 
4.2 Experimental 
4.2.1 Chemicals and reagents 
Carboxylic acids, 2-chloro-1-methylpyridinium iodide (CMPI) and triethylamine 
(TEA) were obtained from Sigma-Aidrich (Poole, Dorset, UK). HPLC grade 
acetonitrile was obtained from Fisher Scientific UK Ltd. (Loughborough, 
Leicestershire, UK). High purity water (18.2 MO) was obtained using an Elga 
Maxima water purifying system. TMPP was synthesised as detailed in Section 
3.2.2. 
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4.2.2 Preparation of coupling reagent 
Solutions of CMPI were prepared by dissolving an appropriate amount (typically 
38 mg) of CMPI in approximately 20 mL of acetonitrile in a 25 mL volumetric flask. 
The corresponding amount of triethylamine was added, and the solution made up 
to volume with acetonitrile. 
4.2.3 Coupling of TMPP propylamine with carboxylic acids 
To 500 J.LL of carboxylic acid in 90:1 0 % (v/v) water:acetonitrile were added 500 J.LL 
of CMPI/TEA coupling reagent (prepared as above). After thorough mixing for five 
minutes at room temperature, 500 J.LL of a TMPP propylamine solution in 
acetonitrile was added. The solution was left to react for 30 minutes in an 
ultrasonic bath at room temperature. 
4.2.4 HPLC-SF-ICP-MS analyses 
For HPLC-SF-ICP-MS analyses, a modular chromatography system (HP1050, 
Agilent Technologies, Stockport, U.K.) equipped with a C18(2) reversed phase 
column (Phenomenex Luna, 100 x 4.6 mm, 3 Jlm particle size) was used. The 
mobile phase comprised of a binary system of: eluent A, water/acetonitrile (90:10 
% v/v) containing 0.05% formic acid (v/v); and eluent 8, water/acetonitrile (10:90 
% v/v) containing 0.05% (v/v) formic acid. The linear gradient employed started at 
100% A, changing to 40% A and 60% B over 20 minutes. The flow rate was 1 mL 
min-1 with an injection volume of 5 Jll. All experiments were performed using a 
sector-field inductively coupled plasma mass spectrometer (SF-ICP-MS, Thermo 
Elemental Axiom, Winsford, U.K.), using a mass resolution setting of 3000. 
Operating conditions are shown in Table 4.1. 
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Table 4.1 
ICP 
Nebuliser gas flow/Lmin"1 
Auxiliary gas flow/Lmin"1 
Coolant gas flow/Lmin"1 
Nebuliser 
Spray Chamber 
Torch 
Interface 
Sampling cone 
Skimmer cone 
Single ion monitoring 
Resolution 
Slit settings 
Masses monitored 
Dwell time/ms 
Scanning 
Resolution 
Slit setting 
Masses monitored 
Dwell time/ms 
Points 
Operating conditions for SF-ICP-MS 
1.10 
0.85 
14.0 
Micromist (Glass Expansion, Switzerland) 
Jacketed quartz cyclonic, cooled to 5 oc 
Quartz Fassel-type with quartz bonnet, without 
shield 
Nickel 1 mm i.d. 
Nickel, 0. 7 mm i.d. 
3000 
Source, 330; collector, 220 
Single ion monitoring for 31 P+ at m/z 30.974 
500 
3000 
Source, 330; collector, 220 
Scanning between mlz 30.838 and 31.109 
50 
20 
lt is common, in large phannaceutical companies, to adopt a standard HPLC 
elution method which can be used in the majority of cases. The method is often 
standardised to a simple linear elution of acetonitrile/water which can run up to 
100 % organic phase (v/v). Such a high volume fraction of acetonitrile is 
incompatible with the nonnal operation of ICP-MS unless an extremely low flow 
nebuliser is used. One solution to this, which was adopted in this work, is to use a 
membrane desolvation system, which removes the vast majority of solvent and 
allows routine operation of gradient elution up to 1 00 % volume fraction acetonitrile 
at standard 1 ml min"1 flow rates (see chapter two). However, it should be noted 
that low molecular weight polar analytes may also be removed by the desolvation 
systems, so caution should be used when adopting this approach. In this work the 
HPLC column was coupled with the SF-ICP-MS simply by inserting the end of the 
tubing from the column into the sample uptake inlet of the nebuliser, and the 
output from the spray chamber was introduced into a Universal Interface Model B 
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desolvation device (Vestec Corporation, Houston, USA). The sweep gas was 
optimised daily at approximately 2.0 L min"1 to ensure the maximum signal for 31 P+ 
was achieved. The dry aerosol exiting the desolvator was then transferred to the 
ICP torch via 1 m of 0.25 in. i.d. Tygon tubing. 
4.2.5 HPLC·Eiectrospray ionisation mass spectrometry 
HPLC was performed using a binary pump (P580A, Dionex-Softron GmbH, 
Germering, Germany) coupled with a C18(2) reversed phase column 
(Phenomenex Luna, 100 x 4.6 mm, 3 Jlm particle size) with the same gradient 
elution used for HPLC-SF-ICP-MS. The flow rate (1 ml min"1) was split post 
column (high pressure micro-splitter valve; Upchurch Scientific Ltd, Oak Harbor, 
WA, USA), and a portion (-200 Jll min"1) was diverted to the mass spectrometer 
and the residue to waste. Sample injections (5 Jll) were made manually with a 
metal-free injection valve (Rheodyne 9125, CA, USA). Mass spectrometry analysis 
was performed using an ion trap mass spectrometer fitted with an electrospray 
interface (ThermoQuest Finnigan Mat LCQ, San Jose, CA). Data were acquired 
and processed with Xcalibur 1.0 software. Instrument optimization was performed 
by infusing a 100 ng mL·1 solution of TMPP at 3 Jll min·1 monitoring for the 
characteristic positive ion at 590 m/z. The following instrument parameters were 
used: source voltage, +4.50 kV; capillary voltage, +20 V; tube lens offset, -10.00V; 
capillary temperature, 220 'C; nitrogen sheath gas flow rate, 60 (arbitrary units), 
and nitrogen auxiliary gas flow rate 20 (arbitrary units). Mass spectra were 
recorded in the positive ion mode within m/z 190-1000. 
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4.3 Results and Discussion 
4.3.1 Phosphorus selective detection 
Chromatograms of maleic acid (MA), after derivatisation with TMPP, are shown in 
Figure 4.1. Detection was performed by using SF-ICP-MS with 31P+ selective 
detection at 30.974 m/z (Figure 4.1 A and B), and ESI-MS (Figure 4.1 C and D). 
As can be seen, the TMPP derivatising reagent contained many phosphorus 
containing impurities (Figure 4.1 A), so it was necessary to optimise the 
chromatography such that the derivatised maleic acid (MA) was separated from 
these peaks (Figure 4.1 B), and particularly the large peak for unreacted TMPP. 
For comparison, and for confirmatory purposes, detection was also performed 
using ESI-MS and the major peak at 8.43 min was found to have a mass of 590 
m/z, which corresponds to the mass of TMPP. Likewise, the peak at 12.65 min 
was found to have a molecular ion at 688 m/z, indicating it to be MA derivatised 
with TMPP (Figure 4.1 D). A comparison of the chromatogram obtained using ICP-
MS (Figure 4.1 B) with the total ion chromatogram obtained using ESI-MS 
detection (Figure 4.1 C) indicates that the former method yielded a slightly 
improved signal-to-noise ratio, which should result in better detection limits. 
However, in this case, ESI-MS showed better signal-to-noise when single ion 
monitoring at the base peak of 688 m/z was performed. This highlights both the 
advantages and disadvantages of the two techniques, namely that ICP-MS is 
useful for high sensitivity screening purposes when confirmation that a compound 
contains phosphorus (or any other element for that matter) is required. Hence, 
once these peaks in the chromatogram have been identified, then ESI-MS can be 
used in single ion monitoring mode to perform further quantitative analysis. In this 
case the TMPP was synthesised in-house so was not particularly pure, however, it 
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is envisaged that a purer form of the reagent would alleviate some of the problems 
caused by interfering peaks in the ICP-MS chromatogram. 
Figure 4.1 
. 
-
.... 
' nooo-:111 .. 
A 
8 
D 
Unreacted TMPP 
Derivatised 
maleic acid 
Chromatograms of derivatised maleic acid. A, blank injection of 
TMPP and 31P+ selective detection using SF-ICP-MS; B, 
derivatised maleic acid and 31P+ selective detection using SF-
ICP-MS; C, derivatised maleic acid and total ion current using 
+ve ion ESI-MS; D, derivatised maleic acid and selective ion 
monitoring at 688 m/z using +ve ion ESI-MS. 
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4.3.2 Optimisation of derivatisation reaction 
In order to achieve optimal sensitivity the concentrations of the derivatisation 
reagents were optimised using a 2-factor, 3-level factorial design (Table 4.2). 
Concentrations of TMPP and CM PI were set at 0.1 mM, 1 mM and 10 mM for the 
derivatisation of 0.1 mM of MA. Triethylamine (TEA) was also present as the base 
for the reaction so its concentration was adjusted to equal the sum of the 
concentrations of TMPP and MA, in order to maintain the stoichiometry of the 
reagents. At higher concentrations of TMPP, many impurities were observed, thus 
making it difficult to identify the peak due to derivatised MA (see Figure 4.2 B). lt is 
desirable to achieve a situation where the derivatisation of MA is maximum for the 
lowest concentration of reagents, but that the reagents are always in sufficient 
excess to ensure constant reaction efficiency for varying concentrations of acid. In 
this case, maximum signal for derivatised MA (at 0.1 mM), and hence maximum 
reaction efficiency, was achieved at concentrations of 1 mM (TMPP) and 10 mM 
(CMPI), with the concentration of TEA at 11 mM. The effect of TMPP on the 
derivatisation of MA is shown in Figure 4.2. At a TMPP:MA ratio of 10:1 (1.0 mM 
TMPP, 0.1 mM MA) a net peak height signal of approximately 1,500 for derivatised 
MA was observed {Figure 4.2 A). At a TMPP:MA ratio of 100:1 (10 mM TMPP, 0.1 
mM MA) the peak height signal was similar at approximately 1, 700; however, 
impurities in the TMPP eluted close to the analyte peak (Figure 4.2 B) which made 
identification of the derivatised MA more difficult. A rough estimate of the efficiency 
of the reaction was obtained by ratioing the peak height of the derivatised MA to 
the sum of the derivatised acid plus the residual TMPP reagent peak, then 
expressing this as a percentage of the expected theoretical ratio calculated from 
the known concentrations. This assumes equal instrumental response for the two 
compounds, which should hold roughly true in this case given that a desolvator 
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was used and the nebuliser efficiency was similar over the duration of the gradient 
in which the peaks eluted. This is illustrated in Figure 4.2 A, where it is evident that 
the baseline signal, resulting from phosphorus impurities in the eluent, increased 
in a linear manner by only a factor of 2 over the course of the chromatographic 
run, and only by a factor of approximately 1.5 between the elution of TMPP and 
MA. Hence, for equimolar concentrations of MA and TMPP (1 mM) the reaction 
efficiency was 22%, and when TMPP was in 10-fold excess the reaction efficiency 
was 16%. Hence, it is likely that only between 10-20% of MA was derivatised 
under the conditions used and detection limits could be improved further by 
improving the efficiency of the reaction. 
Table 4.2 Two factor, three level full factorial design experiment to 
determine the optimal conditions for derivatisation of 0.1 mM 
maleic acid 
Solution CM PI TMPP TEA 
Number Concentration Concentration Concentration 
{mM) {mM) {mM) 
1 1.0 1.0 1.1 
2 0.1 1.0 1.1 
3 1.0 0.1 0.2 
4 1.0 10.0 10.1 
5 10.0 0.1 0.2 
6 0.1 10.0 10.1 
7 10.0 10.0 10.1 
8 0.1 0.1 0.2 
9 10.0 1.0 1.1 
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Figure 4,2 HPLC-ICP-MS chromatograms measuring 31P+ at 30.974 m/z for 
the derivatisation of 0.1 mM maleic acid with: (A) 10 mM CMPI 
and 1.0 mM TMPP and (B) 10 mM CMPI and 10 mM TMPP 
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An approximate limit of detection for derivatised MA, using 31 P+ selective detection 
by ICP-MS, was calculated as the concentration of MA which resulted in a peak 
height of 3x baseline noise. This resulted in a detection limit of 0.05 mM for a 5 ~L 
injection. This is confirmed by Figure 4.2 A, where a 0.1 mM injection can clearly 
be seen to be close to the detection limit. For comparison, detection limits for 
TMPP obtained in this work, and for malathion from previous work on the same 
instrument, are shown in Table 4.3. As can be seen, the compound specific 
detection limit for TMPP was approximately 5-6 times lower than that for 
derivatised MA (in molar terms) reflecting the 10-20% reaction efficiency of the 
latter. The 31 P+ specific detection limit for malathion achieved previously88 was 
approximately 1 0-times lower than the detection limit for TMPP determined in this 
work. The probable explanation for this is that a plasma shield was not used on 
this occasion which resulted in a 1 0-fold reduction in sensitivity, with a consequent 
increase in the detection limit. 
Table 4.3 Approximate absolute limits of detection for a 5 J.LL injection 
Compound specific 31 P+ specific 
(nmol) (ng) (ng) Ref. 
TMPP (bromide salt) 0.046 30 1.4 this work 
MA (derivatised) 0.25 29 7.8 this work 
Malathiona 0.16 88 
a 1 00 pL injection 
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4.3.3 Analysis of derivatised carboxylic acids 
The usefulness of the derivatisation reaction was tested for the detection of 
several other carboxylic acids, namely, fumaric, sorbic and salicylic acids. 
Detection using both HPLC-SF-ICP-MS e1P+ selective) and LC-ESI-MS (total ion 
and extracted ion ranges) was performed to verify which of the phosphorus 
containing peaks was due to the derivatised acids (Figure 4.3). Derivatised MA 
was observed at 12.6 minutes (Figure 4.2), sorbic acid at 14.4 minutes and 
fumaric acid at 12.0 minutes (Figure 4.3). No peak was observed with either 31 P+ 
selective ICP-MS or ESI-MS detection for derivatised salicylic acid. This is 
probably due to strong internal hydrogen bonding making salicylic acid a poor 
nucleophile, leading to an inefficient reaction with the CMPI activating reagent. lt 
should be possible to derivatise a range of carboxylic acids using this method, as 
described by Leavens et al. 78 They did not give any indication as to the efficiency 
of the reaction or detection limits. lt may be possible to improve the reaction 
efficiency by optimising the derivatisation chemistry, and utilising a solid phase 
analytical approach as described by Pilus et al. 89 
4.4 Conclusions 
HPLC-SF-ICP-MS has been used for the detection of maleic, sorbic and fumaric 
acids after derivatisation with the phosphorus containing reagent tris(2,4,6-
trimethoxyphenyl) phosphonium propylamine. This allowed 31 P+ selective detection 
to be performed on organic compounds, which are normally un-detectable by ICP-
MS, at low concentrations. The derivatisation reaction was partially optimised for 
maleic acid; however, there is scope for further improving the reaction efficiency to 
achieve lower detection limits and improved quantitative analysis. Further work on 
the preparation of a multiply brominated TMPP reagent (described in Chapter 6) 
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should allow simultaneous bromine and phosphorus selective detection. Multiple 
bromination should improve detection limits and make possible the use of this 
reagent to determine the degree of phosphorylation of peptides. The scope of 
application for reagents such as these is great, particularly in proteomics and 
genomics where ever more selective and sensitive methods of analysis are 
required. 
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Figure 4.3 Chromatograms of derivatised sorbic (left) and fumaric (right) 
acids. A, 31P+ selective detection using SF-ICP-MS; B total ion 
current using +ve ion ESI-MS; C, selective ion monitoring using 
+ve ESI-MS. 
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Chapter Five 
Synthesis of Tris(3,5-dibromo-2,4,6-trimethoxyphenyl) 
phosphonium propylamine bromide {BrTMPP) and its use as a 
derivatising reagent for carboxylic acids 
5.1 Introduction 
The derivatisation of carboxylic acids with TMPP has enhanced detection using 
ESI-MS and made possible phosphorus selective ICP-MS detection of these 
acids. However, the TMPP derivatising reagent has a mass of 590 m/z but only a 
single phosphorus atom of 31 m/z per molecule is detected by ICP-MS. However, 
if the carboxylic acids were derivatised with a molecule containing multiple 
heteroatoms, then enhanced detection using ICP-MS may be possible. This could 
be achieved in a number of ways, either by developing an alternative derivatising 
reagent with the attendant problems associated with this, or by modifying the 
existing TMPP reagent to facilitate enhanced detection. This could be achieved by 
incorporating more heteroatoms onto the molecule using a commercially available 
halogen containing reagent for preparing the related derivatising reagent. One 
such reagent is tris(4-chlorophenyl) phosphine which could be used instead of 
tris(2,4,6-trimethoxyphenyl) phosphine in the synthesis of tris(4-chlorophenyl) 
phosphonium propylamine bromide according to Scheme 5.1. This synthesis 
would utilise the reaction scheme as detailed in section 4.2.2. Derivatisation with 
this reagent would yield three chlorine atoms to each phosphorus atom, leading to 
a potential increase in detection sensitivity for the acids. 
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Br~NH2 
.HBr 
3-bromopropylamlne hydrobromlde 
Xylene 
Tris(4-chlorophenyl)phospt-ooium propylamine bromide 
Cl 
Tris(4-chlorophenyl)poosphine 
Scheme 5.1 Synthesis of tris(4-chlorophenyl)phosphonium propylamine 
bromide from tris(4-chlorophenyl) phosphine 
A simpler alternative is to halogentate the existing TMPP molecule at the un-
substituted carbon atoms on the aromatic rings. This halogenation of aromatics 
involves the following three steps. 
1) Generation of a positive halogen (electrophile) 
2) Attachment of the positive halogen to the aromatic ring (slow step) 
3) Removal of a proton to yield a neutral halogenated aromatic species 
(fast step) 
An example of this electrophilic aromatic substitution is the single chlorination of 
benzene90 shown in Scheme 5.2. The key step (2) is the attachment of the positive 
chlorine electrophile to the aromatic ring. As free Cl+ is not involved, ferric chloride 
is needed to form the complex in ( 1 ), from which chlorine is transferred to the ring, 
thus the generation of this electrophile is important. Other reagents that have been 
used to yield positive halogens for electrophilic aromatic substitution include 
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trifluoroacetyl hypohalites91 , hypobromous acid92• 93 hypochlorous acid93• 94 
bromine93, chlorine93 and bromine chloride93. 
GC±) 
1) Cl2 + FeCI3 - CI3Fe-CI-CI -
GC±) H (±); 
2) CI3Fe-CI-CI + CsHs- C6H\ + FeCI4- (Slow) 
H Cl 
3) 
(±); 
FeCI4- - C6H5CI + HCI + FeCI3 C6H\ + (Fast) 
Cl 
Scheme 5.2 Mechanism for the chlorination of benzene 
The TMPP molecule contains three aromatic rings each of which is tri-substituted 
with methoxy functional groups. These methoxy groups are electron donating, thus 
yielding a more negative charge on the ring, leaving it more reactive to an 
electrophile. This enables even weaker electrophiles to be utilised to halogenate at 
the non-substituted 3 and 5-carbons on the ring. If all unsubstituted carbons are 
successfully halogenated, six halogen atoms will be incorporated into the 
molecule. This would enable both phosphorus and halogen detection to be utilised 
for the derivatised carboxylic acids, with the added benefit of detecting six 
halogens compared to the single phosphorus atom as described in chapter 4. In 
this chapter, the synthesis of tris(3,5-dibromo-2,4,6-trimethoxyphenyl) 
phosphonium propylamine bromide (BrTMPP) derivatising reagent and it's 
subsequent characterisation is described. The use of this reagent to derivatise 
carboxylic acids and detect them using bromine and phosphorus selective ICP-MS 
detection is also described. 
107 
5.2 Experimental 
5.2.1 Chemicals and reagents 
Maleic acid, 2-chloro-1-methylpyridinium iodide (CMPI), triethylamine (TEA), 
sodium bromate, sulphuric acid, perchloric acid and formic acid were obtained 
from Sigma-Aidrich (Poole, Dorset, UK). Acetonitrile (HPLC grade) was obtained 
from Fisher Scientific UK Ltd. (Loughborough, Leicestershire, UK). High purity 
water (18.2 MO) was obtained using an Elga Maxima water purifying system. 
5.2.2 Preparation of hypobromous acid 
Hypobromous acid was prepared from sodium bromate in strong acidic medium 
using an adaptation of the method detailed by Noszticzius et a/.95 Sodium bromate 
(2 ml of a 1 M aqueous solution) was added drop wise to a stirred mixture of 3 ml 
of water and 5 ml of concentrated sulphuric acid at 0 ·C. The mixture was slowly 
warmed to 40 ·c using a water bath. When the vigorous evolution of oxygen 
ceased, the mixture was stored in a refrigerator until needed. In the strong acidic 
medium, the bromate decomposes to hypobromous acid according to the following 
equation: 
In this acidic medium, an equilibration reaction occurs yielding a bromine 
electophile according to the following equation: 
HOBr + H+ 
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The hypobromous acid solution must be freshly prepared as the hypobromous 
acid further decomposes to bromine according to the following equation: 
5.2.3 Synthesis of Tris(3,5-dibromo-2,4,6-trimethoxyphenyl) phosphonium 
propylamine bromide (BrTMPP) 
TMPP was synthesised in-house using the procedure detailed in section 4.2.2. 
TMPP (90.3 mg of the previously synthesised material) was dissolved in 25 ml of 
ethanol. 1 ml of perchloric acid and all the hypobromous acid prepared as 
detailed in 5.2.2 were added. The solutions were left stirring on a magnetic stirrer 
for 1.5 hours. The solution was left overnight for the ethanol to evaporate off. A 
yellow precipitate was formed, which was isolated by filtration and dried overnight 
at 30 ·c to give the title compound shown in Scheme 5.3. 
TMPP tmlz 590\ 
Scheme 5.3 Synthesis of 
Excess Br+ MeO 0 OMe 
,_../NH2 
Br~p•»Me Br 
Br- I 
0 MeO eMeO OMe 
Br Br 
BrTMPP tm/z 1064\ 
Tris(3,5-dibromo-2,4,6-trimethoxyphenyl) 
phosphonium propylamine bromide (BrTMPP) 
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5.2.4 Preparation of coupling reagent 
The optimum concentrations of 10 mM CM PI and 11 mM TEA for derivatisation 
were determined in Section 4.3.3. Thus, 68.3 mg of CMPI was dissolved in 
approximately 20 mL of acetonitrile in a 25 mL volumetric flask. Triethylamine 
(39.8 IJL) was added, and the solution made up to volume with acetonitrile. 
5.2.5 Coupling of BrTMPP propylamine with maleic acid 
To maleic acid (500 f.1L) in 90:10 % (v/v) water:acetonitrile were added 500 flL of 
CMPI/TEA coupling reagent (prepared as above). After thorough mixing for five 
minutes at room temperature, 500 flL of 1 mM BrTMPP propylamine solution in 
acetonitrile was added. The solution was left to react for 30 minutes in an 
ultrasonic bath at room temperature. The reaction scheme is identical to that 
detailed in Scheme 4.2, except this time it is with brominated TMPP. 
5.2.6 HPLC-ICP-MS analyses 
For HPLC-ICP-MS analyses, a HP1090 chromatography system incorporating a 
UV/vis detector (Agilent Technologies, Stockport, U.K.) equipped with a C18(2) 
reversed phase column (Phenomenex Luna, 100 x 4.6 mm, 3 flm particle size) 
was used. The mobile phase comprised a binary system of: eluent A, 
water:acetonitrile (90:10 % v/v) containing 0.05% formic acid (v/v); and eluent B, 
water/acetonitrile (10:90 % v/v) containing 0.05% (v/v) formic acid. The linear 
gradient employed started at 100% volume fraction A, changing to 1 0% volume 
fraction A and 90% volume fraction B over 30 minutes. The flow rate was 1 mL 
min·1 with an injection volume of 5 fll. All experiments were performed using a 
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quadrupole inductively coupled plasma mass spectrometer (Thermo Elemental 
PQ3, Winsford, U.K.). Operating conditions are shown in Table 5.1. 
Table 5.1 Operating conditions for quadrupole-ICP-MS 
ICP 
Nebuliser gas flow/Lmin"1 
Auxiliary gas flow/Lmin-1 
Coolant gas flow/Lmin"1 
RF Forward Power/W 
Nebuliser 
Spray Chamber 
Torch 
Interface 
Sampling cone 
Skimmer cone 
Time Resolved Analysis 
Masses monitored 
Dwell time/ms 
1.10 
0.85 
14.0 
1450 
Glass Concentric (Glass Expansion, Switzerland) 
Jacketed quartz cyclonic, cooled to 5 oc 
Quartz Fassel-type without shield 
Nickel1 mm i.d. 
Nickel, 0. 7 mm i.d. 
Monitoring for 31 P+ at 31 m/z and 79Br• at 79 m/z 
500 
The HPLC column was coupled with the Q-ICP-MS simply by inserting the end of 
the tubing from the column into the sample uptake inlet of the nebuliser, and the 
output from the spray chamber was introduced into a Universal Interface Model B 
desolvation device (Vestec Corporation, Houston, USA). The sweep gas was 
optimised daily at approximately 2.0 L min-1 to ensure the maximum signal for 31 P+ 
was achieved. The dry aerosol exiting the desolvator was then transferred to the 
ICP torch via 1 m of 0.25 in. i.d. Tygon tubing. 
5.2.7 HPLC-Eiectrospray ionization mass spectrometry 
HPLC was performed using a binary pump (P580A, Dionex-Softron GmbH, 
Germering, Germany) coupled with a C18{2) reversed phase column 
{Phenomenex Luna, 100 x 4.6 mm, 3 Jlm particle size) with the same gradient 
elution used for HPLC-ICP-MS. The 1 ml min"1 flow rate was split post column 
(high pressure micro-splitter valve; Upchurch Scientific Ltd, Oak Harbor, WA, 
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USA), and a portion of the stream (-200 J!L min"1) was diverted to the mass 
spectrometer and the residual to waste. Sample injections (5 J!L) were made 
manually with a metal-free injection valve (Rheodyne number 9125, CA, USA). 
Mass spectrometric analysis was performed using an ion trap mass spectrometer 
fitted with an electrospray interface (ThermoQuest Finnigan Mat LCQ, San Jose, 
CA). Data were acquired and processed with Xcalibur 1.0 software. Instrument 
optimization was performed by infusing a 100 ng mL"1 solution of TMPP at 3 J!L 
min"1 monitoring the characteristic positive ion at 590 m/z. The following instrument 
parameters were used: source voltage, +4.50 kV; capillary voltage, +20 V; tube 
lens offset, -10.00V; capillary temperature, 220 ·c; nitrogen sheath gas flow rate, 
60 (arbitrary units), and nitrogen auxiliary gas flow rate 20 (arbitrary units). Mass 
spectra were recorded in the positive ion mode within m/z 150-1500. For 
characterisation of the synthesised BrTMPP, the same system set-up was used, 
except no HPLC column was adopted. The mass spectrum was recorded in the 
positive ion mode within 190-2000 m/z. 
5.2.8 Nuclear Magnetic Resonance 
All 1H NMR spectra were acquired at 270 MHz using a Jeol EX270 Fourier 
Transform NMR spectrometer in deuterated methanol (CD30D, Goss Scientific, 
Great Baddow, UK). 31 P NMR spectra were acquired using the same instrument at 
109 MHz, but in this case the centre of the spectral window acquired, 700 ppm, 
was set to o 0 ppm and used to reference the spectra as the solvent used does not 
contain any phosphorus to reference the signal to. 
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5.3 Results and Discussion 
5.3.1 Synthesis of Tris(3,5-dibromo-2,4,6-trimethoxyphenyl) phosphonium 
propylamine bromide (BrTMPP) 
Initial attempts to synthesise a halogenated phosphonium derivatising reagent 
focussed on the synthesis of a tris (4-chlorophenyl) phosphonium propylamine 
bromide, using the commercially available tris (4-chlorophenyl) phosphine. This 
utilised the synthetic procedure detailed in Scheme 5.1, starting with the 
commercially available tris (4-chlorophenyl) phosphine. Despite many attempts at 
this synthesis, it proved unsuccessful, with no reaction appearing to take place. 
This is probably due to the inductive effect of chlorine as opposed to the high 
activating effect of the methoxy groups on the phenyl rings for nucleophilic attack. 
The electron withdrawing effect of three chlorine atoms may result in some de-
activation of the phosphorus lone pair, making it a poor nucleophile. This synthesis 
was repeated, but at a higher temperature to attempt to increase the rate· of 
reaction. Xylene (boiling point 138 oc) was used as the solvent instead of toluene 
(boiling point 11 0 °C}, but again this proved unsuccessful. 
The second approach was to use the already synthesised TMPP reagent, and 
halogenate it at the non-substituted atoms of the phenyl rings. To do this a 
bromine electrophile would need to be prepared. Two initial ideas were to use 
bromine or hypobromous acid to produce the bromine electrophile. Although 
bromine generally needs a Lewis acid catalyst to react with aromatic rings, more 
highly reactive aromatic rings (i.e. those whose TT-electrons are more available) do 
react with halogens in the absence of any Lewis acid90. As the TMPP molecule 
contains methoxy substituents, then a more reactive ring is formed, thus 
bromination using bromine liquid was a possibility. However, when this was 
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attempted, no bromination occurred, with only the original TMPP starting material 
being produced after the synthesis. This is likely to be due to the fact that bromine 
on its own yields only a very weak electrophile, produced by a dipole-dipole bond. 
lt appears that a much stronger electrophile is needed for this electrophilic 
aromatic substitution. 
A stronger bromine electrophile is produced by hypobromous acid. These are still 
relatively weak electrophiles93, which only react with aromatic substrates with 
activated rings. As the TMPP molecule contains three methoxy substituents, which 
activate the ring, they are susceptible to electrophilic attack by relatively weak 
electrophiles. When the hypobromous acid was prepared fresh as detailed in 
Section 5.2.2, and was added to the TMPP, a yellow solution was produced. After 
the solvent was removed, a yellow precipitate was isolated with a yield of 0.80 g, 
50.3%. To characterise this material, 1H and 31 P NMR, and infusion ESI-MS were 
used. The mass spectrum of the synthesised material yielded a large peak with a 
mass of 1064 m/z (most abundant ion of isotope cluster) in positive ion mode 
(Figure 5.1 ), which is the characteristic mass of the most abundant mono isotopic 
peak of the already positively charged BrTMPP molecule. Further evidence that 
this material was BrTMPP was collected by examining the isotope pattern 
produced. The BrTMPP molecule contains six bromine atoms so a characteristic 
bromine isotope pattern would be expected. The BrTMPP molecule elemental 
composition was entered into an isotope distribution program software package 
(Anton Erasmuson, Upper Hutt, New Zealand) and its distinctive isotope pattern 
was calculated (Figure 5.2). The predicted/calculated isotope pattern was almost 
identical to that obtained experimentally from the synthesised material. 
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Figure 5.1 Positive ion ESI mass spectrum of the synthesised BrTMPP 
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Figure 5.2 Calculated isotope pattern for BrTMPP 
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To further confinn that this material was BrTMPP, 1H NMR and 31 P NMR spectra 
were obtained. The 1H NMR spectrum obtained for this material dissolved in 
deuterated methanol is shown in Figure 5.3 along with the spectral data in Table 
5.2. The 1H spectrum showed no peaks at a chemical shift of 6-9 ppm, thereby 
confinning the absence of aromatic protons of the original TMPP (chemical shift of 
6.21 ppm, see Figure 3.2). This suggested that electrophilic aromatic substitution 
of the hydrogens on the phenyl ring had taken place. However, when assigning 
the spectrum, it appeared that it did not yield the correct integral values for the 
propylamine side chain. This was probably due to the low purity of the synthesised 
product, and the weak signal of these protons. The spectrum also showed a large 
unidentified peak at 3.6 ppm (d) which was probably due to the solvent. Further 
evidence that the synthesised product was obtained is shown in the 31 P NMR 
spectrum which showed one major peak at a chemical of shift of 11.18 ppm 
(Figure 5.4). This was different to that obtained for TMPP which produced a 
chemical shift of 6.65 ppm (see Figure 3.5). The 1H and 31 P NMR data obtained, 
along with the mass spectral data confinn that the BrTMPP was synthesised 
successfully. 
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Figure 5.3 1H NMR spectrum for synthesised BrTMPP, the data for each 
signal (lettered) is shown in Table 5.2 
Table 5.2 1H NMR spectral data and peak assignment for the synthesised 
BrTMPP 
Peak I.D. Chemical Integral 
Shift (ppm) 
a 4.90 
b 4.01 9 
c 3.76 18 
d 3.66 5 
e 
f 
g 
h 
3.31 
3.20 
2.79 
1.94 
1.34 
2.3 
0.5 
0.4 
Coupling 
pattern 
Singlet 
Singlet 
Singlet 
Multiplet 
Triplet 
Multiplet 
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Assignment 
Residual water in solvent 
4- OCH3 
2- and 6- OCH3 
Unidentified 
From Solvent 
Cf:hCH2CH2NH2 
CH2CH2C.lliNH2 
From Solvent 
400 300 200 100 0 -100 -200 -300 -400 
Bppm 
Figure 5.4 31P NMR spectrum for BrTMPP in deuterated methanol 
5.3.2 Phosphorus and bromine selective detection 
Chromatograms of maleic acid (MA}, after derivatisation with BrTMPP, are shown 
in Figure 5.5 and Figure 5.6. Detection was performed using ICP-MS with 31 P+ and 
79Bt selective detection at 31 m/z and 79 m/z respectively (Figure 5.5), and ESI-
MS (Figure 5.6). As can be seen, the BrTMPP derivatising reagent contained 
many phosphorus and bromine containing impurities (Figure 5.5), so it was 
necessary to optimise the chromatography such that the derivatised maleic acid 
(MA) was separated from these peaks and particularly the large peak for 
unreacted BrTMPP at 11 minutes. For comparison, and confirmatory purposes, 
detection was also performed using ESI-MS (Figure 5.6) and the peak at 10.61 
minutes was found to have a mass of 1064 m/z (most abundant monoisotpic peak 
of isotope cluster), which corresponded to the mass of the most abundant isotope 
of BrTMPP. Likewise, the peak at 16.55 min. was found to have a mass of 1162 
m/z (most abundant monoisotopic peak of isotope cluster}, indicating it to be MA 
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derivatised with BrTMPP (Figure 5.6 B). This was further confirmed by checking 
the bromine isotope ratio pattern, which was identical to that shown in Figure 5.1. 
There was a slight difference in retention time between ICP-MS and ESI-MS 
peaks, which was the result of the extra tubing required to connect the LC system 
to the ICP-MS and also the extra time required to transport the aerosol through the 
desolvator to the plasma. A comparison of the chromatograms obtained using 
ICP-MS indicates that by monitoring bromine rather than phosphorus a larger 
signal was achieved, as expected. After examining the chromatograms, a nine-fold 
increase in signal was achieved. The ICP-MS chromatogram contained many 
impurity peaks, so ESI-MS was essential in identifying and confirming which peak 
was the derivatised MA. In this case both the TMPP and the BrTMPP derivatising 
reagents synthesised in-house were not particularly pure. If the initial step of 
synthesising the TMPP and the subsequent BrTMPP synthesis were purified this 
may alleviate some of the problems caused by interfering peaks in the ICP-MS 
chromatograms. 
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4e6 79Br+ selective detection 
31 p+ selective detection 
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X10 
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Derivatised Maleic acid 
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10 12 14 16 16 20 
Time, mins 
Figure 5.5 LC-ICP-MS chromatograms for derivatised maleic acid detecting 
79Br+ and 31 p+ at a concentration of 330 tJM 
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RT: 0 .00 - 20.97 Derivatised Maleic acid 
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Time (m in ) 
Figure 5.6 LC-ESI-MS chromatograms for derivatised maleic acid at a 
concentration of 30 IJM. A, derivatised maleic acid and total ion 
current using +ve ion ESI-MS; B, derivatised maleic acid and 
extracted ion chromatogram for 1162 m/z using +ve ion ESI-MS 
5.4 Conclusions 
Tris(3,5-dibromo-2,4,6-trimethoxyphenyl) phosphonium propylamine bromide 
(BrTMPP) has been successfully synthesised using hypobromous acid to generate 
the bromine electrophile. The synthesised product was characterised by 1H NMR 
and electrospray mass spectrometry. HPLC-SF-ICP-MS has been used for the 
determination of maleic acid, after derivatisation with BrTMPP. This allowed 31 P+ 
and 79Br+ selective detection to be performed on organic compounds which are 
normally invisible to detection by ICP-MS at low concentrations. By derivatising 
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Chapter Six 
Liquid Chromatography Coupled to Inductively Coupled Plasma 
Mass Spectrometry for the Determination of Phosphorylated 
Peptides 
6.1 Introduction 
6.1.1 Protein phosphorylation 
Dynamic post-translational modification is a general mechanism for maintaining 
and regulating protein structure and function96. Among the many post-translational 
modifications that have been characterised, protein phosphorylation plays a very 
important role. lt was over forty years ago since it was first recognised that the 
enzymatic phosphorylation and dephosphorylation of proteins and peptides, often 
referred to as 'reversible phosphorylation', was a dynamic process involved in the 
regulation of cellular functions. Prior to this, these proteins were generally thought 
to have nutritional functions, for example, providing a source of phosphorus for 
growing organisms. Up until the studies by Earl Sutherland and his colleagues97"100 
and by Ed Fischer and Edwin Krebs 101 .103 there was no idea that rapid tu mover of 
protein-bound phosphate might occur, and there was no knowledge of the 
mechanisms involved in the formation of phosphorylated proteins. These studies 
recognised the process involved for reversibly altering the function and structure of 
proteins. 
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The direct involvement of protein phosphorylation in a metabolic pathway of a 
eukaryotic system was first demonstrated by Krebs and Fischer in 1956101 • 102• 
They showed that the activity of skeletal muscle glycogen phosphorylase, an 
enzyme involved in glycogenolysis, is regulated by reversible modification. The 
chemical reactions involved with this system were subsequently reported by the 
same group in 1958103, which together with further work in this area won them the 
joint 1992 Nobel Prize in Physiology or Medicine:t. Almost at the same time, 
pioneering work by Bumett and Kennedy104 on the phosphorylation of casein 
dispelled the theories that this reversible phosphorylation was utilised only by 
enzymes involved in glycogen metabolism. More recently, increasing numbers of 
phosphoenzymes and phosphoproteins have been characterised in a wide range 
of eukaryotic systems from fungi to mammals 105. During this rapid spread of 
interest in protein phosphorylation, it has been apparent that this applies to many 
areas of research. These include, for example, researchers involved in protein 
synthesis, muscle contraction, oocyte maturation and the cell cycle, virology, 
transcriptional regulation, lymphocyte activation, secretion, and ion channels 106. 
Protein phosphorylation is essentially incorporated in almost all areas of biological 
research 106. 
Reversible phosphorylation of proteins at serine, threonine, and tyrosine residues 
is probably the most important regulatory mechanism in gene expression and 
protein synthesis 107• 108. Cell signalling, controlled by protein phosphorylation, 
regulates many cellular functions at receptors, ion channels, transcription factors, 
kinases and contractile proteins 108• This regulation can occur via modulation of eo-
operative binding of contractile proteins,109 protein-protein interactions, or by 
~The prize was awarded jointly to Edmond H. Fischer and Edwin G. Krebs "for their discoveries 
concerning reversible protein phosphorylation as a biological regulatory mechanism" 
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autoinhibition of protein kinases 110. All these interactions involve the alteration of 
the charge of the newly formed phosphorylated amino acid, which instigates local 
or global changes 108. Therefore, the alteration of a single residue via reversible 
phosphorylation is capable of initiating complex cellular signals involved in almost 
all-physiological processes: metabolism, differentiation, and contraction, etc110-112 . 
This demonstrates the need to understand reversible phosphorylation qualitatively 
(i.e., the site where the modification is taking place) and quantitatively (to what 
degree the site is modified). 
6.1.2 Protein phosphorylation mechanism 
Protein kinases are enzymes which transfer phosphate groups from a nucleoside-
triphosphate onto an acceptor amino acid in a substrata protein 105• The protein 
kinase enzymes catalyse the transfer of a phosphate group from adenosine 
triphosphate (ATP) to the target protein. This can yield an activated or deactivated 
protein, depending on its function and its phosphorylated state. Protein 
phosphatase enzymes do the opposite; they are responsible for removing the 
phosphorylated group from the protein, yielding the unphosphorylated form again. 
For this reason, the process is described as reversible (Figure 6.1 ). Changes in 
the level, subcellular location and activity of these kinases and phosphatases have 
consequences on normal cell function and maintenance of cellular homeostasis. 
These protein kinases and phosphatases play an essential role in many signalling 
pathways, and therefore have the potential to contribute to diseases ranging from 
cancer and inflammation to diabetes and cardiovascular disorders, not to mention 
cell growth, survival and many other biological functions. Recent investigations 
reveal that there are over 500 human kinases, making them one of the most 
populated classes of druggable targets. 
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Figure 6.1 Simplified schematic diagram of reversible phosphorylation 
6.1.3 Methods to determine protein phosphorylation 
Many methods have been used to examine protein phosphorylation. The usual 
procedure is based on labelling the phosphate fraction with 32P, purification and 
enzymatic digestion followed by peptide separation. The separated peptides are 
then subjected to Edman sequencing whereby the sites of phosphorylation are 
determined by the radioactive label during the Edman cycles 113• In Edman 
sequencing, each amino acid is cleaved in sequence from the N-terminus of the 
protein/peptide, and detected. By piecing together this amino acid sequence, the 
structure of the peptide/protein can be deduced. This method does give a high 
degree of sensitivity and robustness, but there are some important disadvantages. 
The radiation emitted by the labelled 32P can stress biological systems, and 
therefore can interfere with any in-vivo incorporation of 32P-Iabelled phosphate, 
hampering the cell cycle studies. In vitro incorporation of 32P can give access to 
attached phosphate groups in addition to those incorporated in the protein, and 
therefore provides no truly reliable insights into the sites of phosphorylation. 
Generally, 32P labelling alone gives only poor information on the specific site of its 
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incorporation. Finally, as 32P is radioactive, the extra safety precautions needed to 
be adopted for its use may be forbidden for some laboratories. 
This has lead to a number of attempts to develop non-radioactive methods for 
analysing protein phosphorylation, primarily based on the combination of 
enzymatic digestion and mass spectrometry. The advantages of these techniques 
include the relative speed, sensitivity and adaptability of MS, with a +80 Da mass 
increase being indicative of the attachment of a phosphate group. This method 
was successfully adopted for the determination of phosphorylation sites in the 
internal repeat of rat profilaggrin 114• In the work by Resing et al., tryptic peptides of 
filaggrin and profilaggrin were fractionated by reversed-phase HPLC and analysed 
by electrospray ionisation mass spectrometry. Nine phosphopeptides were 
identified as those with masses of 80 Da (or multiples of 80 Da) greater than the 
unphosphorylated peptides. In order to determine the exact site of 
phosphorylation, peptide sequencing with collisionally induced dissociation (CID) 
is needed. Problems did occur in that several multiply-phosphorylated peptides 
underwent neutral loss of H3P04 during collisional activation, leading to 
complications when interpreting the MS/MS spectra. 
A more specific method for phosphopeptide identification uses the specificity of 
phosphatase enzymes 115. Peptide mapping using MALDI before and after 
phosphatase treatment detects phosphatase by the shift of 80 Da due to the 
removal of the phosphate moiety. The 80-Da difference and the difference in 
retention times between the enzyme-treated and untreated sample identifies the 
phosphopeptides. 
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Protein phosphorylation sites have also been determined using in-gel digestion 
and nanoelectrospray tandem mass spectrometry116. This method detected the 
phosphopeptides of [3-casein after in gel digestion at the level of 250 fmol of 
protein applied to the gel. This method is not very rapid so, if specificity about the 
site is required, then this method becomes very laborious. 
A further problem with the use of mass spectrometry for phosphopeptide detection 
is that the ionisation efficiency of both MALDI and electrospray ionisation mass 
spectrometry is compound dependent, which leads to reduced ionisation efficiency 
for phosphopeptides compared to unmodified peptides. Thus, these methods tend 
to only yield qualitative information about the phosphorylation status of a protein. 
Large phosphopeptides (mol wt > 2500) may also not be detected due to their 
poor fragmentation characteristics. A recent paper published by Ruse et a/.108 
compensated for this by using an internal standard that was present in the digest 
from the protein studied, but unmodified by the modification reaction. Liquid 
chromatography coupled to mass spectrometry was used for the analysis of the 
peptides produced by in-gel digestion and separated by SDS-PAGE. This method 
is ideally suited to measure a phosphorylation reaction, but is not necessarily 
ideally suited for a screening exercise. 
Much of the recent work on protein phosphorylation analysis is based on element 
specific mass spectrometry with phosphorus selective detection. This approach 
should overcome some of the limitations of the current radioactive and mass 
spectrometric methods. This quantitative technique of element selective analysis 
has seen increasing biological applications in recent years, especially when 
coupled to chromatography. 
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Much of the phosphoprotein analysis using inductively coupled plasma mass 
spectrometry has been performed by Mathias Winds' group at the Cancer 
Research Centre in Germany. In the first paper, published in 2001 83, his group 
used capillary liquid chromatography with element specific 31 P+ detection using 
ICP-MS and electrospray ionisation mass spectrometry for confirmation of the 
phosphoproteins. This technique was successfully adopted for the analysis of 
digests of three phosphoproteins, ~-casein, activated human MAP kinase ERK1, 
and protein kinase A catalytic subunit. The chromatography used for their 
separation did, however, only identify a single monophosphorylated fragment for 
~-casein, when in fact there are two phosphopeptides produced when ~-casein is 
digested with trypsin. The other highly phosphorylated fragment was retained on 
the column, and hence was not detected by either ICP-MS or MS83. 
In a separate pape~2 • Wind's group determined the degree of phosphorylation 
using the stoichiometric phosphorus to sulphur ratio e1P to 32S) determined in 
phosphopeptides containing cysteine and/or methionine residues. This was then 
converted into the degree of phosphorylation using protein/peptide sequence 
information. The major drawback with this approach is that the number of cysteine 
and/or methionine residues must be known. 
Another separation technique often used in protein/peptide separations is gel 
electrophoresis. Marshal! et a/.117 used this separation technique with laser 
ablation (LA) ICP-MS to determine protein phosphorylation on electrophoresis gel 
blots. The detection limit on the gel blots for phosphorus using ICP-MS were found 
to be 16 pmol. This does have considerable potential for protein phosphorylation 
and also for the determination of metals. This paper also detailed some of the 
129 
problems of using LA-ICP-MS for 31P+ selective detection of electrophoresis gels 
due to the large background obtained from the gels themselves. 
6.1.4 Aims of this study 
The work described in this chapter utilises phosphorus selective detection by ICP-
MS to detect phosphorylated peptides. Reversed phase chromatography was 
used, so a membrane desolvation device attached prior to the aerosol entering the 
plasma was necessary to enable gradient elution with up to 90% acetonitrile. By 
comparing UV and 31P+ selective detection, phosphorylated peptides should be 
easily distinguishable from un-phosphorylated peptides. Detection of 
phosphorylated and un-phosphorylated peptides is compared, along with detection 
of an in-solution tryptic digest of bovine J3-casein. 
This only yields qualitative data of where the peptide is phosphorylated. To 
determine the actual extent of phosphorylation, the technology developed for the 
derivatisation of carboxylic acids with BrTMPP can be adopted. The BrTMPP 
molecule contains one phosphorus atom and six bromine atoms. Hence, it can be 
used to derivatise a peptide at the C-terminus and by monitoring the Br/P ratio 
using LC-ICP-MS the extent of phosphorylation can be determined. For example, 
if a singly phosphorylated peptide was derivatised with BrTMPP the Br/P molar 
ratio would be 9:2, whereas if a doubly phosphorylated peptide was derivatised, a 
ratio of 9:3 would be achieved, and so on. Problems do arise if the peptide 
contains carboxylic acid side chains. If the BrTMPP reagent successfully 
derivatises the side chain which, if derivatised along with the C-terminus, would 
yield a different Br/P ratio. Table 6.1 shows the calculated theoretical ratios that 
would be obtained depending on the extent of phosphorylation and derivatisation 
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of the phosphorylated peptides. The theory generally works but if a ratio of 9:2 or 
9:3 was obtained, this could be interpreted in several ways. One solution would be 
to use LC-ESI-MS in parallel. The examination of the mass obtained for the peak 
of interest in LC-ESI-MS, and its bromine isotope ratio pattern, would show the 
number of BrTMPP molecules attached to the peptide. Hence, with this 
information the degree of phosphorylation could be deduced. 
Table 6.1 Bromine to phosphorus ratios theoretically obtained for 
BrTMPP derivatised phosphorylated peptides 
Number of BrTMPP 
molecules added 
1 
2 
3 
Number of Phosphorylation sites 
0 
9:1 
18:2 
27:3 
1 
9:2 
18:3 
27:4 
2 
9:3 
18:4 
27:5 
3 
9:4 
18:5 
27:6 
A further problem with derivatising peptides comes with the chemistry involved in 
the derivatisation reaction. The reaction utilises the intermediate activation of the 
carboxylic acid, prior to a condensation reaction with an amine (from the 
derivatising reagent) to form a stable amide bond. However, both these reactive 
groups are present in peptides (which is the main reason CMPI reagents were 
developed) so the peptides can preferentially react with themselves to make 
polymers of the same peptide sequence. To overcome this preferential self 
reactions of the peptides, N-terminus protected peptides need to be used for this 
purpose. 
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6.2 Experimental 
6.2.1 Chemicals and reagents 
High purity water (DDW) {18.2 MO) was purified in house using an Elga Maxima 
water purifying system. Acetonitrile was of HPLC grade quality and was purchased 
from Fisher Scientific UK Ltd. (Loughborough, Leicestershire, UK). Trypsin, (3-
casein, HPLC peptide standard mix (H2016), ammonium acetate, sodium 
polyphosphate, bovine (3-casein, trypsin, ammonium bicarbonate, 3-
(methylphosphinico)propionic acid, potassium P,P-dimethylphosphonoacetate, 
diethylphosphonoacetic acid • 2-chloro-1-methylpyridinium iodide (CMPI), and 
triethylamine (TEA) were all obtained from Sigma-Aidrich (Poole, Dorset, UK). The 
phosphorylated peptide (pp60 c-src) was obtained from Bachem, (Weil am Rhein, 
Germany) and the other two synthesised phosphorylated peptides (PRN5220 and 
PRN5221) were obtained from Biomollntemational (Exeter, Devon, UK). 
6.2.2 Preparation of samples for qualitative determination of 
phosphorylation 
The peptide standard mix and the phosphorylated peptide (pp60 c-src) samples 
were prepared to contain 1 mg mL·1 of the compound dissolved in DDW. The 
sample was a 50:50 %(v/v) mixture of these two samples. 
6.2.3 Tryptic Digest of bovine P-casein 
Many different protocols exist in the literature for performing tryptic digests, but 
most of these are utilised for in-gel digestions. The following protocol was used 
due to its ease of use and it's applicability to in-solution digests. A 10:1 mass ratio 
of (3-casein (0.3 g) to trypsin (0.03 g) was added into 25 mL of a solution 
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containing 25 mM ammonium bicarbonate in DDW. The mixture was then 
incubated at 37 oc with shaking overnight, prior to analysis. 
6.2.4 Preparation of coupling reagent 
The optimum concentrations of CM PI ( 1 0 mM) and TEA ( 11 mM) for derivatisation 
were determined in Section 4.3.2. Thus, 68.3 mg of CMPI was dissolved in 
approximately 20 mL of acetonitrile in a 25 mL volumetric flask. Triethylamine 
(39.8 IJL) was added, and the solution made up to volume with acetonitrile. 
6.2.5 Coupling of BrTMPP propylamine with carboxylic acids and 
phosphorylated peptides 
To 500 flL of 1 mM carboxylic acid (3-(methylphosphinico)propionic acid, 
potassium P,P-dimethylphosphonoacetate or diethylphosphonoacetic acid) in 
90:10 % (v/v) water:acetonitrile or 10 mM phosphorylated peptide (see Section 
6.4.4) in water were added 500 flL of CMPI/TEA coupling reagent (prepared as 
above). After thorough mixing for five minutes at room temperature, 500 flL of 1 
mM BrTMPP propylamine solution in acetonitrile was added. The solution was left 
to react for 30 minutes in an ultrasonic bath at room temperature. 
6.2.6 HPLC-ICP-MS analyses for qualitative phosphorylated peptide 
analysis 
For HPLC-ICP-MS analyses, a HP1 090 chromatography system incorporating a 
UV/vis detector (Agilent Technologies, Stockport, U.K.) equipped with a C18 250 x 
4.6 mm analytical column (Hypersii-Keystone PEP 300A, Thermo Electron 
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Corporation, Runcom, UK) was used. The mobile phase comprised a binary 
system of: eluent A, 0.05 M ammonium acetate in water and eluent B, acetonitrile. 
For the determination of detection limits using sodium polyphosphate (Na5P30 10) a 
simple isocratic elution with 99 o/o(v/v) eluent A, 1 o/o(v/v) eluent B was used. For 
the peptide HPLC test mix (a standard mixture of five peptides obtained from 
Sigma-Aidrich, Poole, Dorset) and/or phosphorylated peptide standard (pp60 c-
src), a gradient of 0-30 min. 0-30% solvent B was used. For the ~-casein analysis, 
the gradient was increased to 0-60 min, 0-50% solvent B to ensure all components 
were eluted from the HPLC column. All experiments used a 20 IJL injection 
volume. All experiments were performed using a quadrupole inductively coupled 
plasma mass spectrometer (Thermo Elemental PQ3, Winsford, U.K.). Operating 
conditions are shown in Table 6.2. The HPLC column was coupled with the ICP-
MS simply by inserting the end of the tubing from the column into the sample 
uptake inlet of the nebuliser, and the output from the spray chamber was 
introduced into a Universal Interface Model B desolvation device (Vestec 
Corporation, Houston, USA). The sweep gas was optimised daily at approximately 
2.0 L min-1 to ensure the maximum signal for 31 P+ was achieved. The dry aerosol 
exiting the desolvator was then transferred to the ICP torch via 1 m of 0.25 in. i.d. 
Tygon tubing. 
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Table 6.2 Operating conditions for quadrupole-ICP-MS 
ICP 
Nebuliser gas flow/Lmin"1 
Auxiliary gas flow/Lmin·1 
Coolant gas flow/Lmin·1 
RF Forward Power/W 
Nebuflser 
Spray Chamber 
Torch 
Interface 
Sampling cone 
Skimmer cone 
Single Ion Monitoring 
Masses monitored 
Dwell time/ms 
1.10 
0.85 
14.0 
1450 
Glass Concentric (Glass Expansion, Switzerland) 
Jacketed quartz cyclonic, cooled to 5 oc 
Quartz Fassel-type without shield 
Nickel1 mm i.d. 
Nickel, 0.7 mm i.d. 
Monitoring for 31 P+ at 31 m/z and 79Br+ at 79 m/z 
500 
6.2.7 HPLC-ICP-MS analyses of derivatised carboxylic acids and 
phosphorylated peptides 
For HPLC-ICP-MS analyses, a HP1090 chromatography system incorporating a 
UV/vis detector (Agilent Technologies, Stockport, U.K.) equipped with a C18(2) 
reversed phase column (Phenomenex Luna, 100 x 4.6 mm, 3 Jlm particle size) 
was used. The mobile phase comprised a binary system of: eluent A, 
water:acetonitrile (90:10 % v/v) containing 0.05% formic acid (v/v); and eluent B, 
water/acetonotrile (10:90 % v/v) containing 0.05% (v/v) formic acid. The linear 
gradient employed started at 100% A, changing to 10% A and 90% B over 30 
minutes. The flow rate was 1 ml min"1 with an injection volume of 5 Ill. All 
experiments were performed using a Q-ICP-MS (Thermo Elemental PQ3, 
Winsford, U.K.). Operating conditions are shown in Table 6.2. 
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6.2.8 HPLC-Eiectrospray ionisation mass spectrometry of derivatised 
carboxylic acids and phosphorylated peptides 
HPLC was performed using a binary pump (P580A, Dionex-Softron GmbH, 
Germering, Germany) coupled with a C18(2) reversed phase column 
{Phenomenex Luna, 100 x 4.6 mm, 3 ~m particle size) with the same gradient 
elution used for HPLC-ICP-MS. The 1 ml min·1 flow rate was split post column 
(high pressure micro-splitter valve; Upchurch Scientific Ltd, Oak Harbor, WA, 
USA), with a portion of the stream (-200 ~L min-1) diverted to the mass 
spectrometer and the residual to waste. Sample injections (5 ~L) were made 
manually with a metal-free injection valve {Rheodyne model number 9125, CA, 
USA). Mass spectrometric analysis was performed using an ion trap mass 
spectrometer fitted with an electrospray interface {ThermoQuest Finnigan Mat 
LCQ, San Jose, CA). Data were acquired and processed with Xcalibur 1.0 
software. Instrument optimization was performed by infusing a 100 ng ml-1 
solution of TMPP at 3 ~L min-1 and monitoring the characteristic positive ion at 590 
m/z. The following instrument parameters were used: source voltage, +4.50 kV; 
capillary voltage, +20 V; tube lens offset, -10.00V; capillary temperature, 220 'C; 
nitrogen sheath gas flow rate, 60 (arbitrary units), and nitrogen auxiliary gas flow 
rate 20 (arbitrary units). Mass spectra were recorded in the positive ion mode 
within m/z 150-1500. For characterisation of the synthesised BrTMPP, the same 
system set-up was used, except no HPLC column was adopted. The spectrum 
was recorded in the positive ion mode within 190-2000 m/z for the derivatised 
carboxylic acids, and 190-3000 m/z for the derivatised phosphorylated peptides. 
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6.3 Results and Discussion 
6.3.1 Phosphorus selective detection 
For this work, a membrane desolvation device was used. As this removes the 
majority of the solvent, and thus the polyatomic interferences associated with 31 P 
detection, a low resolution ICP-MS instrument could be utilised. Using a standard 
quadrupole instrument with the desolvator, the background phosphorus signal was 
reduced to approximately 3000 counts per second, enabling low phosphorus 
levels to be detected even when using chromatography. The membrane 
desolvator also ensured the chromatography used (up to 90% volume fraction 
acetonitrile in this case) had little detrimental effect on the plasma. For the 
determination of the detection limit, samples containing between 1 ng ml"1 and 1 
!Jg ml-1 of phosphorus from sodium polyphosphate were analysed by HPLC-ICP-
MS. The chromatograms obtained were exported into Masslynx software (Waters, 
Massachusetts, USA). This software enabled the peaks to be integrated, yielding 
peak areas. Using the peak areas, a linear graph was obtained for peak area 
against phosphorus concentration based on a 20 !JL injection. The limit of 
detection, calculated as the concentration of 31 P+ which resulted in a peak height 
of 3 times the baseline noise, was calculated to be 10 ng ml-1 of 31 P+. 
6.3.2 Detection of phosphorylated peptides 
To determine the feasibility of HPLC-UV-ICP-MS with membrane desolvation for 
determining phosphorylated peptides, a HPLC peptide standard mix was injected 
onto the HPLC-UV-ICP-MS system. The mix is a commercially available standard, 
containing five un-phosphorylated peptides. The chromatograms produced are 
shown in Figure 6.2. The UV chromatogram clear1y shows the five peptides, 
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although two are not very well resolved. No peaks were observed on the 31 P+ 
selective ICP-MS chromatogram. This is exactly as expected because the HPLC 
standard did not contain any phosphorylated peptides. There is a small peak at 
approximately 27 minutes, but this is just about at the level of detection of the 
instrument, and was probably due to a small phosphorus containing impurity in the 
mixture. 
100 
80 uv-----+ 
60 ICP-MS 
-60 Time I Mins 
Figure 6.2 UV at 220 nm and 31 P+ ICP-MS chromatograms for the HPLC 
peptide test mix 
The chromatogram obtained for a singly phosphorylated peptide (pp60 c-src) is 
shown in Figure 6.3, which produced only one peak in the UV chromatogram and 
one main peak using phosphorus selective ICP-MS detection, as expected. 
Several other small peaks were observed on the UV and ICP-MS chromatograms, 
but these were probably due to impurities in the sample, which was stated to only 
contain 86.3% of the peptide. lt is also worth noting the slight difference in 
retention time between the UV and ICP-MS responses. This was due to the time 
delay between the UV and ICP-MS detectors. 
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100 
80 
uv----+ 
60 +-- ICP-MS 
-60 
-80 
-1oo Time I M ins 
Figure 6.3 UV at 220 nm and 31 P+ ICP·MS chromatograms for the singularly 
phosphorylated peptide (pp60 c-src) 
In order to demonstrate that the HPLC-UV-ICP-MS system could be used to 
distinguish between phosphorylated and un-phosphorylated peptides, a mixture of 
the peptide test mix and the phosphorylated peptide was prepared and injected. 
The UV and ICP-MS chromatograms are shown in Figure 6.4. As expected , only 
one major peak was observed using 31 p+ selective detection, but five peaks were 
obtained using UV detection. The last two peptides from the standard test mix 
appear to have eo-eluted. However, by using both UV and ICP-MS together, this 
simple system enables phosphorylated peptides to be distinguished easily from 
un-phosphorylated peptides. 
139 
100 
80 ~ 
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60 
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-40 
-60 
-80 Time I Mins 
Figure 6.4 UV at 220 nm and 31 P+ ICP-MS chromatograms for the peptide 
test mix spiked with the singularly phosphorylated peptide 
This approach has been shown to be suitable for model peptides, but in "real" life 
protein samples, there may be matrix effects and other interferences. To ensure 
that this system was suitable for "real" protein samples, a bovine r,3-casein sample 
was digested with trypsin overnight. Bovine r,3-casein was chosen as this is 
commercially available and is known to contain phosphorylated peptides, so is 
often used as a reference compound to demonstrate specific detection of 
phosphopeptides in tryptic digests83. Using the initial 30 minute gradient elution 
profile utilised for the peptide mix and phosphorylated peptide, it appeared that 
some of the digested compounds had not eluted from the column. Thus, the 
slower and longer 60-minute gradient elution was used. Figure 6.5 shows the UV 
and ICP-MS chromatograms obtained for this digest. Two peaks were observed in 
the ICP-MS response for the digest, which is as expected because a tryptic digest 
of r,3-casein produces two phosphorylated peptides83. One of these is a singly 
phosphorylated peptide, presumably the smaller peak, and the other which 
contains four phosphorylated amino acids, probably the larger peak. The second 
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larger peak is the phosphorylated peptide that was retained on the column and 
hence wasn't detected in the work by Wind et al. 83 The known difference in 
retention time observed with the phosphorylated peptide (pp60 c-src) can be 
calculated and used to determine which ICP-MS peak correlates to which UV 
peak. If electrospray ionisation mass spectrometry was utilised in parallel with 
ICP-MS detection, with the difference in retention times correlated, then both 
detection techniques could be used to provide ease of identification of the 
phosphorylated peptides along with molecular mass spectral data. If ESI-MS or 
UV alone was used, then it would be extremely difficult to find which peak was due 
to the phosphorylated peptides due to the large amounts of peaks in the spectrum 
(approximately 50). Hence, the use of ICP-MS simultaneously with ESI-MS 
permits the targeted analysis and characterisation of phosphorylated peptides 
within a single chromatographic run. 
100 
80 ICP-MS ~uv 
60 l Q) 
Cl) 
c: 40 0 
c. 
Cl) 
Q) 
~ 20 
~ 0 
0 
10 50 60 
-20 
-40 Time I Mins 
Figure 6.5 UV at 220 nm and 31 P+ ICP-MS chromatograms for an in-
solution tryptic digest of bovine P-casein 
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6.3.3 Analysis of phosphorus containing acids 
The BrTMPP reagent has already been successfully used for the derivatisation of 
maleic acid, with a consequent improvement in detection using Br selective 
detection (see Chapter 5). However, the Br/P ratio can also be used to determine 
the number of phosphorus atoms on the derivatised molecule. In order to test this 
theory, three phosphorus containing carboxylic acids were derivatised with 
BrTMPP. These were 3-(methylphosphinico)propionic acid, potassium P,P-
dimethylphosphonoacetate and diethylphosphonoacetic acid (see Figure 6.6 for 
the structures of these acids), chosen because they are all commercially available 
in a high purity. 
0 
0, 11 'p~OH 
/' 0 
3-(methylphosphinico )propionic acid Potassium P ,P-dimethylphosphonoacetate 
Diethylphosphonoacetic acid 
Figure 6.6 Structure of the phosphorus containing carboxylic acids 
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LC-ESI-MS chromatograms of potassium P,P-dimethylphosphonoacetate, after 
derivatisation with BrTMPP are shown in Figure 6.7. When the total ion current 
chromatogram (Figure 6. 7 A) was compared to a BrTMPP blank, a new peak at 
15.80 minutes was observed. This was confirmed to be the derivatisation product 
of potassium P ,P-dimethylphosphonoacetate when the theoretical mass of the 
product was extracted, and a single peak was observed in the single ion 
monitoring trace (Figure 6.7 B). This then enabled element selective detection of 
31 P+ and 79Br+ to be used. By examining the ICP-MS chromatograms at the elution 
time of the derivatised acid, a peak was observed at 1020 seconds (17.0 minutes) 
for both the bromine and phosphorus signals (Figure 6.8). The difference between 
this retention time, and that obtained by LC-ESI-MS was the difference in time for 
the eluent to get to the respective detectors. To prove the concept that this method 
could be used to determine the amount of phosphorus in the molecule, the Br:P 
ratios were calculated for the peak of interest and the excess BrTMPP peak at 780 
seconds (13.0 minutes). For the underivatised BrTMPP, a Br:P ratio of 9.02 was 
obtained, however, for the derivatised acid, a ratio of 4.46 was obtained. This is 
almost exactly half the ratio obtained for underivatised BrTMPP, thus confirming 
that the acid has one phosphorus atom in the molecule. When the LC-ESI-MS 
chromatograms for the derivatised 3-(methylphosphinico)propionic acid and 
diethylphosphonoacetic acid were examined, and their selected masses extracted, 
no peaks were observed. This indicates that these acids may not be derivatised 
very efficiently with this BrTMPP reagent. The LC-ICP-MS chromatograms did not 
yield conclusive evidence for the derivatisation either, and thus the Br/P ratios 
could not be determined. 
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Figure 6.7 LC-ESI-MS chromatograms for BrTMPP derivatised potassium 
.., 
c 
0 
¥ 
• i 
~ 
:I 
0 
0 
X5 
P ,P-dimethylphosphonoacetate 
... 
79Br• selective detection 
31 p+ selective detection 
Derivatised Acid 
Figure 6.8 LC-ICP-MS chromatograms for BrTMPP derivatised potassium 
P ,P-dimethylphosphonoacetate 
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6.4.4 Derivatisation and analysis of phosphorylated peptides 
For successful derivatisation using the method described here the phosphorylated 
peptides must be N-terminus end-capped, hence two peptides were specifically 
synthesised for this purpose by Biomol International (Exeter, Devon, UK). Both 
peptides were end-capped with an acetyl group to protect them from self 
polymerising during the derivatisation reaction. The amino acid sequences for the 
peptides obtained are shown below: 
PRN5220 AC-Thr-Ser-Giu-Pro-Gin-Tyr( P03H2)-Gin-Pro-Giy-Giu-Asn-Leu-OH 
PRN5221 AC-Thr-Ser-Tyr(P03H2)-Gin-Tyr(P03H2)-Giy-Leu-OH 
PRN5220 was chosen because this sequence is identical to the phosphorylated 
peptide used for the qualitative analysis in Section 6.3.1, and PRN5221 was 
chosen, because it contains two phosphorylated tyrosine amino acids, thus a 
different Br:P ratio would be expected. 
The peptides were derivatised with 1 mM BrTMPP, and their LC-ESI-MS 
chromatograms are shown in Figure 6.9. When the theoretical masses of the 
derivatised peptides were calculated, and their masses extracted from these 
chromatograms, no peaks were observed. However, large peaks were obtained 
for the underivatised peptides at 7.49 minutes for PRN5220 (Figure 6.9 A) and 
6.90 minutes for PRN5221 (Figure 6.9 B). Again this suggests that these peptides 
were not successfully derivatised by the BrTMPP derivatising reagent. This may 
be due to steric hindrance due to the bulky derivatisation group and the size of the 
peptides. Also these peptides may fold to yield a confirmation which does not 
leave the C-terminus available for reactions. The derivatisation efficiency of the 
reaction may also be too low for successful detection. 
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Figure 6.9 LC-ESI-MS chromatograms for the BrTMPP derivatised 
phosphorylated peptides; A PRN5220; B PRN5221 
6.4 Conclusions 
HPLC-UV-ICP-MS has been used to distinguish between phosphorylated and un-
phosphorylated peptides. A detection limit of 10 ng ml -1 for phosphorus with 31 p+ 
selective detection was obtained based on a 20 j.JL injection volume. This system 
has been successfully utilised to distinguish the phosphorylated fragments 
obtained when bovine J3-casein was digested in solution with trypsin. The 
applicability of using this system is wide ranging. lt has been demonstrated that 
this, used in conjunction with electrospray ionisation mass spectrometry detection, 
would make it easier to identify phosphorylated peptides and gather structural 
information. This system is also applicable to chromatographic separations 
utilising strong organic modifiers needed in the elution. 
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The methodology developed using BrTMPP to derivatise carboxylic acids has 
been shown to be successful in derivatising potassium P,P-
dimethylphosphonoacetate and by determining the Br:P ratio the number of 
phosphorus atoms on the molecule was determined. Unfortunately, this BrTMPP 
molecule did not successfully derivatise 3-(methylphosphinico)propionic acid, 
diethylphosphonoacetic acid or the phosphorylated peptides PRN5220 and 
PRN5221. If the efficiency of this reaction could be improved, and made non-
selective, the method has the potential to determine the extent of phosphorylation. 
To further enhance the derivatisation efficiency, solid-phase derivatisation may 
help to alleviate some of these problems. 
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Chapter Seven 
Conclusions and suggestions for future work 
7.1 Conclusions 
A membrane desolvator has been evaluated for coupling HPLC with ICP-MS. This 
interface has enabled the introduction of a range of organic solvents including 
acetonitrile and methanol into an ICP. In addition, it facilitated the use of solvent 
gradients without the need to compensate for the solvent loading on the plasma, 
enabling up to 100 % organic eluents to be utilised for chromatographic 
separations. The membrane desolvation device removed the majority of the 
chromatographic eluent, thereby reducing or eliminating many polyatomic 
interferences such as NOH+ on 31 P+, obviating the need for high resolution mass 
spectrometry. However, one major drawback was the propensity for small polar 
analytes to pass through the membrane. This was highlighted during the analysis 
of Lamotrigine where dichlorobenzaldehyde and dichlorobenzoic acid were not 
detected by 35CI+ selective ICP-MS, presumably because they were removed 
along with the solvent. 
HPLC-ICP-MS has been used for the determination of some pharmaceutically 
important carboxylic acids after derivatisation with the phosphorus containing 
reagent TMPP. This allowed 31 P+ selective detection to be performed on organic 
compounds which are normally un-detectable by ICP-MS. The derivatisation also 
enabled the enhanced detection of maleic, fumaric and sorbic acids after 
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derivatisation with TMPP by HPLC-ESI-MS/MS. Detection was compared pre- and 
post-derivatisation, with up to a twelve-fold increase being observed for these 
three acids. The method was also successfully used for the determination of sorbic 
acid in a sample of Panadol™. The derivatisation of salicylic acid was not as 
successful resulting in an increased limit of detection observed with ESI-MS-MS 
detection. This was also highlighted with phosphorus selective ICP-MS detection, 
where derivatised salicylic acid was not detected. 
TMPP was successfully brominated to yield Tris(3,5-dibromo-2,4,6-
trimethoxyphenyl) phosphonium propylamine bromide (BrTMPP) using 
hypobromous acid to generate the bromine electrophile. 1H NMR spectroscopy 
and infusion ESI-MS were used to verify that bromination had occurred. This 
BrTMPP derivatising reagent was used to successfully derivatise maleic acid, and 
was detected by HPLC-SF-ICP-MS. This enabled both 31 P+ and 79Br+ selective 
detection to be performed on this organic acid which is normally invisible to 
detection by ICP-MS. By derivatising maleic acid with BrTMPP, an increase in 
signal of approximately nine times was achieved by monitoring bromine as 
opposed to phosphorus. 
HPLC-UV-ICP-MS with a membrane desolvator interface has also been used to 
distinguish between phosphorylated and un-phosphorylated peptides. A detection 
limit of 10 ng ml·1 for phosphorus with 31 P+ selective detection was obtained using 
chromatography with a 20 IJL injection volume and a quadrupole ICP-MS. This 
system was successfully utilised to distinguish the phosphorylated fragments 
obtained when bovine 13-casein was digested in solution with trypsin. The 
applicability of using this system is wide ranging. lt has been demonstrated that 
this, used in conjunction with electrospray ionisation mass spectrometry detection, 
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would make it easier to identify phosphorylated peptides and gather structural 
information. 
The methodology developed using BrTMPP to derivatise carboxylic acids was 
shown to be successful in derivatising a phosphorus containing carboxylic acid, 
potassium P,P-dimethylphosphonoacetate. By determining the Br:P ratio using 
ICP-MS, the number of phosphorus atoms on the molecule was determined. 
Unfortunately, this BrTMPP molecule did not successfully derivatise 3-
(methylphosphinico)propionic acid, diethylphosphonoacetic acid or the 
phosphorylated peptides PRN5220 and PRN5221. If this reaction could be 
improved, and made non-selective, the method has the potential to determine the 
extent of phosphorylation. 
7.2 Suggestions for future work 
During the course of this work a number of areas have been identified for further 
study. Although the use of membrane desolvators has enabled highly organic 
reversed phase eluents to be utilised with ICP-MS analysis, some analytes of 
interest may be removed by the membrane. If a non-selective membrane could be 
sourced and evaluated so it did not remove analytes of interest, but successfully 
removed the solvents, this would yield higher confidence in detection of unknowns. 
The derivatisation of carboxylic acids resulted in improved ESI-MS detection (in 
most acids) and also enabled these derivatised acids to be detected with ICP-MS. 
However, if the reaction efficiency of the derivatisation reaction could be improved, 
lower detection limits should be possible. This improvement in reaction efficiency 
may also be possible if other coupling reagents were used to aid the reaction. 
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N,N'-carbonyldiimidazole11s-121 is one such reagent which was examined during 
this study, but this had an adverse effect on derivatisation efficiency with these 
compounds. Other such reagents could be sourced to test whether any 
enhancements may be achieved. 
Other possible ways to enhance the derivatisation efficiency is to use solid phase 
analytical derivatisation 122"124. Here, the reagents, derivatives and side products 
are retained on a solid phase during sorption and derivatisation and in principle, 
can be selectively eluted after the derivative has formed. Thus, derivatisation can 
occur at the same time with isolation from the matrix or can be carried out after 
sorption on the solid phase122• This can yield two possible improvements when 
compared with in-solution derivatisation. Not only can the derivatisation be 
improved by continually adding more reagents, but when the derivatised product is 
washed from the sorbent, theoretically some of the other compounds present (e.g. 
underivatised reagents, excess derivatising products, unwanted by-products) can 
be removed to yield a purer sample for further analysis. 
The preparation of TMPP and subsequent synthesis of BrTMPP involved a multi-
step reaction. If cleaning steps, including some re-crystallisation, were 
incorporated into the reaction scheme, then a purer reagent may be produced 
yielding cleaner chromatograms. This would enable easier identification of the 
peaks which correspond to those of the derivatised product and possibly lower the 
limits of detection. 
Other derivatisations could be examined. Leavens et at.l8· 125 have already 
reported the use of other compounds based on tris(2,4,6-trimethoxyphenyl) 
phosphine, which have been used to derivatise alcohols, aldehydes, ketones and 
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amines. These derivatisations could be examined with ICP-MS detection, for 
compounds which have pharmaceutical relevance. The derivatisation of amines 
with tris(2,4,6-trimethoxyphenyl)phosphonium ethanoic acid bromide is especially 
interesting. This molecule could be examined with the same reaction scheme as 
that used for derivatising with TMPP. If this molecule could be successfully 
brominated, in a similar fashion as TMPP was, then this molecule could be reacted 
at the N-terminus of peptides. This may offer an alternative method for the 
determination of the degree of phosphorylation. 
152 
References 
(1) Pharmaceutical Research and Manufacturers of America Annual Survey, 
June, 2001. 
(2) Mansfield, E. Science 1988, 241, 1769-1774. 
(3) Lee, D. C.; Webb, M., Eds. Pharmaceutical Analysis; Blackwell Publishing 
Company: Oxford, UK, 2003. 
(4) Krstulovic, A. M.; Lee, C. R.; Firmin, S.; Jacquet, G.; Van Dau, C. N.; 
Tessier, D. Le Gc Europe 2002, 15, 31-+. 
(5) Smythe, W. R.; Mattauch, J. Physical Review 1932, 40, 429-433. 
(6) O'Connor, G. T. PhD Thesis, University of Plymouth, Plymouth, 1998. 
(7) Willard, H. H.; Merritt, L. L.; Dean, A. J.; Settle, A. F. In Instrumental 
Methods of Analysis, 7th ed.; Wadsworth Publishing Company: California, 
USA, 1988, pp 465-512. 
(8) · Barker, J. Mass Spectrometry, 2nd ed.; John Wiley & Sons Ltd.: Chichester, 
UK, 1999. 
(9) de Hoffmann, E.; Stroobant, V. Mass Spectrometry: Principles and 
Applications, 2nd ed.; John Wiley & Sons, Ltd.: Chichester, 2001. 
(10) Karasek, F. W.; Clement, R. E. Basic Gas Chromatography- Mass 
Spectrometry, Principles and Techniques; Elsevier Science Publishing 
Company: New York, 1988. 
(11) Chapman, S. Physica1Review1937, 10,184-190. 
(12) Dole, M.; Mack, L. L.; Hines, R. L. Journal of Chemical Physics 1968, 49, 
2240-2249. 
(13) Mack, L. L.; Kralik, P.; Rheude, A.; Dole, M. Journal of Chemical Physics 
1970, 52, 4977-4986. 
153 
(14) Yamashita, M.; Fenn, J. B. Journal of Physical Chemistry 1984, 88, 4451-
4459. 
(15) Yamashita, M.; Fenn, J. B. Journal of Physical Chemistry 1984, 88, 4671-
4675. 
(16) Wong, S. F.; Meng, C. K.; Fenn, J. B. Journal of Physical Chemistry 1988, 
92, 546-550. 
(17) Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M. Mass 
Spectrometry Reviews 1990, 9, 37-70. 
(18) In Journal of Chromatography A; Niessen, W. M. A., Voyksner, R. D., Eds., 
1998; Vol. 794, pp 1-435. 
(19) Burlingame, A. L.; Boyd, R. K.; Gaskell, S. J. Analytical Chemistry 1998, 70, 
647R-716R. 
(20) Niessen, W. M. A. Journal of Chromatography A 1998, 794, 407-435. 
(21) Dass, C. Current Organic Chemistry 1999, 3, 193-209. 
(22) Niessen, W. M. A. Journal of Chromatography A 1999, 856, 179-197. 
(23) Kebarle, P.; Ho, Y. In Electrospray Ionization Mass Spectrometry: 
Fundamentals, Instrumentation and Applications; Cole, R. B., Ed.; John 
Wiley & Sons, Inc.: New York, 1997, pp 3-63. 
(24) Ashcroft, A. E. Ionization Methods in Organic Mass Spectrometry, The 
Royal Society of Chemistry: Cambridge, 1997. 
(25) McCormack, P. J. PhD Thesis, University of Plymouth, Plymouth, 2003. 
(26) Montaser, A.; Mclean, J. A.; Huiying, L. In Inductively Coupled Plasma 
Mass Spectrometry, Montaser, A .. Ed.; Wiley-VCH: New York, 1998, pp 1-
31. 
(27) Greenfield, S.; Jones, I. L.; T., B. C. Analyst 1964, 89, 713-720. 
(28) Gray, A. L. Proceedings of the Society for Analytical Chemistry 1974, 11, 
182-183. 
154 
(29} Date, A. R.; Gray, A. L. Analyst 1983, 108, 159-165. 
(30} Gray, A. L.; Date, A. R. Analyst 1983, 108, 1033-1050. 
(31} Houk, R. S.; Fassel, V. A.; Flesch, G. D.; Svec, H. J.; Gray, A. L.; Taylor, C. 
E. Analytical Chemistry 1980, 52, 2283-2289. 
(32} Cairns, W. R. L. PhD Thesis, University of Plymouth, Plymouth, 1996. 
(33} Beynon, J. H. Nature 1954, 174, 735-737. 
(34} Meyer, V. R. Practical High-Performance Liquid Chromatography, 3rd ed.; 
John Wiley & Sons Ltd: Chichester, 1999. 
(35} Ardrey, R. E. Liquid Chromatography-Mass Spectrometry: An Introduction; 
John Wiley & Sons Ltd.: Chichester, 2003. 
(36} Wolff, J. C.; Barr, L.; Moss, P. Rapid Communications in Mass 
Spectrometry 1999, 13, 2376-2381. 
(37} Bristow, A. W. T.; Webb, K. S. Journal of the American Society for Mass 
Spectrometry2003, 14, 1086-1098. 
(38} Wolff, J. C.; Eckers, C.; Sage, A. B.; Giles, K.; Bateman, R. Analytical 
Chemistry 2001, 73, 2605-2612. 
(39} Sutton, K.; Sutton, R. M. C.; Caruso, J. A. Journal of Chromatography A 
1997, 789, 85-126. 
(40} Sutton, K. L.; Caruso, J. A. Journal of Chromatography A 1999, 856, 243-
258. 
(41) Ackley, K. L.; Sutton, K. L.; Caruso, J. A. Journal of Analytical Atomic 
Spectrometry 2000, 15, 1069-1073. 
(42} Aeon, B. W.; McLean, J. A.; Montaser, A. Journal of Analytical Atomic 
Spectrometry 2001, 16, 852-857. 
(43) Hutton, R. C. Journal of Analytical Atomic Spectrometry 1986, 1, 259-263. 
(44} Cairns, W. R. L.; Ebdon, L.; Hill, S. J. Fresenius Journal of Analytical 
Chemistry 1996, 355, 202-208. 
155 
(45) Blades, M. W.; Caughlin, B. L. Spectrochimica Acta Part B-Atomic 
Spectroscopy 1985, 40, 579-591. 
(46) Axelsson, B. 0.; Jornten-Karlsson, M.; Michelsen, P.; Abou-Shakra, F. 
Rapid Communications in Mass Spectrometry 2001, 15, 375-385. 
(47) Wang, T. B.; Wu, J.; Hartman, R.; Jia, X. J.; Egan, R. S. Journal of 
Pharmaceutical and Biomedical Analysis 2000, 23, 867-890. 
(48) Lewen, N.; Mathew, S.; Schenkenberger, M.; Raglione, T. Journal of 
Pharmaceutical and Biomedical Analysis 2004, 35, 739-752. 
(49) Kannamkumarath, S. S.; Wuilloud, R. G.; Stalcup, A.; Caruso, J. A.; Patel, 
H.; Sakr, A. Journal of Analytical Atomic Spectrometry 2004, 19, 107-113. 
(50) Lam, R.; Salin, E. D. Journal of Analytical Atomic Spectrometry 2004, 19, 
938-940. 
(51) Eckers, C.; Haskins, N.; Langridge, J. Rapid Communications in Mass 
Spectrometry1997, 11, 1916-1922. 
(52) Xu, K. Y.; Arora, V. K.; Chaudhary, A. K.; Cotton, R. B.; Blair, I. A. 
Biomedical Chromatography 1999, 13, 455-461. 
(53) Houk, R. S. Spectrochimica Acta Part B-Atomic Spectroscopy 1998, 53, 
267-271. 
(54) McSheehy, S.; Szpunar, J.; Lobinski, R.; Haldys, V.; Tortajada, J.; 
Edmonds, J. S. Analytical Chemistry 2002, 74, 2370-2378. 
(55) Corcoran, 0.; Nicholson, J. K.; Lenz, E. M.; Abou-Shakra, F.; Castro-Perez, 
J.; Sage, A. B.; Wilson, I. D. Rapid Communications in Mass Spectrometry 
2000, 14, 2377-2384. 
(56) Evans, E. H.; Wolff, J. C.; Eckers, C. Analytical Chemistry 2001, 73, 4722-
4728. 
(57) Brown, A. A.; Ebdon, L.; Hill, S. J. Analytica Chimica Acta 1994, 286, 391-
399. 
156 
(58) Brenner, I. B.; Zander, A.; Plantz, M.; Zhu, J. Journal of Analytical Atomic 
Spectrometry 1997, 12, 273-279. 
(59) Eastgate, A. R.; Fry, R. C.; Gower, G. H. Journal of Analytical Atomic 
Spectrometry 1993, 8, 305-308. 
(60) Luo, S. K.; Berndt, H. Spectrochimica Acta Part B-Atomic Spectroscopy 
1994, 49, 485-492. 
(61) Wendt, R. H.; Fassel, V. A. Analytical Chemistry 1965, 37, 920-922. 
(62) Hess, D. R. Respiratory Care 2000, 45, 609-622. 
(63) Montaser, A.; Minnich, M. G.; McLean, J. A.; Huiying, L. In Inductively 
Coupled Plasma Mass Spectrometry; Montaser, A., Ed.; Wiley-VCH: New 
York, 1998, pp 83-264. 
(64) http://www.cetac.com/prodslariduslaridus.html 15th December 2004. 
(65) Ebdon, L.; Evans, E. H.; Barnett, N. W. Journal of Analytical Atomic 
Spectrometry 1989, 4, 505-508. 
(66) Abian, J. Journal of Mass Spectrometry 1999, 34, 157-+. 
(67) Jones, P. R.; Yang, S. K. Analytical Chemistry 1975, 47, 1000-1003. 
(68) Knapp, D. R. Handbook of Analytical Derivatization Reactions; John Wiley 
& Sons, Inc. : Chichester, 1979. 
(69) Quirke, J. M. E.; Adams, C. L.; Vanberkel, G. J. Analytical Chemistry 1994, 
66, 1302-1315. 
(70) Sun, H. L.; Liu, H. M.; Tsai, S. J. J. Journal of Chromatography A 1999, 
857, 351 -357. 
(71) Toyo'oka, T. Analytica Chimica Acta 2002, 465, 111-130. 
(72) Lunn, G.; Hellwig, L. C. Handbook of Derivatization Reactions for HPLC; 
John Wiley & Sons, Inc.: Chichester, 1998. 
(73) Blau, K. ; Halket, J. M. Handbook of Derivatives for Chromatography, 2nd 
ed.; John Wiley & Sons, Ltd.: Chichester, UK, 1993. 
157 
(74) Johnson, D. W. Rapid Communications in Mass Spectrometry 2000, 14, 
2019-2024. 
(75) Johnson, D. W. Rapid Communications in Mass Spectrometry 2001, 15, 
2198-2205. 
(76) Johnson, D. W.; Trinh, M. U. Rapid Communications in Mass Spectrometry 
2003, 17, 171-175. 
(77) Morita, H.; Konishi, M. Analytical Chemistry 2003, 75, 940-946. 
(78) Leavens, W. J.; Lane, S. J.; Carr, R. M.; Lockie, A. M.; Waterhouse, I. 
Rapid Communications in Mass Spectrometry 2002, 16, 433-441. 
(79) Luong, E. T.; Houk, R. S. Journal of the American Society for Mass 
Spectrometry 2003, 14, 295-301. 
(80) Vogl, J.; Heumann, K. G. Analytical Chemistry 1998, 70, 2038-2043. 
(81) Vogl, J.; Heumann, K. G. Fresenius Journal of Analytical Chemistry 1997, 
359, 438-441. 
(82) Wind, M.; Wesch, H.; Lehmann, W. D. Analytical Chemistry 2001, 73, 3006-
3010. 
(83) Wind, M.; Edler, M.; Jakubowski, N.; Linscheid, M.; Wesch, H.; Lehmann, 
W. D. Analytical Chemistry 2001, 73, 29-35. 
(84) Wind, M.; Kelm, 0.; Nigg, E. A.; Lehmann, W. D. Proteomics 2002, 2, 1516-
1523. 
(85) Marshal!, P.; Heudi, 0.; McKeown, S.; Amour, A.; Abou-Shakra, F. Rapid 
Communications in Mass Spectrometry 2002, 16, 220-228. 
(86) Smith, C.; Jensen, B. P.; Wilson, I. D.; Abou-Shakra, F.; Crowther, D. Rapid 
Communications in Mass Spectrometry 2004, 18, 1487-1492. 
(87) Cartwright, A. J.; Jones, P.; Wolff, J. C.; Evans, E. H. Rapid 
Communications in Mass Spectrometry 2005, 19, 1058-1062. 
158 
(88) Carter, J.; Ebdon, L.; Evans, E. H. Journal of Analytical Atomic 
Spectrometry 2003, 18, 142-145. 
(89) Pilus, R.; Rosenfeld, J. M.; Terlouw, J.; Leavens, W. J. Eighth International 
Symposium on Hyphenated Techniques in Chromatography, Bruges, 
Belgium, February 4-6 2004. 
(90) Morrison, R. T.; Boyd, R. N. Organic Chemistry, 4th ed.; Allyn and Bacon 
Inc.: Newton, MA, 1983. 
(91) Bamett, J. R.; Andrews, L. J.; Keefer, R. M. Journal of the American 
Chemical Society 1972, 94, 6129-6134. 
(92) Gilow, H. M.; Ridd, J. H. Journal of the Chemical Society, Perkin 
Transactions 21973, 10, 1321 -1327. 
(93) Voudrias, E. A.; Reinhard, M. Environmental Science & Technology 1988, 
22, 1049-1056. 
(94) Swain, C. G.; Crist, D. R. Journal of the American Chemical Society 1972, 
94, 3195-3200. 
(95) Noszticzius, Z.; Noszticzius, E.; Schelly, Z. A. Journal of the American 
Chemical Society 1982, 104, 6194-6199. 
(96) Bennett, K. L.; Stensballe, A.; Podtelejnikov, A. V.; Moniatte, M.; Jensen, 0. 
N. Journal of Mass Spectrometry 2002, 37, 179-190. 
(97) Sutherland, E. W.; Cori, C. F. JournalofBiologicaiChemistry1951, 188, 
531-543. 
(98) Sutherland, E. W.; Wosilait, W. D. Nature 1955, 175, 169-171. 
(99) Sutherland, E. W.; Wosilait, W. D. Journal of Biological Chemistry 1956, 
218, 459-468. 
(100) Wosilait, W. D.; Sutherland, E. W. Journal of Biological Chemistry 1956, 
218, 469-481. 
159 
(101) Krebs, E. G.; Fischer, E. H. Journal of Biological Chemistry 1956, 216, 113-
120. 
(102) Fischer, E. H.; Krebs, E. G. Journal of Biological Chemistry 1956, 216, 121-
132. 
(103) Krebs, E. G.; Kent, A. B.; Fischer, E. H. Journal of Biological Chemistry 
1958, 231, 85-92. 
(104) Bumett, G.; Kennedy, E. P. Journal of Biological Chemistry 1954, 211, 969-
980. 
(105) Cozzone, A. J. Biochimie 1998, 80, 43-48. 
(106) Krebs, E. G. Trends in Biochemical Sciences 1994, 19, 439-439. 
(107) Faux, M. C.; Scott, J. D. Trends in Biochemical Sciences 1996, 21, 312-
315. 
(108) Ruse, C. 1.; Willard, B.; Jin, J. P.; Haas, T.; Kinter, M.; Bond, M. Analytical 
Chemistry 2002, 74, 1658-1664. 
(109) Solaro, R. J.; Rarick, H. M. Circulation Research 1998, 83, 471-480. 
(110) Hunter, T. Ce//2000, 100, 113-127. 
(111) Kentish, J. C.; McCioskey, D. T.; Layland, J.; Palmer, S.; Leiden, J. M.; 
Martin, A. F.; Solaro, R. J. Circulation Research 2001, 88, 1059-1065. 
(112) Huang, L.; Wolska, B. M.; Montgomery, D. E.; Burkart, E. M.; Buttrick, P. 
M.; Solaro, R. J. American Journal of Physiology-Cell Physiology 2001, 
280, C1114-C1120. 
(113) Flora, J. W.; Muddiman, D. C. Analytica1Chemistry2001, 73,3305-3311. 
(114) Resing, K. A.; Johnson, R. S.; Walsh, K. A. Biochemistry 1995, 34, 9477-
9487. 
(115) Stensballe, A.; Andersen, S.; Jensen, 0. N. Proteomics 2001, 1, 207-222. 
(116) Neubauer, G.; Mann, M. Analytical Chemistry 1999, 71, 235-242. 
160 
(117) Marshal!, P.; Heudi, 0.; Bains, S.; Freeman, H. N.; Abou-Shakra, F.; 
Reardon, K. Analyst 2002, 127, 459-461. 
(118) Paul, R.; Anderson, G. W. Journal of the American Chemical Society 1960, 
82, 4596-4600. 
(119) Paul, R.; Anderson, G. W. Journal of Organic Chemistry 1962, 27, 2094-
2099. 
(120) Staab, H. A. Angewandte Chemie International Edition 1962, 1, 351-367. 
{121) Poss, M. A.; Reid, J. A. Tetrahedron Letters 1992,33, 1411-1414. 
(122) Rosenfeld, J. M. Journal of Chromatography A 1999, 843, 19-27. 
(123) Rosenfeld, J. M. Analytica Chimica Acta 2002, 465, 93-100. 
(124) Rosenfeld, J. M. Trac-Trends in Analytical Chemistry 2003, 22, 785-798. 
(125) Barry, S. J.; Carr, R. M.; Lane, S. J.; Leavens, W. J.; Manning, C. 0.; 
Monte, S.; Waterhouse, I. Rapid Communications in Mass Spectrometry 
2003, 17, 484-497. 
161 
'·" _,'- '·· 
' 
Appendix 
:Papers. :RtJblislie(f 
~"62 
[- -=;:';----.;~ --;----, . 0 
, ''.~;{-or t ~. 
• > 
1 .=o'<".-. ....... ~. 
Detection of phosphorus tagged carboxylic acids using 
HPLC-SF-ICP-MS 
Andrew J . Cartwright,a Phil Jones,a Jean-Ciaude Wolfr' and E. Hywel Evans*a 
a University of Plymouth, Speciation and Environmental Analysis Research Group. 
School of Earth Ocean and Environmental Sciences, Drake Circus. Plymouth, UK PL4 8AA. 
£-mail: hevans@plymouth.ac.uk; Fax: +44 (0) 1752 23304; Tel: +44 (0) 1752 233040 
b GlaxoSmithK/ine Medicines Research Centre, Gunnels Wood Road. Stevenage, Hertfordshire, 
UK SG1 2NY. £-mail: Jean-Ciaude.Wolff@gsk.com; Fax: +44 (0) 1438-764414; 
Te1: +44 (0) 1438-764783 
Received 14th October 2004, Acu pted 17th December 2004 
First published tU an Ad•ance Article on tire web lOth January 2005 
High performance liqu id chromatography (HPLC) has been coupled with sector field inductively coupled 
plasma mass spectrometry (SF-ICP-MS) for the determination of maleic, sorbic and fumaric acids a fter 
derivatisation with the phosphorus containing reagent tris(2,4,6-trimethoxyphenyl)phosphonium propylamine 
(TMPP). This a llowed 3 1P+ selective detection to be performed fo r these compounds, which a re normally 
invisible to detection by ICP-MS a t low concentra tions. Optimal reagent conditions for the derivatisation of 
0.1 mM maleic acid were: I mM TMPP; 10 mM 2-chlo ro- 1-methylpyridinium iodide (CMPI); 11 mM 
triethylamine. The efficiency of the deriva tisation reaction was estimated to be between I 0-20% a nd 
detection limits, estimated as 3 times baseline noise, were 0.046 nmol for TMPP and 0.25 nmol for 
deriva tised maleic acid, for a 5 ~tl injection. 
Introduction 
The vast majority of organic compo unds are essentia lly 
invisible to detec tion by inductively coupled plasma mass 
spectrometry (ICP-MS) because they only contain H, C, 0 
and N . These elements have extremely high backgro und signals 
because they a re ei ther present in the solvents used during 
sample introduction or present in atmospheric air entra ined 
into the plasma, hence trace analysis is impossible. The excep-
tions to this are the determination of C at minor a nd trace 
levels1- 3 and the element selective detection of organic com-
pounds which contain a hetero-atom such as P, S, Si , Cl, Br, I, 
a metal or metalloid. For exa mple, detection of phosphorus 
conta ining compounds has previously been performed for the 
determination of phosphoryla ted peptides<l-6 and sulfur-co n-
ta ining pharmaceuticals.7 An a lternative has recently been 
proposed by Smith et a/.8 which uses aqueous eluents only 
(at temperatures of 60 •c and 160 •q or isotopically enriched 
solvents to detect carbon in organic compounds by LC-ICP-
MS. If a means of making all organic compounds detectable by 
ICP-MS could be achieved, many new applications would be 
realised. For example, high accuracy quanti tative analysis of 
organic compounds could be achieved using external calibra-
tion; and many bio logical molecules could be detennined in 
metabolic studies.9 
Leavens et a/.10 have previously reported on the synthesis of 
a large molecular weight phosphorus reagent, tris(2,4,6-tri -
methoxyphenyl)phosphonium propylamine bromide (TMPP), 
which was used to deriva tise organic compounds to make them 
amenable to detection by positive ion electrospray ionization 
mass spectrometry (ESI-MS). We have used the T MPP reagent 
for the determ ination of low molecular weight carboxylic acids 
in pharmaceut ical samples, and have determined the limits of 
detection using ESI-MS-MS.11 This reaction incorporates a 
coupling reaction with 1-chloro-4-methylpyridinium iodide 
and triethylamine to activate the carbonyl group on the 
carboxylic acid prior to nucleophilic a ttack by the amine group 
on the coupling reagent. T he resulting derivatised carboxylic 
acid contains a stable amide bond linking the derivatising 
reagent with the carboxylic acid. The majority of carboxylic 
acids do not conta in a heteroatom so cannot be detected using 
ICP-MS. However, by derivatising these acids wi th TMPP they 
have effectively been tagged with phosphorus, so 31 P+ selective 
detection using ICP-MS can be performed. This has useful 
applications in pre-screening for quality control and investiga-
tions involving intellectua l property rights. 7 In this paper, 
detection of some pharmaceutically important carboxylic acids 
(maleic, fumaric, salicylic and sorbic) by LC-ICP-MS, after 
derivatisation, is described. The derivatisation reaction was 
also examined to further enhance the derivatisation procedure 
to lead to more sensitive detection, and hence lower detection 
limits. 
Experimental 
Chemicals and reagents 
Carboxylic acids, 2-chloro- 1-methylpyridinium iodide (CMPI), 
triethylamine (TEA) and formic acid were obtained from 
Sigma-Aldrich (Poole, Dorset, UK). HPLC grade acetonitrile 
was obtai ned from Fishe r Scientific UK Ltd. (Loughborough, 
Leicestershire, UK). Distilled deionised water ( 18.2 MO) was 
obta ined using an Elga Maxima water purifying system. 
Synthesis of tris(2,4,6-trimcthoxyphenyl)phosphonium 
propylamine bromide (TMPP) (Scheme 1) 
TMPP was synthesised in-house using an adaptation of the 
procedure detailed by Leavens e t a/.10 Initia l attempts to 
synthesize this derivatising reagent using the literature method 
were unsuccessful, possibly due to the propylamine side chain 
no t attaching to the tert iary phosphonium. T his may be 
because the 3-bromopropylamine free base was unstable and 
tended to condense with itself by nucleophilic displacement of 
bromide by the primary amine. Hence, it was decided to 
perform the liberation of the free amine from the salt , and 
B~NH2 
.HBr 
3-bom<li ii"'JYYo ..... hydrobnxnide 
t<,C03, H:!O 
Toluene 
Scheme I Synthesis of tris(2,4,6-trimethoxyphenyl)phosphonium propylamine bromide (TMPP). 
the subsequent clarification, as quickly as possible. Thus, the 
followi ng method was developed successfully: To a solution of 
3-bromopropylamine hydrobromide (4.98 g, 22.74 mmol, now 
in large excess) in water (20 ml) was added potassium carbo-
nate (2.24 g) and toluene (20 ml) wi th stirring. The resultant 
toluene phase was isolated, clarified with saturated brine 
(20 ml), and dried over magnesiwn sulfate. Tltis dry toluene 
phase was filtered directly into a pre-reflux.ing solution of 
tris(2,4,6-trimethoxyphenyl)phosphine (2. 12 g, 3.98 mmol) in 
to luene (40 ml) to minimise the time for the 3-bromopropyla-
mine free base to condense with itself. The mixture was refluxed 
for a further 30 min and the resul ting white precipitate was 
isolated by filtration, washed with toluene (2 x 5 ml) and diethyl 
ether (25 ml) and dried overnight a t 30 oc to give the title 
compound. A schematic of the reaction is shown in Scheme I. 
Preparation of coupling reagent 
Solutions of CMPI were prepared by dissolving the amount of 
CMPI in approximately 20 ml of acetonitrile in a 25 ml volu-
metric flask. The corresponding amount of triethylamine was 
added, and the solution made up to volume with acetoni trile. 
Coupling or TMPP pro pyla mine with carboxylic acids 
To 500 1-11 of carboxylic acid in 90 : 10% (vfv) water 
acetonitrile were added 500 ~tl of CM PI/TEA coupling reagent 
(prepa red as above). After thorough mixing for 5 min at room 
OH 
o=< + 
R 
OMe 
Where Ar = 
temperature, 500 1-11 of a TMPP propylamine solution in 
acetonitrile was added. The solution was left to react for 30 
m in in an ultrasonic bath at room temperature. A schematic of 
the reaction is shown in Scheme 2. 
HPLC-SF-lCP-MS analyses 
For HPLC-SF-ICP-MS analyses, a HP 1050 modular chroma-
tography system (Agilent Technologies, Stockport, UK) 
equipped with a Phenomenex Luna C l8(2) reversed phase 
column (100 x 4.6 mm, 3 J.lm particle size) was used. The 
mobile phase comprised a binary system of: eluent A, water : 
acetoni trile (90 : 10% vfv) conLaining 0.05% formic acid (vfv); 
and eluent B, water- acetonitrile (10 : 90% vfv) containing 
0.05% (vfv) formic acid. The linear gradient employed started 
at 100% A, changing to 40% A and 60% B over 20 min. The 
flow rate was I ml min- 1 with an injection volume of 5 IJI. All 
experiments were perfonned using a sector-field inductively 
coupled plasma mass spectrometer (SF-ICP-MS, Thenno Ele-
mental Axiom, Winsford, UK), using a mass resolution setting 
of 3000. Operating conditions are shown in Table I. 
It is common, in large pharmaceutical companies, to adopt a 
standard HPLC elution method which can be used in the 
majority of cases. The method is often standardised to a simple 
linear elution of acetonitrile- water which can run up to 100% 
(v/ 1•). Such a high concentration of acetonitrile is incompatible 
with the normal operation of an ICP-MS unless an extremely 
low flow nebuliser is used. One solution to this, which was 
Ar ~-r 
+ Cl + HI M•O-Q 
OMe ·~ 0 Ar-P N 0 I I 
Ar CH3 
TIM'P pq¥--...a ~a::id Mat¥ P)ridnone 
Scheme 2 Activation of carboxylic acids with 2-chloro-1-methylpyridinium iodide (CM PI) and reaction wi th TMPP propylamine. 
Table I Operating conditions for SF-ICP-MS 
ICP 
Nebuliser gas How/1 min- 1 1.10 
Auxiliary gas How/1 min - 1 0.85 
Coolant gas flow/1 m in - I 14.0 
Nebuliser Micromist (Glass Expansion, Switzerland) 
Spray chamber Jacketed quartz cyclonic, cooled to 5 ' C 
To rch Quartz Fassel-type with q uartz bonnet, 
witho ut shield 
Interface 
Sampling cone 
Skimmer cone 
Single ion monitoring 
Resolution 
Slit settings 
Masses monitored 
Dwell time/ms 
Scanning 
Resolution 
Slit sett ing 
Masses monitored 
Dwell time/ms 
Points 
Nickel I mm id 
Nickel, 0. 7 mm id 
3000 
Source, 330; collector, 220 
Single ion monitoring fo r l ip+ at 
30.974 m/z 
500 
3000 
Source, 330; collecto r, 220 
Scanning between 30.838 a nd 
3 1.109 m/z 
50 
20 
adopted in this work, is to use a membrane desolvation system, 
which removes the vas t majority of solvent and allows routine 
operation of gradient elution up to 100% acetonitrile a t a 
standard I ml m in - I flow ra te. However, it should be noted 
that low molecular weight polar analytes may also be removed 
by the desolvation system, so caution should be used when 
adopting this approach. In this work the HPLC column was 
coupled with the SF-ICP-MS simply by inserting the end of the 
tubing from the co lumn into the sample uptake inlet of the 
nebuliser, and the out put from the spray chamber was intro-
duced int o a Universal Interface Model B desolvation device 
(Vestec Corpora tion, Houston , USA). The sweep gas was 
optimised da ily a t approximately 2.0 I min- 1 to ensure tha t 
the maximum signa l fo r Jt p + was achieved. The dry aerosol 
exiting the desolvato r was then transferred to the IC P torch via 
I m of 0.25 in. id T ygon tubing. 
HPLC-clectrospray ionization mass spectrometry 
HPLC was pcrfonned using a P 580A bina ry pump (Dionex-
Softron GmbH, G ermering, Germany) coupled with a 
Phenomenex Luna C I8(2) reversed phase column ( lOO x 4.6 mm, 
3 J..Lm pa rt icle size) with the same gradient elutio n as is used for 
HPLC-SF-ICP-MS. The I ml min- 1 fl ow ra te was split post-
column (high pressure micro-splitter va lve; Upchurch Scientific 
Ltd, Oak Harbor, WA , USA}, and -200 J..ll min- 1 was 
diverted to the mass spectrometer and the residue to waste. 
Sample injections (5 J..l l) were made manually with a meta l-free 
Rheodyne injector (model number 91 25, CA, USA). Mass 
spectrometry analysis was performed using an ion trap mass 
spectrometer fi tted with an electrospray interface (Thenno-
Quest Finnigan Mat LCQ, San Jose, CA). Da ta were acquired 
and processed with Xcalibur 1.0 software. Instrument optimi-
zation was performed by infusing a 100 ng ml- 1 solution of 
T MPP a t 3 J..ll m in - I , mo nitoring for the characteristic positive 
ion at 590 mfz. The following instrument pa rameters were 
used : source voltage, + 4.50 kV; capillary voltage, +20 V; tube 
lens offset, - I 0.00 V; capilla ry tempera ture, 220 oc ; nitrogen 
sheath gas flow ra te, 60 (arbitrary units) a nd nitrogen auxiliary 
gas flow ra te 20 (arbitrary units). Mass spectra were recorded 
in the positive ion mode wi thin mfz 19(}-1000. 
Results and discussion 
Phosphorus selective detection 
Chromatograms of maleic acid (MA), a fter deriva tisation with 
TMPP, a re shown in Fig. I. Detection was performed using 
SF-ICP-MS with J t p + selective detection a t 30.974 m/z 
(Fig. lA and !B), and ESI-MS (Fig . IC and ID). As can be 
seen, the TMPP derivatising reagent contained many phos-
phorus containing impurities (Fig. lA), so it was necessary to 
. 
-
-
A 
8 
0 
• · t..a '·'* o.u l.t•.,.. 4.M e.n uJ ua 
Derivatised 
maleic acid 
..... 
~: .. 
Fig. I Chroma togra ms of deriva tised maleic acid: A, blank injection 
of TM PP a nd 31 p + selective detection using SF-ICP-MS; B, derivatised 
maleic acid and 31 p + selective detect ion using SF-ICP-MS; C, deriva-
tised maleic acid and to tal ion curren t using positive ion ESI-MS; D, 
derivatised maleic acid and selective ion monitoring at 688 m/z using 
posi tive ion ES I-MS. 
optimise the chromatography such that the derivatised MA was 
separated from these peaks (Fig. I B), and particularly the large 
peak for unreacted TMPP. For comparison, and confirmatory 
purposes, detection was also performed using ESI-MS and the 
major peak at 8.43 min was found to have a mass of 590 m/z, 
which corresponds to the mass ofTMPP. Likewise, the peak at 
12.65 m in was found to have a mass of 688 m/z, indicating it to 
be MA derivatised with TMPP (Fig. ID). A comparison of the 
chromatogram obtained using ICP-MS (fig. I B) with the total 
ion chromatogram obtained using ESI-MS detection (Fig. I C) 
indicates that the former method yielded a slightly improved 
signal-to-noise ratio, which should result in better detection 
limits. However, in this case, ESI-MS showed better signal-
to-noise when single ion monitoring at the base peak of688 m/z 
was performed. This highlights both the advantages and dis-
advan tages of the two techniques, namely that ICP-MS is 
useful for high sensitivity screening purposes, when confirma-
tion that a compound contains phosphorus (or any other 
element for that matter) is required. Hence, once these peaks 
in the chromatogram have been identified, then ESI-MS can be 
used in single ion mode to perform further qualitative ana lysis. 
In this case the TMPP was synthesised in-house so was not 
particularly pure: however, it is envisaged that a purer form of 
the reagent would alleviate some of the problems caused by 
interfering peaks in the ICP-MS chromatogram. 
Optimisation of derivatisation reaction 
In order to achieve optimal sensitivity the concentrations of the 
derivatisation reagents were optimised using a 2-factor, )-level 
factorial design (Table 2). Concentra tions ofTMPP and CM PI 
were set at 0. I mM, I mM and 10 mM for the derivatisation of 
0.1 mM of MA. Triethylamine (TEA) was also present as the 
base for the reaction so its concentration was adjusted to eq ual 
the sum of the concentrations of TMPP and MA, in order to 
maintain the stoichiometry of the reagents. At higher concen-
trations of TMPP, many impurities were observed, thus mak-
ing it difficult to identify the peak due to derivatised MA (see 
Fig. 2B). It is desirable to achieve a situation where the 
derivatisation of MA is at a maximum for the lowest concen-
tra tion of reagents, but the reagents are always in sufficien t 
excess to ensure constant reaction efficiency for varying con-
centrations of acid. In this case, maximum signal for deriva-
tised MA (at 0. 1 mM), and hence maximum reaction efficiency, 
was achieved at concentrations I mM (TMPP) and 10 mM 
(CMPI), with the concentration of TEA at 11 mM. The effect 
ofTMPP on the derivatisation of MA is shown in Fig. 2. At a 
TMPP : MA ratio of 10 : I (1.0 mM TMPP, 0.1 mM MA) a 
net peak height signal of approximately 1500 for derivatised 
MA was observed (fig. 2A). At a TMPP : MA ratio of 100 : I 
(10 mM TMPP, 0. 1 mM MA) the peak height signal was 
Table 2 Two factor, three level full factorial design experiment 
to determine the optimal conditions for derivatisation of 0.1 mM 
maleic acid 
CM PI TMPP TEA 
Solution concentration/ concentration/ concentration/ 
number mM mM mM 
I 1.0 1.0 l. t 
2 0.1 1.0 1. 1 
3 1.0 0.1 0.2 
4 1.0 10.0 10.1 
5 10.0 0.1 0.2 
6 0.1 10.0 10.1 
7 10.0 10.0 10.1 
8 O. t 0.1 0.2 
9 10.0 1.0 1.1 
A 
B 
Fig. 2 HPLC-ICP-MS chromatograms measuring J lp+ at 30.974 m/z 
for the derivatisation of O. t mM maleic acid with: (A) 10 mM CM PI 
and 1.0 mM TMPP: and (B) 10 mM CMPI and 10 mM TMPP. 
similar at approximately 1700; however, impurities in the 
TMPP eluted close to the analyte peak (Fig. 28), which made 
identification of the deriva tised MA more difficult. A rough 
estimate of the efficiency of the reaction was obtained by 
ratioing the peak height of the derivatised MA to the sum of 
the derivatised acid plus the residual TMPP reagent peak, then 
expressing this as a percentage of the expected theoretica l ratio 
ca lculated from the known concentrations. This assumes equal 
instrumental response for the two compounds, which should 
hold roughly true in this case given that a desolvator was used 
and the nebuliser efficiency was similar over the duration of the 
gradient in which the peaks eluted. This is illustrated in Fig. 
2A, where it is evident that the baseline signal, resulting from 
phosphorus impurities in the eluent, increased in a linear 
manner by only a factor of 2 over the course of the chromato-
graphic run, and only by a factor of approximately 1.5 between 
the elution of TMPP and MA. Hence, for eq uimolar concen-
trations of MA and TMPP ( I mM) the reaction efficiency was 
22% and when TMPP was in to-fold excess the reaction effici~ncy was 16%. Hence, it is likely that only between 
10- 20% of MA was derivatised under the conditions used 
and detection limits could be improved further by improving 
the efficiency of the reaction. 
An approximate limit of detection for derivatised MA, using 
31 p+ selective detection by ICP-MS, was calculated as the 
concentration of MA which resulted in a peak height of 3 x 
baseline noise. This resulted in a detection limit of0.05 mM for 
Table J Approximate absolute limits of detec tion for a 5 ~t l injection 
TMPP (bromide salt) 
MA (derivatised) 
Malathion° 
a 100 pi injection. 
Compound specific 
/nmol 
0.046 
0.25 
/ng 
30 
29 
3 1P specific 
/ng Ref. 
1.4 This work 
7.8 This work 
0 .16 12 
A: ICP-MS 
m/z 31p 
8 : ESI-MS 
TIC 
C: ESI-MS 
m/z 684 
, ...... 
u o • 
Derivatised 
sorbic acid 
.._____A A A 
A: ICP-MS 
m/z 31P 
".::. ... 
Derivatised 
fumaric acid 
j 
, . ~ ... 
-· 
-··· " 
Fig. 3 Chromalograms of derivatised sorbic {len) and fumaric (righ t) acids: A, 3 1P+ selective detection using SF-ICP-MS; B total ion current using 
positive ion ESI-MS; C, selective ion monito ring using positive ESI-MS. 
a 5 111 injection. T his is confirmed by Fig. 2A, where a 0.1 mM 
injection can clearly be seen to be close to the detection limit. 
For comparison, detection limits for TMPP o btained in this 
work, a nd for malathion from previous work on the same 
instrument, arc shown in Table 3. As can be seen, the com-
pound specific detect ion limit for TMPP was approxima tely 
5-6 times lower than that for derivatised MA (in molar terms), 
reflecting the I 0-20% reaction efficiency of the latter. The 31 p + 
specific detection limit for malathion achieved previously12 was 
approximately I 0-times lower than the detection limit for 
TMPP determined in this work. T he probable explanation 
for this is tha t a plasma shield was not used on this occasion, 
which resulted in a 10-fold reduction in sensi tivity, wi th a 
consequent increase in the detection limit. 
Analysis of derivatised carboxylic acids 
The usefulness of the derivatisation reaction was tested for the 
detection of several other carboxylic acids, namely, fumaric, 
sorbic a nd salicylic acids. Detection using both HPLC-SF-ICP-
MS e' p + selective) and LC-ESI-MS (total ion and extracted 
ion ranges) was performed to verify which of the p hosphorus 
containing peaks was due to the deriva tised acids (Fig. 3). 
Derivatised MA was observed at 12.6 min (Fig. 2), sorbic acid 
a t 14.4 min and fumaric acid at 12.0 min (Fig. 3). No peak was 
observed with either Jlp+ selective ICP-MS or ESI-MS detec-
tion for deriva tised salicylic acid. T his is probably due to 
strong internal hydrogen bonding making salicylic acid a poor 
nucleophile, leading to an inefficient reaction with the CMPI 
activating reagent. It sho uld be possible to derivatise a range of 
carboxylic acids using this method, as described by Leavens 
el a/. 10 T hey did not give any indica tion as to the efficiency of 
the reaction or detection limits: however, this has been ad-
dressed by us in ano ther paper. 11 It should be possible to 
improve reaction efficiency by optimising the derivatisation 
chemistry, and utilising a solid phase analytical derivatisation 
approach as described by Pilus e1 a/.lJ 
Conclusions 
HPLC-SF-ICP-MS has been used for the determination of 
maleic, sorbic and fumaric acids a ft er deriva tisation with the 
phosphorus conta ining reagent tris(2,4,6-trimethoxyphenyl)-
phosphonium propylamine. This allowed Jl p + selective detec-
tion to be performed on organic compounds which are 
normally not amenable to detection by ICP-MS at low con-
centrations. The derivatisa tion reaction was partially optimised 
for MA: however, there is scope for further improving the 
reaction efficiency to achieve lower detection limits and a more 
quantitative analysis. Work is currently underway, in our 
laboratory, on the preparation of a multiply brominated 
TMPP reagent, which will allow simultaneous bromine and 
phosphorus selective detection . Multiple bromination should 
improve detection limits and make possible the use of this 
reagent to detremine the degree of phosphorylation of pep-
tides. The scope of application for reagents such as these is 
great, particulalrly in proteomics and genomics where ever 
more selective a nd sensitive methods of analysis are required. 
The application of isotopically tagged reagents is a particular 
focus of our work and is now close to publication. 
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Tris(2,4,6-trimethoxyphenyl)phosphonium propylamine bromide (TMPP) has been used for the 
derivatisation of maleic, fumaric, sorbic and salicylic acids to facilitate determination using liquid 
chromatography/electrospray ionisation tandem mass spectrometry (LOESI-MS/MS) in positive 
ion mode. Detection limits, achieved using multiple reaction monitoring mode, were 2, 4, 0.4 and 
540 fmol (5 f.ll injection) for derivatised fumaric, sorbic, maleic and salicylic acids, respectively. In 
comparison, detection limits achieved in negative ion mode for the underivatised acids were 24, 51, 
2, and 117 fmol, respectively. The method was successfully used for the determination of sorbic acid 
in a sample of Panadol™. The derivatisation of salicylic acid was not as successful, probably due to 
poor reaction efficiency. Copyright © 2005 John Wiley & Sons, Ltd. 
Many pharmaceutical drug substances contain carboxylic 
acids as either a main constituent or as impurities at low 
levels. Mass speclrometry is ideally suited to detection 
due to its high sensitivi ty and selectivity. However, car-
boxylic acids tend to be poorly ionised by ionisation sources 
used in mass spectrometry, and hence the derivatisation of 
carboxylic acids to enhance their detection for dlromato-
graphic analysis has been a subject of some investiga-
tion.1-6 By exploring the na ture and chemical properties 
of a molecu le, a method for modification and subsequent 
analysis can be devised. Published methods for derivatising 
carboxylic acids generally involve the incorporation of 
fluorescent tags7 or of functional groups suitable for electro-
chemical de tection melhods,8 with very little concentration 
on analysis by liquid chromatography/ mass speclrometry 
(LC/MS). 
The choice of derivatisation reagent is an important 
consideration. Ideally, the reagent should be pre-charged to 
remove the dependence on the ionisation source to initiate 
ionisation, and must possess a suitable reactive group to react 
with the functional group of the analyte molecule. TI1e 
derivatisation reagent must also be stable and remain intact 
throughout the reaction process to ensure that maximum 
signal is achieved with the derivatised product. The molar 
•Correspondence to: E. H. Evans, University of Plymouth, 
Speciation and Environmental Analysis Researdl Group, 
School of Earth Ocean and Environmental Sciences, Drake 
Circus, Plymouth PL4 8AA, UK. 
E-mail: hevans@plymouth.ac.uk 
Contract/grant sponsors: EPSRC; GlaxoSmithKline. 
mass and s tructure of the derivatisation reagent are also 
important considerations. Smaller reagents have an advan-
tage in that steric hindrance is not an important factor in the 
reaction process, but larger reagents have the advantage that 
their derivatised products have a high mass and thus will 
enable a signal to be observed in the less noisy region of the 
mass spectrum. In addition, the reaction should be a rapid, 
sin gle-step reaction with a high yield, using inexpensive and 
commercially available (oreas ilysynthesised) reagents. Also, 
the derivatisalion product, when not pre-charged, is often 
less polar than the carboxylic acid, thus increasing the 
retention time on a conventional C18 column and improving 
ionisation in electrospray (ESI) due to generation of a more 
stable spray with more organic solvent present. 
There are some d isadvantages in using a derivatisation 
reaction. The reaction procedure adds extra lime to the 
analysis, with extra materials and glassware needed for the 
reaction. The reaction may also produce other compounds 
within the reaction, including partially derivatised products, 
unwanted side products, and the reaction of the carboxylic 
acid with any impurities present in the derivalising reagent. 
The use of chromatography prior to MS detection can 
overcome some of these problems. 
In this paper tris(2,4,6-trimethoxyphenyl)phosphonium 
propylamine bromide is used as the derivatising reagent. 
This is a large positively charged phosphonium reagent that 
enables detection by ESI-MS in the positive ion mode. The 
synthesis of this reagent is described elsewhere by Leavens 
et al} and we have previously reported on its use as a 
derivatising agent for element-selective detection of organic 
Copyright © 2005 John Wiley & Sons, Ltd. 
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Scheme 1. Activation of carboxylic acids with 2-chloro-1-methylpyridinlum iodide (CM PI) and 
reaction with TMPP propylamine. 
compounds by LC with inductively coupled plasma mass 
speclrometry (ICP-MS). 10 The d erivatisation incorporates a 
coupling reaction with 1-<:hloro-4-methylpyridinium iodide 
and triethylamine to activate the carbonyl group on the 
carboxylic acid prior to nucleophilic attack by the amine 
group on the coupling reagent. The resulting derivatised 
carboxylic acid contains a stable amide bond linking the 
derivatising reagent with the carboxylic acid. 
In this work, detection of underivatised maleic, fumaric, 
salicylic and sorbic acids by LC/ESI-MS/MS, operated in 
negative ion mode, has been compared with detection of the 
TMPP-derivatised carboxylic acids in positive mode. 
EXPERIMENTAL 
Chemicals and reagents 
The carboxylic acids, 2-<:hloro-1-methylpyridinium iodide 
(CMPO, triethylamine (TEA) and formic acid were obtained 
from Sigma-Aldrich (Poole, Dorset, UK). HPLC-grade aceto-
nitrile was obtained from Fisher Scientific UK Ltd. (Lough-
boroug h, Leicestershire, UK). Tris(2,4,6-trimethoxyphenyl) 
p hosphonium propylamine bromide (TMPP) was synthe-
sised a t GlaxoSmithKiine using the procedure detailed by 
Leavens et a/.9 Distilled deionised water (18.2Mn) was 
obtained using an Elga Maxima water-purifying system. 
Coupling of TMPP propylamine with 
carboxylic acids 
A solution of CMPl was prepared by dissolving 37.98 mg of 
CMPI in approximately 20 mL of acetonitrile in a 25 mL volu-
metric flask. Triethylamine (41.4 ~L) was added, and the solu-
tion made up to volume with acetonitrile. To 100 ~L of 100 1-1M 
carboxylic acid in 90:10% (v/v) water/acetonitrile were 
added 100 1-1L of CM PI/TEA coupling reagent (prepared as 
above). After thorough mixing for 5 min at room tempera-
ture, 100 1-1L of a 1 mM TMPP propylamine solution in aceto-
nitrile were added. The solution was left to react for 30 min in 
an ultrasonic bath at room temperature. A schematic of the 
reaction is shown in Scheme 1. 
Preparation of Panadol™ sample and subsequent 
derivatisation with TMPP propylamine 
A commercially available Panadol™ (GlaxoSmithKline) 
tablet was cm shed with a pestle and mortar until a fine pow-
der was obtained . A small amount of this powder (18.1 mg) 
was added to a centrifuge tube along with 1 mL of 90:10% 
(v/v) water/acetonitrile, and centrifuged at 13000 rpm for 
8 min. To 100 ~•L of this supernatant were added 1001-lL of 
CMPI/TEA coupling reagent (prepared as described above). 
After thorough mixing for 5 min at room temperature, 100 ~L 
of a 1 mM TMPP propylarnine solution in acetonitrile were 
Table 1. ESI-MS/MS operating conditions for analysis of unde rivatised acids 
Quadrupole I (m/z) 
Quadrupole 3 (m/z) 
Curtain gas (arbitrary units) 
Collision gas (CAD) (arbitrary unjts) 
lonspray potential (15) (V) 
Temperature (•C) 
Nebuliser gas (GSl) (arbitrary units) 
Auxiliary gas (G52) (arbitrary units) 
Declustering potential (V) 
Collision energy (e V) 
Copyright © 2005 John Wiley & Sons, Ltd. 
Maleic 
115 
71 
10 
6 
-4200 
500 
20 
0 
- 25 
-14 
Fumaric 
115 
71 
10 
6 
-4200 
500 
20 
0 
- 30 
- 12 
Acid 
Salicylic Sorbic 
137 111 
93 67 
10 10 
6 6 
-4200 - 4200 
500 500 
20 20 
0 0 
- 30 - 40 
- 24 - 14 
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Table 2. ESI-MS/MS operating conditions for analysis of derivatised acids 
Quadrupole 1 (m/z) 
Quadrupole 3 (rn/z) 
Curtain gas (arbitrary units) 
Collision gas (CAD) (arbitrary units) 
Ionspray potential ([5) (V) 
Temperature ("C) 
Nebuliser gas (GSl) (arbitrary units) 
Auxiliary gas (GS2) (arbitrary units) 
Declustering potential (V) 
Collision energy (eV) 
Maleic 
688 
590 
10 
4.00 
5500 
650 
20 
0 
95 
55 
added. The solution was left to react for 30 min in an ultraso-
nic bath at room temperature prior to analysis. 
Chromatography 
For the LC/ESI-MS/MS analyses, a HP1100 chromatography 
system (Agilen t Technologies, Stockport, UK) was used. All 
separations were performed using a Phenomenex Luna 
C18(2) reversed-phase column (100 x 4.6 mm, 3 J.lm particle 
size) at 40"C. The mobile phases contained the following: 
(A) water/acetonitrile (90:10% v/v) containing 0.05% (v/v) 
A 
Salicylic 
. 
5" 
~eic 
~ 
!-
.... 
:.< 
.g 
Ul .... 
.... 
B 
Maleic 
nme,min 
Figure 1. Chromatograms for a mix1Ure of carboxylic acids 
(2 J.lmol L _,) with detection by multiple reaction monitoring 
with electrospray mass spectrometry: (A) underivatised 
carboxylic acids and negative ion mode ESI-MS/MS and 
(B) derivatised carboxylic acids and positive ion mode ESI-
MS/MS. 
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Acid 
Fumaric Salicylic Sorbic 
688 710 684 
642 590 181 
10 10 10 
4.00 4.00 4.00 
5500 5500 5500 
650 650 650 
20 20 20 
0 0 0 
95 100 100 
75 50 70 
formic acid and (B) water I acetonitrile (1 0:90% vI v) contain-
ing 0.05% (v/v) formic acid. For negative ion LC/ESI-MS/ 
MS a stepped gradient elution was used: 0-5 min, 100% A; 
5-5.5min, 100-70% A; 5.5-15min 70% A; 15-15.5min, 70-
100% A; 15.5- 20 min 100% A. Similarly, for positive ion 
ESI-MS/MS, an isocratic stepped gradient elution was 
used: 0- 10min, 70% A; 10- 10.1 min, 70-50% A; 10.1-
13 min 50% A; 13-13.1 min, 50-70% A; 13.1-20 min 70% A. 
The flow rate was 1 mLmin- 1 with an analyte injection 
volume of 5 J.!L. These s tep gradients were chosen to enhance 
quantitation using ESI-MS. 
Electrospray mass spectrometry 
For analysis of the underivatised carboxylic acids, negative 
ion mass spectra were acquired, whereas, for derivatised car-
boxylic acids, positive ion mode was used. The mass spectro-
meter was an Applied Biosystems MDS Sciex API 4000 
(Applied Biosystems Ltd., Foster City, CA, USA) triple quad-
rupole equipped with a Turbo-V lonspray ionisation source. 
The detection limits were determined using MRM (multiple 
reaction monitoring) which is the most sensitive technique 
available with a triple-quad rupole instrument. The other 
Table 3. Calculated detection limits obtained for the 
underivatised carboxylic acids obtained using LC/ESI-MS/ 
MS in negative ion mode 
Q1 m/z OJ m/z Detection 
Acid (precursor) (product) limit (fmol) 
Fumaric 115 71 24 
Sorbic 111 67 51 
Maleic 115 71 2 
Salicylic 137 93 117 
Table 4. Calculated detection limits for the derivatised 
carboxylic acids obtained using LC/ESI-MS/MS in positive 
ion mode 
Acid 
Fumaric 
Sorbic 
Maleic 
Salicylic 
Q1 m/z 
(precursor) 
688 
684 
688 
710 
OJ m/z 
(product) 
642 
181 
590 
590 
Detection 
limit (fmol) 
2 
4 
0.4 
540 
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Figure 2. Selected ion chromatograms for PanadoiTM samples, showing the 
presence of sorbate, obtained in (A) negative ion mode without derivatisation and 
(B) positive ion mode after derivalisation with TMPP. 
parameters used are shown in Tables 1 and 2. Data processing 
was performed using Analyst 1.3 software. 
they are commonly found in many pharmaceutical products 
as additives or impurities, and are difficult to determine 
using conventional ESI-MS because they do not form positive 
ions and have low molecular weights. Negative ion ionisation 
is possible but, due to the low molecular weights, there is a Lot 
of chemical noise in the mass spectra, e.g. from common LC 
additives such as acetic acid, formic acid, and especially tri-
fluoroacetic acid (m/z 113 and its proton-bound d immer ion at 
RESULTS AND DISCUSSION 
Derivatisation of carboxylic acids 
The determination of fumaric, sorbic, maleic and salicylic 
acids was investigated. These acids were chosen because 
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mfz 227). In addition, since these organic acids are poorly 
retained on conventional reversed-phase columns that are 
typically used for pharmaceutical analyses, they elute in a 
highly aqueous matrix which is not ideal for ESI (an unstable 
spray if the organic content of the eluent is too low). It would 
be advantageous to be able to determine these compounds 
using the standard approach of reversed-phase LC coupled 
with ESI-MS operated in positive ion mode, to enable eo-
determination of all analytes. 
In order to evaluate any possible benefits of derivatisation 
of the acids with TMPP, the analysis was performed using 
both LC/ESI-MS/MS in negative ion mode w ithout deriva-
tisation and in positive ion mode with derivatisation. 
Chromatograms showing the separation and detection of 
the four acids using both modes of detection are shown in 
Fig. 1. Detection was performed by monitoring the appro-
priate precursor ion in quadrupole 1 and the most abundant 
fragment ion in quadrupole 3 (Tables 1 a nd 2). For the 
underivatised acids, the most abundant fragment ion 
corresponded to the loss of 44 Da (assigned as C~) from 
the [M-Hr precursor ion; for the derivatised acids the most 
efficient fragmentation was variable, so the most abundant 
fragment for each tes t a nalyte was used in the analyses. In 
order to improve the duty cycle all product ions were not 
monitored throughout the entire chromatographic run, but 
instead the mass spectrometer was switched to the most 
appropriate mfz values during elution of each individual 
carboxylic acid; this led to the changes in baseline observed in 
Fig. 1(A). 
A three-point calibration was performed for each of the 
acids, a nd detection limits were calculated based on 3cr of the 
baseline noise. Detection limits for the underivatised and 
derivatised carboxylic acids are given in Tables 3 a nd 4, 
respectively. Detection limits for fumaric, sorbic and maleic 
acid s were approximately one order of magnitude lower in 
positive mode after derivatisation, thereby confirming the 
utility of this method for the enhanced detection of these 
acids. ln contrast, a fivefold increase in the detection limit was 
observed for salicylic acid; this is probably due to s trong 
internal hydrogen bonding that makes salicylic acid a poor 
nucleophile, leading to a n inefficient reaction with the CMPI 
activating reagent. 
Analysis of Panadol™ tablets 
Panadol Extra ™ is the proprietary nam e of an oral analgesic 
medicine manufactured by GlaxoSmithKLine, w hich would 
normally contain paracetamol, caffeine and potassium sor-
bate (used as preservative), together with excipients. Hence, 
the absence of sorbate in any so-called Panadol Extra ™ pro-
duct would indicate that the product was counterfeit. Analy-
sis was performed using LC/ ESI-MS/ MS in both nega tive 
Copyright © 2005 John Wiley & Sons, Ltd. 
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and positive ion mode a fter derivatisation with TMPP propy-
larnine; the resulting chromatograms are shown in Fig. 2. 
Derivatisation of the sorbic acid (Fig. 2(B)) resulted in an 
improvement in chromatographic resolution and signal-to-
noise compared to the underivatised sample (Fig. 2(A)). An 
added advantage of the derivatisation is that the analysis 
can be performed using positive ion mode, so both paraceta-
mol and caffeine can also be determined s imultaneously if 
necessary. Using this method it should be possible to quantify 
the concentration of sorbate in Panadol Extra ™ provided 
that appropriate validation is performed; however, the meth-
od was used in a purely qualitative fashion in this work. 
CONCLUSIONS 
Enhanced detection of maleic, fumaric and sorbic acids has 
been achieved by derivatisation with TMPP and d etection 
using positive ion LC/ESI-MS in multiple reaction mode. 
The method was successfully used for the determination of 
sorbic acid in a sample of Panadol™. The derivatisation of 
salicylic acid was not as successful, probably due to poor 
reaction efficiency. So far, the reagents have only been tested 
under ideal conditions, and work is currently underway to 
derivatise peptides and proteins in samples of biological 
fluids. The use of these reagents in conjunction with comple-
mentary detection by ESl-MSand ICP-MSoffers considerable 
potential in proteomics and genomics whenever more selec-
tive and sensitive methods of analysis are required. 
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